<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">asurgery</journal-id><journal-title-group><journal-title xml:lang="ru">Амбулаторная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Ambulatornaya khirurgiya = Ambulatory Surgery (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8741</issn><issn pub-type="epub">2782-2591</issn><publisher><publisher-name>ООО «ГРУППА РЕМЕДИУМ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/18/1995-1477-2020-3-4-140-206</article-id><article-id custom-type="elpub" pub-id-type="custom">asurgery-217</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОФИЦИАЛЬНЫЙ ДОКУМЕНТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OFFICIAL DOCUMENT</subject></subj-group></article-categories><title-group><article-title>Российские клинические рекомендации по диагностике и лечению C1 клинического класса хронических заболеваний вен (ретикулярный варикоз и телеангиэктазии)</article-title><trans-title-group xml:lang="en"><trans-title>Russian clinical practice guidelines for the management of c1 clinical class of chronic venous disorders (reticular veins and telangiectasias)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3940-0787</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богачев</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogachev</surname><given-names>V. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Богачев Вадим Юрьевич, д.м.н., профессор, кафедра факультетской хирургии №2</p><p>117997, Россия, Москва, ул. Островитянова, д. 1</p><p>117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31</p></bio><bio xml:lang="en"><p>Vadim Yu. Bogachev, Dr. of Sci. (Med.), Professor, Department of Faculty Surgery No.2</p><p>1, Ostrovityanov St., Moscow, 117997, Russia</p><p>31, Dmitry Ulyanov St., Moscow, 117447, Russia</p></bio><email xlink:type="simple">vadim.bogachev63@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5202-6398</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Росуховский</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rosukhovski</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Росуховский Дмитрий Александрович, к.м.н., ведущий научный сотрудник</p><p>197376, Россия, Санкт-Петербург, ул. Академика Павлова, д. 12</p></bio><bio xml:lang="en"><p>Dmitriy A. Rosukhovski, Cand. of Sci. (Med.), Senior Researcher</p><p>12, Akademik Pavlov St., St Petersburg, 197376, Russia</p></bio><email xlink:type="simple">rosukhovski@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1455-9916</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борсук</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Borsuk</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борсук Денис Александрович, к.м.н., главный врач</p><p>454091, Россия, Челябинск, ул. Пушкина, д. 50</p></bio><bio xml:lang="en"><p>Denis A. Borsuk, Cand. of Sci. (Med.), Chief Physician</p><p>50, Pushkin St., Chelyabinsk, 454091, Russia</p></bio><email xlink:type="simple">borsuk-angio@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шонов</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shonov</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шонов Олег Александрович, сосудистый хирург, руководитель направления флебологии</p><p>197110, Россия, Санкт-Петербург, ул. Корпусная, д. 3</p></bio><bio xml:lang="en"><p>Oleg A. Shonov, Vascular Surgeon, Head of Phlebology Department</p><p>3, Korpusnaya St., St Petersburg, 197110, Russia</p></bio><email xlink:type="simple">shonov.o@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7281-7939</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манджикян</surname><given-names>О. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Manjikian</surname><given-names>H. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Манджикян Овсеп Петросович, сердечно-сосудистый хирург, руководитель флебологической службы</p><p>129327, Россия, Москва, ул. Ленская, д. 15, стр. 2</p></bio><bio xml:lang="en"><p>Hovsep P. Manjikian, Cardio-Vascular Surgeon, Head of Vein Center</p><p>15, Bldg. 2, Lenskaya St., Moscow, 129327, Russia</p></bio><email xlink:type="simple">manjikyan@gmail.com</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5358-7218</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобастов</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobastov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лобастов Кирилл Викторович, к.м.н., доцент кафедры общей хирургии и лучевой диагностики лечебного факультета</p><p>117997, Россия, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Kirill V. Lobastov, Cand. of Sci. (Med.), Associate Professor of the Department of General Surgery and X-Ray Diagnostics of the Faculty of Medicine</p><p>1, Ostrovityanov St., Moscow, 117997, Russia</p></bio><email xlink:type="simple">lobastov_kv@mail.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1817-9937</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурлева</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Burleva</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бурлева Елена Павловна, д.м.н., профессор кафедры хирургии, эндоскопии и колопроктологии, сердечно-сосудистый хирург</p><p>620028, Россия, Екатеринбург, ул. Репина, д. 3</p></bio><bio xml:lang="en"><p>Elena P. Burleva, Dr. of Sci. (Med.), Professor at the Department of Surgery, Endoscopy and Coloproctology, Cardiovascular Surgeon</p><p>3, Repin St., Ekaterinburg, 620028, Russia</p></bio><email xlink:type="simple">e.p.burleva@gmail.com</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3742-8954</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беленцов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Belentsov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беленцов Сергей Михайлович, д.м.н., профессор, сердечно-сосудистый хирург</p><p>620063, Россия, Екатеринбург, ул. Большакова, д. 95</p></bio><bio xml:lang="en"><p>Sergey M. Belentsov, Dr. of Sci. (Med.), Professor, Vascular Surgeon</p><p>95, Bolshakov St., Ekaterinburg, 620063, Russia</p></bio><email xlink:type="simple">belentsov@list.ru</email><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3610-8382</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сапелкин</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sapelkin</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сапелкин Сергей Викторович, д.м.н., ведущий научный сотрудник, отделение сосудистой хирургии</p><p>117997, Россия, Москва, ул. Большая Серпуховская, д. 27</p></bio><bio xml:lang="en"><p>Sergey V. Sapelkin, Dr. of Sci. (Med.), Leading Researcher, Vascular Department</p><p>27, Bolshaya Serpukhovskaya St., Moscow, 117997, Russia</p></bio><email xlink:type="simple">ssapelkin@yandex.ru</email><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5411-6437</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фокин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fokin</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фокин Алексей Анатольевич, д.м.н., профессор, заведующий кафедрой хирургии факультета послевузовского и дополнительного профессионального образования</p><p>454092, Россия, Челябинск, ул. Воровского, д. 64</p></bio><bio xml:lang="en"><p>Alexey A. Fokin, Dr. of Sci. (Med.), Professor, Head of the Department of Surgery of the Faculty of Postgraduate and Additional Professional Education</p><p>64, Vorovsky St., Chelyabinsk, 454092, Russia</p></bio><email xlink:type="simple">alanfokin@yandex.ru</email><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0429-3117</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дворников</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Dvornikov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дворников Антон Сергеевич, д.м.н., заведующий кафедрой дерматовенерологии лечебного факультета, декан лечебного факультета</p><p>117997, Россия, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Anton S. Dvornikov, Dr. of Sci. (Med.), Head of the Department of Dermatology and Venereology, Dean of School of Medicine</p><p>1, Ostrovityanov St., Moscow, 117997, Russia</p></bio><email xlink:type="simple">dvornikov_as@rsmu.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9478-8414</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прядко</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pryadko</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Прядко Сергей Иванович, к.м.н., заведующий отделением</p><p>121552, Россия, Москва, Рублевское шоссе, д. 135</p></bio><bio xml:lang="en"><p>Sergey I. Pryadko, Cand. of Sci. (Med.), Head of the Department</p><p>135, Rublevskoe Shosse, Moscow, 121552, Russia</p></bio><email xlink:type="simple">sipryadko@bakulev.ru</email><xref ref-type="aff" rid="aff-11"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гужков</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Guzhkov</surname><given-names>O. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гужков Олег Николаевич, д.м.н., профессор, заведующий отделением</p><p>150042, Россия, Ярославль, Тутаевское шоссе, д. 31</p></bio><bio xml:lang="en"><p>Oleg N. Guzhkov, Dr. of Sci. (Med.), Professor, Head of Department</p><p>31, Tutaevskoe Shosse, Yaroslavl, 150042, Russia</p></bio><email xlink:type="simple">flebolog@yandex.ru</email><xref ref-type="aff" rid="aff-12"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7160-3333</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бредихин</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bredikhin</surname><given-names>R. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бредихин Роман Александрович, д.м.н., заведующий отделением сосудистой хирургии</p><p>420101, Россия, Республика Татарстан, Казань, ул. Карбышева, д. 12а</p></bio><bio xml:lang="en"><p>Roman A. Bredikhin, Dr. of Sci. (Med.), Head of the Department of Vascular Surgery</p><p>12a, Karbyshev St., Kazan, Republic of Tatarstan, 420101, Russia</p></bio><email xlink:type="simple">rbredikhin@mail.ru</email><xref ref-type="aff" rid="aff-13"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баринов</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Barinov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баринов Виктор Евгеньевич, д.м.н., заведующий 2 хирургическим отделением; профессор кафедры хирургии с курсом эндоскопии</p><p>121352, Россия, Москва, ул. Староволынская, д. 10</p><p>121359, Россия, Москва, ул. Маршала Тимошенко, д. 19, стр. 1а</p></bio><bio xml:lang="en"><p>Victor E. Barinov, Dr. of Sci. (Med.), Head of the 2nd Department of Surgery; Professor of the Department of Surgery and Endoscopy</p><p>10, Starovolinskaya St., Moscow, 121352, Russia</p><p>19, Bldg. 1а, Marshal Timoshenko St., Moscow, 121359, Russia</p></bio><email xlink:type="simple">vicbarin@mail.ru</email><xref ref-type="aff" rid="aff-14"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сорока</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Soroka</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сорока Владимир Васильевич, д.м.н., профессор, руководитель отдела неотложной сердечно-сосудистой хирургии</p><p>192242, Россия, Санкт-Петербург, Будапештская ул., д. 3а</p></bio><bio xml:lang="en"><p>Vladimir V. Soroka, Dr. of Sci. (Med.), Professor, Head of the Department of Emergency Cardio-Vascular Surgery</p><p>Budapeshtskaya St., 3а, St Petersburg, 192242, Russia</p></bio><email xlink:type="simple">soroka@emergency.spb.ru</email><xref ref-type="aff" rid="aff-15"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ларин</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Larin</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ларин Сергей Иванович, д.м.н., профессор, главный врач; генеральный директор</p><p>400119, Россия, Волгоград, ул. Авиаторская, д. 1б</p><p>3580011, Россия, Республика Калмыкия, Элиста, ул. Рокчинского, д. 3б</p></bio><bio xml:lang="en"><p>Sergey I. Larin, Dr. of Sci. (Med.), Professor, Chief Physician; CEO</p><p>1b, Aviatorskaya St. Volgograd, 400119, Russia</p><p>3b, Rokchinsky St., Elista, Kalmykia, 358011, Russia</p></bio><email xlink:type="simple">larinclinic@gmail.com</email><xref ref-type="aff" rid="aff-16"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бережной</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Berezhnoi</surname><given-names>E. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бережной Евгений Юрьевич, к.м.н., хирург-флеболог</p><p>350051, Россия, Краснодар, ул. Репина, д. 1/2, корп. 3</p></bio><bio xml:lang="en"><p>Evgenii Y. Berezhnoi, Cand. of Sci. (Med.), Surgeon/Phlebologist</p><p>1/2, Apt. 3, Repin St., Krasnodar, 350051, Russia</p></bio><email xlink:type="simple">eberezhnoy@mail.ru</email><xref ref-type="aff" rid="aff-17"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8816-2183</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенов Артем Юрьевич, к.м.н., хирург, флеболог, врач УЗИ, руководитель центра</p><p>115407, Россия, Москва, ул. Якорная, д. 7, стр. 1</p></bio><bio xml:lang="en"><p>Artem Yu. Semenov, Cand. of Sci. (Med.), Surgeon, Phlebologist, Ultrasound Doctor, Head</p><p>7, Bldg. 1, Yakornaya St., Moscow, 115407, Russia</p></bio><email xlink:type="simple">phlebologsemenov@gmail.com</email><xref ref-type="aff" rid="aff-18"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8295-9458</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Раскин</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Raskin</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Раскин Владимир Вячеславович, к.м.н., сосудистый хирург, флеболог, врач УЗИ, ведущий сотрудник</p><p>115407, Россия, Москва, ул. Якорная, д. 7, стр. 1</p></bio><bio xml:lang="en"><p>Vladimir V. Raskin, Cand. of Sci. (Med.), Vascular Surgeon, Phlebologist, Ultrasound Specialist, Senior Research Associate</p><p>7, Bldg. 1, Yakornaya St., Moscow, 115407, Russia</p></bio><email xlink:type="simple">vr25000@gmail.com</email><xref ref-type="aff" rid="aff-19"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Альбицкий</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Albitskii</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Альбицкий Александр Владимирович, к.м.н., руководитель центра эндовазальной лазерной флебологии</p><p>109147, Россия, Москва, ул. Таганская, д. 36, корп. 2</p></bio><bio xml:lang="en"><p>Aleksandr V. Albitskii, Cand. of Sci. (Med.), Head of Endovenous laser Phlebology</p><p>36, Bldg. 2, Taganskaya St., Moscow, 109147, Russia</p></bio><email xlink:type="simple">Swordfish57@yahoo.com</email><xref ref-type="aff" rid="aff-20"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аркадан</surname><given-names>Н. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Arkadan</surname><given-names>N. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аркадан Наталья Руслановна, главный врач</p><p>117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31</p></bio><bio xml:lang="en"><p>Natalia R. Arkadan, Chief Physician</p><p>31, Dmitry Ulyanov St., Moscow, 117447, Russia</p></bio><email xlink:type="simple">phlebo1@yandex.ru</email><xref ref-type="aff" rid="aff-21"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белянина</surname><given-names>Е. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyanina</surname><given-names>E. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белянина Елена Олеговна, к.м.н., врач-косметолог</p><p>111250, Россия, Москва, ул. Лефортовский Вал, д. 5, стр. 7</p></bio><bio xml:lang="en"><p>Elena O. Belyanina, Cand. of Sci. (Med.), Cosmetologist</p><p>5, Bldg. 7, Lefortovsky Val St., Moscow, 111250</p></bio><email xlink:type="simple">laserSurgeon2014@gmail.com</email><xref ref-type="aff" rid="aff-22"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4488-9123</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдин</surname><given-names>Б. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldin</surname><given-names>B. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болдин Борис Валентинович, д.м.н., профессор, заведующий кафедрой факультетской хирургии № 2</p><p>117997, Россия, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Boris V. Boldin, Dr. of Sci. (Med.), Professor, Head of the Department of Faculty Surgery No.2,</p><p>1, Ostrovityanov St., Moscow, 117997, Russia</p></bio><email xlink:type="simple">facultysurgery@gmail.com</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глаголева</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Glagoleva</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глаголева Екатерина Николаевна, президент Ассоциации регенеративной эстетической медицины, главный врач; научный сотрудник экспериментальной лаборатории лазерных технологий</p><p>191014, Россия, Санкт-Петербург, ул. Парадная, д. 3, корп. 2, стр. 282н</p><p>197022, Россия, Санкт-Петербург, ул. Льва Толстого, д. 6–8</p></bio><bio xml:lang="en"><p>Ekaterina N. Glagoleva, President of the Association of Regenerative Aesthetic Medicine, Medical Director; Researcher of the Experimental Laboratory of laser Technologies</p><p>3, Bldg. 2, p. 282-н, Paradnaya St., St Petersburg, 191014, Russia</p><p>6–8, Lev Tolstoy St., St Petersburg, 197022, Russia</p></bio><email xlink:type="simple">lekate@yandex.ru</email><xref ref-type="aff" rid="aff-23"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Денисов</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Denisov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денисов Владимир Евгеньевич, к.м.н., флеболог</p><p>614000, Россия, Пермь, Тополевый пер., д. 6</p></bio><bio xml:lang="en"><p>Vladimir E. Denisov, Cand. of Sci. (Med.), Phlebologist</p><p>6, Topolevy Lane, Perm, 614000, Russia</p></bio><email xlink:type="simple">wed1965@mail.ru</email><xref ref-type="aff" rid="aff-24"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3811-5156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дженина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dzenin</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дженина Ольга Вадимовна, к.м.н., врач-хирург, сосудистый хирург</p><p>117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31</p></bio><bio xml:lang="en"><p>Olga V. Dzenina, Cand. of Sci. (Med.), Surgeon, Vascular Surgeon</p><p>31, Dmitry Ulyanov St., Moscow, 117447, Russia</p></bio><email xlink:type="simple">helgelman@mail.ru</email><xref ref-type="aff" rid="aff-21"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Доронин</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Doronin</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доронин Игорь Владимирович, к.м.н., заведующий отделением хирургии</p><p>111024, Россия, Москва, 2-я Кабельная ул., д. 2, стр. 25</p></bio><bio xml:lang="en"><p>Igor V. Doronin, Cand. of Sci. (Med.), Head of the Department of Surgery</p><p>2, Bldg. 25, 2nd Cabelnaya St., Moscow, 111024, Russia</p></bio><email xlink:type="simple">ronin-st@yandex.ru</email><xref ref-type="aff" rid="aff-25"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5516-0744</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванов Олег Олегович, к.м.н., главный врач, хирург</p><p>54041, Россия, Новокузнецк, проспект Дружбы, д. 3, пом. 181</p></bio><bio xml:lang="en"><p>Oleg O. Ivanov, Cand. of Sci. (Med.), Chief Physician, Surgeon</p><p>3, office 181, Druzhby Ave., Novokuznetsk, 654041, Russia</p></bio><email xlink:type="simple">flebolog42@mail.ru</email><xref ref-type="aff" rid="aff-26"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8411-8609</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Капериз</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaperiz</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Капериз Константин Александрович, сосудистый хирург, узи -специалист, флеболог, хирург</p><p>101000, Россия, Москва, Петроверигский пер., д. 10</p></bio><bio xml:lang="en"><p>Konstantin A. Kaperiz, Vascular Surgeon, Ultrasound Specialist, Phlebologist, Surgeon</p><p>10, Petroverigskiy Lane, Moscow, 101990, Russia</p></bio><email xlink:type="simple">konstantin.kaperiz@gmail.com</email><xref ref-type="aff" rid="aff-27"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карев</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Karev</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Карев Максим Анатольевич, хирург-флеболог, главный врач клиники</p><p>143002, Россия, Одинцово, Можайское шоссе, д. 55;</p></bio><bio xml:lang="en"><p>Maksim A. Karev, Surgeon-Phlebologist, Chief Physician of Clinic</p><p>55, Mozhaiskoe Shosse, Odinсovo, 143002, Russia</p></bio><email xlink:type="simple">mkarev1975@gmail.com</email><xref ref-type="aff" rid="aff-28"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крылов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Krylov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крылов Александр Владимирович, заведующий отделением дерматологии; дерматолог, научный сотрудник экспериментальной лаборатории лазерных технологий</p><p>196084, Россия, Санкт-Петербург, Московский проспект, д. 109а</p><p>197022, Россия, Санкт-Петербург, ул. Льва Толстого, д. 6–8</p></bio><bio xml:lang="en"><p>Aleksandr V. Krylov, Head of Dermatology Department; Dermatologist, Researcher of the Experimental Laboratory of laser Technologies</p><p>109a, Moskovsky Ave., St Petersburg, 196084, Russia</p><p>6–8, Lev Tolstoy St., St Petersburg, 197022, Russia</p></bio><email xlink:type="simple">krylspb@mail.ru</email><xref ref-type="aff" rid="aff-29"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0328-0223</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крылов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Krylov</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крылов Алексей Юрьевич, д.м.н., профессор</p><p>119435, Россия, Москва, ул. Большая Пироговская, д. 2, стр. 4</p></bio><bio xml:lang="en"><p>Alexey Yu. Krylov, Dr. of Sci. (Med.), Professor</p><p>2, Bldg. 4, Bolshaya Pirogovskaya St., Moscow, 119435, Russia</p></bio><email xlink:type="simple">Doctoriwng@mail.ru</email><xref ref-type="aff" rid="aff-30"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Летуновский</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Letunovsky</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Летуновский Евгений Анатольевич, к.м.н., сосудистый хирург, руководитель клиники</p><p>123458, Россия, Москва, ул. Таллинская, д. 13, корп. 1</p></bio><bio xml:lang="en"><p>Evgeny A. Letunovsky, Cand. of Sci. (Med.), Vascular Surgeon, Head of the Clinic</p><p>13, Bldg. 1, Tallisnkaya St., Moscow, 123458, Russia</p></bio><email xlink:type="simple">flebolog@bk.ru</email><xref ref-type="aff" rid="aff-31"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобанов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobanov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лобанов Виктор Николаевич, врач-хирург, сосудистый хирург, генеральный директор</p><p>117447, Россия, Москва, ул. Дмитрия Ульянова, д. 31</p></bio><bio xml:lang="en"><p>Victor N. Lobanov, Surgeon, Vascular Surgeon, CEO</p><p>31, Dmitry Ulyanov St., Moscow, 117447, Russia</p></bio><email xlink:type="simple">phlebo1@yandex.ru</email><xref ref-type="aff" rid="aff-21"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартынов</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Martynov</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мартынов Вадим Станиславович, главный врач</p><p>690106, Россия, Владивосток, Океанский проспект, д. 54</p></bio><bio xml:lang="en"><p>Vadim S. Martynov, Chief Physician</p><p>54, Okeansky Ave., Vladivostok, 690106, Russia</p></bio><email xlink:type="simple">martynovvadim@inbox.ru</email><xref ref-type="aff" rid="aff-32"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Моренко</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Morenko</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Моренко Дмитрий Николаевич, флеболог</p><p>236006, Россия, Калининград, ул. Больничная, д. 13–15</p></bio><bio xml:lang="en"><p>Dmitry N. Morenko, Phlebologist</p><p>13–15, Bolnichnaya St., Kaliningrad, 236006, Russia</p></bio><email xlink:type="simple">dr.morenko@gmail.com</email><xref ref-type="aff" rid="aff-33"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пироженко</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pirozhenko</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пироженко Пётр Александрович, к.м.н., флеболог</p><p>353925, Россия, Новороссийск, ул. Пионерская д. 4</p></bio><bio xml:lang="en"><p>Petr A. Pirozhenko, Cand. of Sci. (Med.), Phlebologist</p><p>4, Pionerskaya St., Novorossiysk, 353935, Russia</p></bio><email xlink:type="simple">phdrpit@yandex.ru</email><xref ref-type="aff" rid="aff-34"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савинова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Savinova</surname><given-names>Y. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савинова Юлия Валериевна, врач-косметолог, директор</p><p>295033, Россия, Республика Крым, Симферополь, ул. Косухина, д. 16</p></bio><bio xml:lang="en"><p>Yulia V. Savinova, Cosmetologist, Director</p><p>16, Kosukhina St., Simferopol, Republic of Crimea, 295033, Russia</p></bio><email xlink:type="simple">Doctor_savinov@mail.ru</email><xref ref-type="aff" rid="aff-35"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суворов</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Suvorov</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Суворов Константин Сергеевич, сердечно-сосудистый хирург высшей категории, флеболог</p><p>119146, Россия, Москва, 2-я Фрунзенская ул., д. 4</p></bio><bio xml:lang="en"><p>Konstantin S. Suvorov, Cardiovascular Surgeon, Phlebologist</p><p>4, 2nd Frunzenskaya St., Moscow, 119146, Russia</p></bio><email xlink:type="simple">dr.suvorov@gmail.com</email><xref ref-type="aff" rid="aff-36"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терехов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Terekhov</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терехов Алексей Михайлович, сердечно-сосудистый хирург</p><p>410005, Россия, Саратов, ул. Степана Разина, д. 77</p></bio><bio xml:lang="en"><p>Aleksey M. Terekhov, Cardio-Vascular Surgeon</p><p>77, Stepan Razin St., Saratov, 410005, Russia</p></bio><email xlink:type="simple">tereho@mail.ru</email><xref ref-type="aff" rid="aff-37"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6262-4770</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Туркин</surname><given-names>П. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Turkin</surname><given-names>P. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Туркин Павел Юрьевич, к.м.н., доцент, кафедра факультетской хирургии №2</p><p>117997, Россия, Москва, ул. Островитянова, д. 1</p></bio><bio xml:lang="en"><p>Pavel Yu. Turkin, Cand. of Sci. (Med.), Associate Professor, Department of Faculty Surgery No.2</p><p>1, Ostrovityanov St., Moscow, 117997, Russia</p></bio><email xlink:type="simple">pavelturkin@gmail.com</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хафизов</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Khafizov</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хафизов Азат Рафитович, к.м.н., руководитель клиники</p><p>450005, Россия, Уфа, ул. Пархоменко, д. 96/98</p></bio><bio xml:lang="en"><p>Azat R. Khafizov, Cand. of Sci. (Med.), Chief Physician</p><p>96/98, Parkhomenko St., Ufa, 450005, Russia</p></bio><email xlink:type="simple">azatKhafizovR@yandex.ru</email><xref ref-type="aff" rid="aff-38"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чаббаров</surname><given-names>Р. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chabbarov</surname><given-names>R. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чаббаров Рустям Гиняятуллаевич, к.м.н., сосудистый хирург, пластический хирург, главный врач</p><p>410031, Россия, Саратов, ул. Комсомольская, д. 46</p></bio><bio xml:lang="en"><p>Rustyam G. Chabbarov, Cand. of Sci. (Med.), Vascular Surgeon, plastic Surgeon, Chief Physician</p><p>46, Komsomolskaya St., Saratov, 410031, Russia</p></bio><email xlink:type="simple">mail@omegaclinic.ru</email><xref ref-type="aff" rid="aff-39"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шарипов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sharipov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шарипов Асхат Сагынович, к.м.н., исполнительный вице-президент Казахского общества флебологии, руководитель</p><p>050026, Казахстан, Алматы, ул. Карасай батыра, д. 152, 4 этаж</p></bio><bio xml:lang="en"><p>Askhat S. Sharipov, Cand. of Sci. (Med.), Executive Vice-President of Kazakh Society of Phlebology, Head of the Center</p><p>152, 4th floor, Karasai Batyr St., Almaty, 050026, Kazakhstan</p></bio><email xlink:type="simple">phlebomedkz@mail.ru</email><xref ref-type="aff" rid="aff-40"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корниевич</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kornievich</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Корниевич Сергей Николаевич, к.м.н., вице-президент Балтийского общества флебологов, сосудистый хирург высшей категории, заведующий отделением хирургии сосудов</p><p>Республика Беларусь, Минская область, а/г Лесной, д. 1</p></bio><bio xml:lang="en"><p>Sergei N. Kornievich, Cand. of Sci. (Med.), Vice President of the Baltic Society of Phlebology, Vascular Surgeon, Head of the Department of Vascular Surgery</p><p>1, a/g Lesnoi, Minsk Region, Republic of Belarus</p></bio><email xlink:type="simple">kornievich@Doctor.com</email><xref ref-type="aff" rid="aff-41"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зокирхонов</surname><given-names>Ш. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Zokirkhonov</surname><given-names>S. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зокирхонов Шохзод Дилшодович, к.м.н., заместитель председателя Ассоциации флебологов Узбекистана, сосудистый хирург, флеболог, главный врач</p><p>100084, Узбекистан, Ташкент, ул. Чингиза Айтматова, д. 38</p></bio><bio xml:lang="en"><p>Shokhzod D. Zokirkhonov, Cand. of Sci. (Med.), Deputy Chairman of the Association of Phlebologists of Uzbekistan, Vascular Surgeon, Phlebologist, Chief Physician</p><p>38, Chingiz Aytmatov St., Tashkent, 100084, Uzbekistan</p></bio><email xlink:type="simple">angio.shahzod@gmail.com</email><xref ref-type="aff" rid="aff-42"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7260-4968</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шайдаков</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shaydakov</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шайдаков Евгений Владимирович, д.м.н., профессор, председатель Совета СРО Ассоциации «Национальная коллегия флебологов», президент Санкт-Петербургской Ассоциации флебологов, профессор кафедры госпитальной хирургии; ведущий научный сотрудник</p><p>185910, Россия, Республика Карелия, Петрозаводск, проспект Ленина, д. 33</p><p>197758, Россия, Санкт-Петербург, пос. Песочный, ул. Ленинградская, д. 68</p></bio><bio xml:lang="en"><p>Evgeniy V. Shaydakov, Dr. of Sci. (Med.), Professor, Chairman of the National college of phlebology (Russia), President of St Petersburg Society of Phlebology, Professor of the Department of Surgery; Leading Researcher</p><p>33, Lenin Ave., Republic of Karelia, Petrozavodsk, 185910, Russia</p><p>68, Leningradskaya St., Pesochnyy Settlement, St Petersburg, 197758, Russia</p></bio><email xlink:type="simple">evgenyshaydakov@gmail.com</email><xref ref-type="aff" rid="aff-43"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет имени Н.И. Пирогова; Первый флебологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University; First Phlebological Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт экспериментальной медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Experimental Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Клиника флебологии и лазерной хирургии «Васкулаб»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic of Phlebology and laser Surgery “Vasculab”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Клиника лазерной косметологии “Delete”</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Laser Center “Delete”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Городская клиническая больница им. А.К. Ерамишанцева Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>tate Clinical Hospital named after A.K. Eramishantseva of the Department of Health of Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет имени Н.И. Пирогова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Уральский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>Медицинский центр «Ангио Лайн»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center ”Angio Line”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр хирургии им. А.В. Вишневского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Vishnevsky National Medical Research Center of Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-10"><aff xml:lang="ru"><institution>Южно-Уральский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-11"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Bakulev National Medical Research Center of Cardiovascular Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-12"><aff xml:lang="ru"><institution>Клиническая больница №9</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Hospital No. 9</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-13"><aff xml:lang="ru"><institution>Межрегиональный клинико-диагностический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Interregional Clinical Diagnostic Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-14"><aff xml:lang="ru"><institution>Клиническая больница №1 (Волынская); Центральная государственная медицинская академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Hospital No. 1 (Volynskaya); Central State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-15"><aff xml:lang="ru"><institution>Санкт-Петербургский научно-исследовательский институт скорой помощи имени И.И. Джанелидзе</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg Research Institute of Emergency Medicine n.a. I.I. Dzhanelidze</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-16"><aff xml:lang="ru"><institution>Волгоградский флебологический центр профессора Ларина С.И.; Республиканский центр флебологии и проктологии проф. С.И. Ларина</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Larin Volgograd Phlebo Center; Larin Kalmykia Center of Phlebology and Proctology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-17"><aff xml:lang="ru"><institution>Клиника «Флебоарт»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>“Fleboart” clinic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-18"><aff xml:lang="ru"><institution>Медицинский инновационный флебологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Innovation Phlebology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-19"><aff xml:lang="ru"><institution>Медицинский Инновационный флебологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Innovation Phlebology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-20"><aff xml:lang="ru"><institution>Клиника «Медалье»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic “Medalie”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-21"><aff xml:lang="ru"><institution>Первый флебологический центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>First Phlebological Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-22"><aff xml:lang="ru"><institution>«Фрау Клиник»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Frau Clinic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-23"><aff xml:lang="ru"><institution>Клиника эстетической медицины «ComeMode Medical»; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Aesthetic clinic “ComeMode Medical”; Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-24"><aff xml:lang="ru"><institution>Медицинский центр «Флеболог»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center “Phlebolog”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-25"><aff xml:lang="ru"><institution>Скандинавский Центр Здоровья</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scandinavian Health Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-26"><aff xml:lang="ru"><institution>Клиника флебологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic of Phlebology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-27"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр профилактической медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-28"><aff xml:lang="ru"><institution>Международный медицинский центр «Медикал Он Груп – Одинцово»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>International Medical Center Меdical On Group – Odincovo</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-29"><aff xml:lang="ru"><institution>Медицинский центр «Клиника Аллергомед»; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center “Clinic Allergomed”; Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-30"><aff xml:lang="ru"><institution>Сеченовский Университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-31"><aff xml:lang="ru"><institution>Центр лазерной хирургии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center for laser Surgery</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-32"><aff xml:lang="ru"><institution>Центр флебологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Phlebology Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-33"><aff xml:lang="ru"><institution>Медицинский центр «Надежда»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Center “Nadejda”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-34"><aff xml:lang="ru"><institution>Клиника лечения варикоза «Флебоцентр»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic for the Treatment of Varicose Veins “PhleboCenter”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-35"><aff xml:lang="ru"><institution>Центр флебологии доктора Савинова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Center of Phlebology of Dr. Savinov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-36"><aff xml:lang="ru"><institution>Поликлиника №2 Управления делами Президента РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Polyclinic №2 of the Presidential Administration of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-37"><aff xml:lang="ru"><institution>Медицинская клиника «СОВА»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical clinic “SOVA”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-38"><aff xml:lang="ru"><institution>Клиника современной флебологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinic of Modern Phlebology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-39"><aff xml:lang="ru"><institution>Клиника «Омега»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omega Clinic</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-40"><aff xml:lang="ru"><institution>Флебологический центр «Флебомед»</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>Phlebology Centre “Phlebomed”</institution><country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-41"><aff xml:lang="ru"><institution>Минская областная клиническая больница</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Minsk Regional Clinical Hospital</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-42"><aff xml:lang="ru"><institution>Клиника современной флебологии “Phlebolife”</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Clinic of Contemporary Phlebology “Phlebolife”</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-43"><aff xml:lang="ru"><institution>Петрозаводский государственный университет; Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Petrozavodsk State University; Petrov National Medical Cancer Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>16</day><month>01</month><year>2021</year></pub-date><volume>0</volume><issue>3-4</issue><fpage>140</fpage><lpage>206</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Богачев В.Ю., Росуховский Д.А., Борсук Д.А., Шонов О.А., Манджикян О.П., Лобастов К.В., Бурлева Е.П., Беленцов С.М., Сапелкин С.В., Фокин А.А., Дворников А.С., Прядко С.И., Гужков О.Н., Бредихин Р.А., Баринов В.Е., Сорока В.В., Ларин С.И., Бережной Е.Ю., Семенов А.Ю., Раскин В.В., Альбицкий А.В., Аркадан Н.Р., Белянина Е.О., Болдин Б.В., Глаголева Е.Н., Денисов В.Е., Дженина О.В., Доронин И.В., Иванов О.О., Капериз К.А., Карев М.А., Крылов А.В., Крылов А.Ю., Летуновский Е.А., Лобанов В.Н., Мартынов В.С., Моренко Д.Н., Пироженко П.А., Савинова Ю.В., Суворов К.С., Терехов А.М., Туркин П.Ю., Хафизов А.Р., Чаббаров Р.Г., Шарипов А.С., Корниевич С.Н., Зокирхонов Ш.Д., Шайдаков Е.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Богачев В.Ю., Росуховский Д.А., Борсук Д.А., Шонов О.А., Манджикян О.П., Лобастов К.В., Бурлева Е.П., Беленцов С.М., Сапелкин С.В., Фокин А.А., Дворников А.С., Прядко С.И., Гужков О.Н., Бредихин Р.А., Баринов В.Е., Сорока В.В., Ларин С.И., Бережной Е.Ю., Семенов А.Ю., Раскин В.В., Альбицкий А.В., Аркадан Н.Р., Белянина Е.О., Болдин Б.В., Глаголева Е.Н., Денисов В.Е., Дженина О.В., Доронин И.В., Иванов О.О., Капериз К.А., Карев М.А., Крылов А.В., Крылов А.Ю., Летуновский Е.А., Лобанов В.Н., Мартынов В.С., Моренко Д.Н., Пироженко П.А., Савинова Ю.В., Суворов К.С., Терехов А.М., Туркин П.Ю., Хафизов А.Р., Чаббаров Р.Г., Шарипов А.С., Корниевич С.Н., Зокирхонов Ш.Д., Шайдаков Е.В.</copyright-holder><copyright-holder xml:lang="en">Bogachev V.Y., Rosukhovski D.A., Borsuk D.A., Shonov O.A., Manjikian H.P., Lobastov K.V., Burleva E.P., Belentsov S.M., Sapelkin S.V., Fokin A.A., Dvornikov A.S., Pryadko S.I., Guzhkov O.N., Bredikhin R.A., Barinov V.E., Soroka V.V., Larin S.I., Berezhnoi E.Y., Semenov A.Y., Raskin V.V., Albitskii A.V., Arkadan N.R., Belyanina E.O., Boldin B.V., Glagoleva E.N., Denisov V.E., Dzenin O.V., Doronin I.V., Ivanov O.O., Kaperiz K.A., Karev M.A., Krylov A.V., Krylov A.Y., Letunovsky E.A., Lobanov V.N., Martynov V.S., Morenko D.N., Pirozhenko P.A., Savinova Y.V., Suvorov K.S., Terekhov A.M., Turkin P.Y., Khafizov A.R., Chabbarov R.G., Sharipov A.S., Kornievich S.N., Zokirkhonov S.D., Shaydakov E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.a-surgeon.ru/jour/article/view/217">https://www.a-surgeon.ru/jour/article/view/217</self-uri><abstract><p>Накопившиеся научные данные по диагностике и лечению С1-клинического класса хронических заболеваний вен, широкая распространенность и недопустимо высокая вариабельность врачебной практики в отношении указанной категории пациентов, а также отсутствие каких-либо регламентирующих документов на этот счет, послужили причиной разработки Саморегулируемой организацией Ассоциацией «Национальная коллегия флебологов» клинических рекомендаций по лечению пациентов с ретикулярным варикозом и ТАЭ нижних конечностей, а также с расширением вен различных частей тела. Целью написанного de novo документа стала систематизация существующей сегодня доказательной базы и разработка минимальных стандартов помощи при рассматриваемой патологии.</p></abstract><trans-abstract xml:lang="en"><p>Recently collated scientific data on the management of C1 clinical class of chronic venous disorders; wide prevalence of the disease and high variability amongst medical practitioners in relation to managing this category of patients and absence of any regulatory documents has prompted the development of clinical guidelines for the treatment of patients with reticular varicose veins and telangiectasias of the lower extremities and various parts of the body. These guidelines have been developed by a self-regulated organization Association “The National College of Phlebology”. The purpose of the de novo guidelines is to systematize the existing evidence and offer minimal standards of care for chronic venous disorders in C1 patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>клинические рекомендации</kwd><kwd>телеангиэктазии</kwd><kwd>ретикулярный варикоз</kwd><kwd>склеротерапия</kwd><kwd>чрескожная лазерная коагуляция</kwd><kwd>хронические заболевания вен</kwd></kwd-group><kwd-group xml:lang="en"><kwd>clinical practice guidelines</kwd><kwd>telangiectasias</kwd><kwd>reticular veins</kwd><kwd>sclerotherapy</kwd><kwd>percutaneous laser ablation</kwd><kwd>chronic venous disorders</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю. Склеротерапия. Шаг за шагом. Телангиэктазии. Амбулаторная хирургия. 2019;(1–2):52–58. doi: 10.21518/1995-1477-2019-1-2-52-58.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Yu. Sclerotherapy. Step by step. Telangiectasia. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2019;(1–2):52–58. (In Russ.) doi: 10.21518/1995-1477-2019-1-2-52-58.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю., Болдин Б.В., Лобанов В.Н., Аркадан Н.Р., Ермак М.Ю. Адьювантная флеботропная терапия и ее влияние на провоспалительный ответ после склеротерапии. Ангиология и сосудистая хирургия. 2016;22(4):90–95. Режим доступа: http://angiologia.ru/journals/angiolsurgery/2016/4/13.php.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Yu., Boldin B.V., Lobanov V.N., Arkadan N.R., Ermak M.Yu. Adjuvant phlebotrophic therapy and its effect on anti-inflammatory response after sclerotherapy. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2016;22(4):90–95. (In Russ.) Available at: http://angiologia.ru/journals/angiolsurgery/2016/4/13.php.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю., Болдин Б.В., Туркин П.Ю. Детралекс- флебосклерозирующее лечение. Результаты национальной многоцентровой наблюдательной программы Vein Act Prolonged-C1. Ангиология и сосудистая хирургия. 2018;24(1):102–106. Режим доступа: http://angiolsurgery.org/en/magazine/2018/1/12.htm.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Yu., Boldin B.V., Turkin P.Yu. Detralex-phlebosclerosing treatment. results of the national multicenter follow up programme Vein Act Prolonged-C1. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2018;24(1):102–106. (In Russ.) Available at: http://www.angiolsurgery.org/en/magazine/2018/1/12.htm.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю., Болдин Б.В., Туркин П.Ю., Лобанов В.Н. Местные препараты в лечении и снижении частоты развития нежелательных реакций после склеротерапии телеангиоэктазов. Ангиология и сосудистая хирургия. 2019;25(4):102–107. doi: 10.33529/ANGIO2019405.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Iu., Boldin B.V., Turkin P.Iu., Lobanov V.N. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. doi: 10.33529/ANGIO2019405.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev V.Iu., Boldin B.V., Turkin P.Iu., Lobanov V.N. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. doi: 10.33529/ANGIO2019405.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Yu., Grusha YA.O. The first experience with sclerotherapy of superficial periorbital veins. Flebologiya. 2010;4(2):17–22. (In Russ.) Available at: https://mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023/annotation.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю., Груша Я.О. Первый опыт склерооблитерации поверхностных периорбитальных вен. Флебология. 2010;4(2):17–22. Режим доступа: https://mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023/annotation.</mixed-citation><mixed-citation xml:lang="en">Burleva E.P., Burleva N.A. Russian observational programme SPEKTR: analysis of age-specific structure of patients with chronic venous diseases. Angiologiya i sosudistaya khirurgiya = Angiologists and Vascular Surgeons. 2013;19(2):67–72. (In Russ.) Available at: http://www.angiolsurgery.org/magazine/2013/2/8.htm.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev V.Yu., Grusha YA.O. The first experience with sclerotherapy of superficial periorbital veins. Flebologiya. 2010;4(2):17–22. (In Russ.) Available at: https://mediasphera.ru/issues/flebologiya/2010/2/031997-6976201023/annotation.</mixed-citation><mixed-citation xml:lang="en">Burleva E.P., Ektova M.V., Belentsov S.M., Chukin S.A., Makarov S.E., Veselov B.A. Treatment of lower extremity telangiectasias by thermocoagulation method using TS-3000 apparatus. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2018;(1–2):72–79. (In Russ.) doi: 10.21518/1995-14772018-1-2-72-79.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Бурлева Е.П., Бурлева Н.А. Российская обсервационная программа СПЕКТР: анализ возрастной структуры пациентов с хроническими заболеваниями вен. Ангиология и сосудистая хирургия. 2013;19(2):67–72. Режим доступа: http://angiolsurgery.org/magazine/2013/2/8.htm.</mixed-citation><mixed-citation xml:lang="en">Butov Yu.S, Demina O.M. Revisitinglaser therapy of telangiectasias. Rossiyskiy Zhurnal Kozhnyh i Venericheskih Bolezney = Russian Journal Of Skin And Venereal Diseases. 2006;(2):53–57. (In Russ.) Available at: https://elibrary.ru/item.asp?id=9196560.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Бурлева Е.П., Эктова М.В., Беленцов С.М., Чукин С.А., Макаров С.Е., Веселов Б.А. Лечение телеангиэктазий нижних конечностей методом термокоагуляции с использованием аппарата ТС-3000. Амбулаторная хирургия. 2018;(1–2):72–79. doi: 10.21518/1995-14772018-1-2-72-79.</mixed-citation><mixed-citation xml:lang="en">Volkov A.S., Dibirov M.D., Shimanko A.I., Rybakov G.S., Tsuranov S.V., Tyurin D.S. et al. Laser Percutaneous Photocoagulation of Facial and Lower Extremities Telangiectasia. Flebologiya. 2019;13(1):52–59. (In Russ.) doi: 10.17116/flebo20191301152.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Бутов Ю.С., Демина О.М. К вопросу о лазерной терапии телеангиэктазий. Российский журнал кожных и венерический болезней. 2006;(2):53–57. Режим доступа: https://elibrary.ru/item.asp?id=9196560.</mixed-citation><mixed-citation xml:lang="en">Livandovskiy Iu.A., Pavlova O.Iu. Telangiectasia. Klinicheskaya dermatologiya i venerologiya = Russian Journal of Clinical Dermatology and Venerology. 2010;8(5):6–15. (In Russ.) Available at: https://mediasphera.ru/issues/klinicheskaya-dermatologiya-i-venerologiya/2010/5/031997-2849201051.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Волков А.С., Дибиров М.Д., Шиманко А.И., Рыбаков Г.С., Цуранов С.В., Тюрин Д.С. и др. Лазерная чрескожная коагуляция телеангиэктазий лица и нижних конечностей. Флебология. 2019;13(1):52–59. doi: 10.17116/flebo20191301152.</mixed-citation><mixed-citation xml:lang="en">Lobastov K.V. Impact of Microcirculatory Disorders on the Symptoms of Chronic Venous Disease and Their Pharmacological Correction. Flebologiya = Journal of Venous Disorders. 2020;14(1):30–39. (In Russ.) doi: 10.17116/flebo20201401130.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ливандовский Ю.А., Павлова О.Ю. Телеангиэктазии. Клиническая дерматология и венерология. 2010;8(5):6-15. Режим доступа: https://mediasphera.ru/issues/klinicheskaya-dermatologiya-i-venerologiya/2010/5/031997-2849201051.</mixed-citation><mixed-citation xml:lang="en">Lobastov K.V., Bondarchuk D.V., Borsuk D.A., Bredikhin R.A., Bukina O.V., Pankov A.S. et al. Diagnosis and treatment of chronic venous obstruction: consensus statement of the Russian experts (part 1). Khirurg = Surgeon. 2020;(5–6):5–37. (In Russ.) doi: 10.33920/med-15-2003-01.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Лобастов К.В. Значение микроциркуляторных нарушений в развитии симптомов хронического заболевания вен и возможность их фармакологической коррекции. Флебология. 2020;14(1):30–39. doi: 10.17116/flebo20201401130.</mixed-citation><mixed-citation xml:lang="en">Appraisal of Guidelines for Research &amp; Evaluation (AGREE) Instrument. The AGREE Collaboration. September 2001. 26 p. (In Russ.) Available at: https://agreetrust.org/wp-content/uploads/2013/06/AGREE_Instrument_Russian.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Лобастов К.В., Бондарчук Д.В., Борсук Д.А., Бредихин Р.А., Букина О.В., Панков А.С. и др. Диагностика и лечение хронической венозной обструкции: согласованное мнение российских экспертов (Часть 1). Хирург. 2020;(5–6):5–37. doi: 10.33920/med-15-2003-01.</mixed-citation><mixed-citation xml:lang="en">Ponomareva A.A. Traditional and modern ideas about blood supply to skin. Zhurnal fundamentalnoy meditsiny i biologii = Journal of Fundamental Medicine and Biology. 2018;(2):34–44. (In Russ.) Available at: http://rostgmu.ru/wp-content/uploads/2018/06/ЖФМиБ-2018-№2-3.pdf.]</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Опросник по экспертизе и аттестации руководств. The AGREE Collaboration. September 2001. 26 с. Режим доступа: https://agreetrust.org/wp-content/uploads/2013/06/AGREE_Instrument_Russian.pdf.</mixed-citation><mixed-citation xml:lang="en">Rebrova O.Yu. Three ways to develop clinical guidelines. ADAPTE and AGREE GRS procedures. Problemy ehndokrinologii = Problems of Endocrinology. 2019;65(3):197–203. (In Russ.) doi: 10.14341/probl10100.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарева А.А. Традиционные и современные представления о кровоснабжении кожи. Журнал фундаментальной медицины и биологии. 2018;(2):34–44. Режим доступа: http://rostgmu.ru/wpcontent/uploads/2018/06/ЖФМиБ-2018-№2-3.pdf.</mixed-citation><mixed-citation xml:lang="en">Savelev V.S., Kirienko A.I., Zolotukhin I.A., Seliverstov E.I. Prospective observational study SPECTRUM: the registry of patients with chronic venous diseases. Flebologiya = Flebologiya. Journal of Venous Disorders. 2012;6(1):4–9. (In Russ.) Available at: https://mediasphera.ru/issues/flebologiya/2012/1/031997-6976201211/annotation.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Реброва О.Ю. О трех способах подготовки клинических рекомендаций. Инструменты ADAPTE и AGREE GRS. Проблемы эндокринологии. 2019;65(3):197–203. doi: 10.14341/probl10100.</mixed-citation><mixed-citation xml:lang="en">Sinitsyn A.A., Bukina O.V. Glucose versus sodium tetradecyl sulphate for sclerotherapy of telangiectasias: a prospective randomized clinical trial. Abstracts of Conference of Phlebologists “White Nights”, 24–25 May 2019, Saint Petersburg. Flebologiya = Journal of Venous Disorders. 2019;13(2):166–184. Available at: https://library.ru/item.asp?id=38245150.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Савельев В.С., Кириенко А.И., Золотухин И.А., Селиверстов С.Е. Проспективное обсервационное исследование СПЕКТР: регистр пациентов с хроническими заболеваниями вен нижних конечностей. Флебология. 2012;6(1):4–9. Режим доступа: https://www.mediasphera.ru/issues/flebologiya/2012/1/031997-6976201211/annotation.</mixed-citation><mixed-citation xml:lang="en">Standards and regulations of a self-regulating organization “The National College of Phlebology (Russia)”. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2020;(1–2):125–144. (In Russ.) doi: 10.21518/1995-1477-2019-3-4-125-144.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Синицын А.А., Букина О.В. Сравнение глюкозы и тетрадецилсульфата натрия для склеротерапии телеангиэктазий: проспективное рандомизированное клиническое исследование. Тезисы докладов Ежегодной флебологической конференции «Белые ночи», 24–25 мая 2019 г., Санкт-Петербург. Флебология. 2019;13(2):166–184. Available at: https://elibrary.ru/item.asp?id=38245150.</mixed-citation><mixed-citation xml:lang="en">Stoyko Yu.M., Kirienko A.I., Zatevakhin I.I., Pokrovskiy A.V., Karpenko A.A., Zolotukhin I.A. et al. Diagnostics and Treatment of Chronic Venous Disease: Guidelines of Russian Phlebological Association. Flebologiya = Journal of Venous Disorders. 2018;12(3):146–240. doi: 10.17116/flebo20187031146.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Стандарты и правила Саморегулируемой организации Ассоциации «Национальная коллегия флебологов». Амбулаторная хирургия. 2020;(1–2):125–144. doi: 10.21518/1995-1477-2019-3-4-125-144.</mixed-citation><mixed-citation xml:lang="en">Tsukanov Iu.T., Tsukanov A.Iu., Bazhenov V.N., Kornienko I.F. Telangiectasias and reticular varicosis in women: clinical features and indications for treatment. Flebologiya = Flebologiya. 2010;(1):34–38. (In Russ.) Available at: https://elibrary.ru/item.asp?id=15626112.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Стойко Ю.М., Кириенко А.И., Затевахин И.И., Покровский А.В., Карпенко А.А., Золотухин И.А. и др. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;12(3):146–240. doi: 10.17116/flebo20187031146.</mixed-citation><mixed-citation xml:lang="en">Shaydakov E.V., Bubnova N.A., Sabelnikov V.V., Soroka V.V., Bogachev V.Yu., Sapelkin S.V. et al. Saint Petersburg venous forum and its role in development of rassian phlebology. Angiologiya i sosudistaya khirurgiya = Angiologists and Vascular Surgeons. 2020;26(3):74–80. (In Russ.) Available at: https://elibrary.ru/item.asp?id=43878779.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Цуканов Ю.Т., Цуканов А.Ю., Баженов В.Н., Корниенко И.Ф. Телеангиэктазии и ретикулярный варикоз у женщин: особенности течения и показания к лечению. Флебология. 2010;1(1):34–38. Режим доступа: https://elibrary.ru/item.asp?id=15626112.</mixed-citation><mixed-citation xml:lang="en">Adamič M., Pavlović M.D., Troilius Rubin A., Palmetun-Ekbäck M., Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for laser Dermatology. J Eur Acad Dermatol Venereol. 2015;29(9):1661–1678. doi: 10.1111/jdv.13177.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Шайдаков Е.В., Бубнова Н.А., Сабельников В.В., Сорока В.В., Богачев В.Ю., Сапелкин С.В., и др. Санкт-Петербургский венозный форум и его роль в развитии российской флебологии. Ангиология и сосудистая хирургия. 2020;26(3):74–80. Режим доступа: https://elibrary.ru/item.asp?id=43878779.</mixed-citation><mixed-citation xml:lang="en">Adamic M., Troilius A., Adatto M., Drosner M., Dahmane R. Vascular lasers and IPLS: guidelines for care from the European Society for laser Dermatology (ESLD). J Cosmet laser Ther. 2007;9(2):113–124. doi: 10.1080/14764170701280693.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Adamič M., Pavlović M.D., Troilius Rubin A., Palmetun-Ekbäck M., Boixeda P. Guidelines of care for vascular lasers and intense pulse light sources from the European Society for laser Dermatology. J Eur Acad Dermatol Venereol. 2015;29(9):1661–1678. doi: 10.1111/jdv.13177.</mixed-citation><mixed-citation xml:lang="en">Adrian R.M., Tanghetti E.A. Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg. 1998;24(1):71–74. doi: 10.1111/j.1524-4725.1998.tb04055.x.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Adamic M., Troilius A., Adatto M., Drosner M., Dahmane R. Vascular lasers and IPLS: guidelines for care from the European Society for laser Dermatology (ESLD). J Cosmet laser Ther. 2007;9(2):113–124. doi: 10.1080/14764170701280693.</mixed-citation><mixed-citation xml:lang="en">Ai D., Yang J., Fan J., Zhao Y., Song X., Shen J. et al. Augmented reality based real-time subcutaneous vein imaging system. Biomed Opt Express. 2016;7(7):2565–2585. doi: 10.1364/BOE.7.002565.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Adrian R.M., Tanghetti E.A. Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg. 1998;24(1):71–74. doi: 10.1111/j.1524-4725.1998.tb04055.x.</mixed-citation><mixed-citation xml:lang="en">Alam M., Dover J.S., Arndt K.A. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg. 2003;29(7):681–684; discussion 685. doi: 10.1046/j.1524-4725.2003.29181.x.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ai D., Yang J., Fan J., Zhao Y., Song X., Shen J. et al. Augmented reality based real-time subcutaneous vein imaging system. Biomed Opt Express. 2016;7(7):2565–2585. doi: 10.1364/BOE.7.002565.</mixed-citation><mixed-citation xml:lang="en">Alam M., Warycha M. Complications of lasers and light treatments. Dermatol Ther. 2011;24(6):571–580. doi: 10.1111/j.1529-8019.2012.01476.x.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Alam M., Dover J.S., Arndt K.A. Treatment of facial telangiectasia with variable-pulse high-fluence pulsed-dye laser: comparison of efficacy with fluences immediately above and below the purpura threshold. Dermatol Surg. 2003;29(7):681–684; discussion 685. doi: 10.1046/j.1524-4725.2003.29181.x.</mixed-citation><mixed-citation xml:lang="en">Albanese A.R., Albanese A.M., Albanese E.F. Lateral subdermic varicose vein system of the legs. Its surgical treatment by the chiseling tube method. Vasc Surg. 1969;3(2):81–89. doi: 10.1177/153857446900300205.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Alam M., Warycha M. Complications of lasers and light treatments. Dermatol Ther. 2011;24(6):571–580. doi: 10.1111/j.1529-8019.2012.01476.x.</mixed-citation><mixed-citation xml:lang="en">Allegra C., Antignani P.L., Bergan J.J., Carpentier P.H., Coleridge-Smith P., Cornu-Thénard A. et al. International Union of Phlebology Working Group. The “C” of CEAP: suggested definitions and refinements: an International Union of Phlebology conference of experts. J Vasc Surg. 2003;37(1):129–131. doi: 10.1067/mva.2003.47.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Albanese A.R., Albanese A.M., Albanese E.F. Lateral subdermic varicose vein system of the legs. Its surgical treatment by the chiseling tube method. Vasc Surg. 1969;3(2):81–89. doi: 10.1177/153857446900300205.</mixed-citation><mixed-citation xml:lang="en">Alòs J., Carreño P., López J.A., Estadella B., Serra-Prat M., Marinel- Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg. 2006;31(1):101–107. doi: 10.1016/j.ejvs.2005.08.018.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Allegra C., Antignani P.L., Bergan J.J., Carpentier P.H., Coleridge-Smith P., Cornu-Thénard A. et al. International Union of Phlebology Working Group. The “C” of CEAP: suggested definitions and refinements: an International Union of Phlebology conference of experts. J Vasc Surg. 2003;37(1):129–131. doi: 10.1067/mva.2003.47.</mixed-citation><mixed-citation xml:lang="en">Alster T.S., Khoury R.R. Treatment of laser complications. Facial Plast Surg. 2009;25(5):316–323. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243080.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Alòs J., Carreño P., López J.A., Estadella B., Serra-Prat M., Marinel- Lo J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg. 2006;31(1):101–107. doi: 10.1016/j.ejvs.2005.08.018.</mixed-citation><mixed-citation xml:lang="en">Altshuler G.B., Anderson R.R., Manstein D., Zenzie H.H., Smirnov M.Z. Extended theory of selective photothermolysis. Lasers Surg Med. 2001;29(5):416–432. doi: 10.1002/lsm.1136.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Alster T.S., Khoury R.R. Treatment of laser complications. Facial Plast Surg. 2009;25(5):316–323. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243080.</mixed-citation><mixed-citation xml:lang="en">Andelman S.M., Walsh A.L., Rubin T.A., Hausman M.R. Acute Hand Ischemia Following Elective Venous Sclerotherapy for Dorsal Hand Varicose Veins. J Hand Surg Am. 2017;42(8):666.e1–666.e5. doi: 10.1016/j.jhsa.2017.03.018.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Altshuler G.B., Anderson R.R., Manstein D., Zenzie H.H., Smirnov M.Z. Extended theory of selective photothermolysis. Lasers Surg Med. 2001;29(5):416–432. doi: 10.1002/lsm.1136.</mixed-citation><mixed-citation xml:lang="en">Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–527. Available at: https://science.sciencemag.org/content/220/4596/524.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Andelman S.M., Walsh A.L., Rubin T.A., Hausman M.R. Acute Hand Ischemia Following Elective Venous Sclerotherapy for Dorsal Hand Varicose Veins. J Hand Surg Am. 2017;42(8):666.e1–666.e5. doi: 10.1016/j.jhsa.2017.03.018.</mixed-citation><mixed-citation xml:lang="en">Anderson R.R., Parrish J.A. The optics of human skin. J Invest Dermatol. 1981;77(1):13–19. doi: 10.1111/1523-1747.ep12479191.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524–527. Available at: https://science.sciencemag.org/content/220/4596/524.</mixed-citation><mixed-citation xml:lang="en">Apperti M., Furino E., Sellitti A., Quarto G. The use of transillumination as a rational approach to sclerotherapy and endovascular laser ablation of varices. Results in the use of an original instrument. Ann Ital Chir. 2016;87:396–399. Available at: https://pubmed.ncbi.nlm.nih.gov/27681276/.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson R.R., Parrish J.A. The optics of human skin. J Invest Dermatol. 1981;77(1):13–19. doi: 10.1111/1523-1747.ep12479191.</mixed-citation><mixed-citation xml:lang="en">Bains R.D., Thorpe H., Southern S. Hand aging: patients’ opinions. Plast Reconstr Surg. 2006;117(7):2212–2218. doi: 10.1097/01.prs.0000218712.66333.97.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Apperti M., Furino E., Sellitti A., Quarto G. The use of transillumination as a rational approach to sclerotherapy and endovascular laser ablation of varices. Results in the use of an original instrument. Ann Ital Chir. 2016;87:396–399. Available at: https://pubmed.ncbi.nlm.nih.gov/27681276/.</mixed-citation><mixed-citation xml:lang="en">Barton J.K., Frangineas G., Pummer H., Black J.F. Cooperative phenomena in two-pulse, two-color laser photocoagulation of cutaneous blood vessels. Photochem Photobiol. 2001;73(6):642–650. doi: 10.1562/0031-8655(2001)0730642CPITPT2.0.CO2.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bains R.D., Thorpe H., Southern S. Hand aging: patients’ opinions. Plast Reconstr Surg. 2006;117(7):2212–2218. doi: 10.1097/01.prs.0000218712.66333.97.</mixed-citation><mixed-citation xml:lang="en">Bäumler W., Ulrich H., Hartl A., Landthaler M., Shafirstein G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364–371. doi: 10.1111/j.1365-2133.2006.07314.x.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Barton J.K., Frangineas G., Pummer H., Black J.F. Cooperative phenomena in two-pulse, two-color laser photocoagulation of cutaneous blood vessels. Photochem Photobiol. 2001;73(6):642–650. doi: 10.1562/0031-8655(2001)0730642CPITPT2.0.CO2.</mixed-citation><mixed-citation xml:lang="en">Beasley K.L., Weiss R.A., Weiss M.A., Munavalli G. Treatment of postsclerotherapy hyperpigmentation with a novel Q-switched combination 532/1,064 nm Nd:YAG laser. Lasers Med Surg. 2004;34(16 suppl.):15.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bäumler W., Ulrich H., Hartl A., Landthaler M., Shafirstein G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006;155(2):364–371. doi: 10.1111/j.1365-2133.2006.07314.x.</mixed-citation><mixed-citation xml:lang="en">Bencini P.L., Tourlaki A., De Giorgi V., Galimberti M. Laser use for cutaneous vascular alterations of cosmetic interest. Dermatol Ther. 2012;25(4):340–351. doi: 10.1111/j.1529-8019.2012.01463.x.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Beasley K.L., Weiss R.A., Weiss M.A., Munavalli G. Treatment of postsclerotherapy hyperpigmentation with a novel Q-switched combination 532/1,064 nm Nd:YAG laser. Lasers Med Surg. 2004;34(16 suppl.):15.</mixed-citation><mixed-citation xml:lang="en">Benigni J.P., Bihari I., Rabe E., Uhl J.F., Partsch H., Cornu-Thenard A. et al. Venous symptoms in C0 and C1 patients: UIP consensus document. Int Angiol. 2013;32(3):261–215. Available at: https://pubmed.ncbi.nlm.nih.gov/22990502/.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Bencini P.L., Tourlaki A., De Giorgi V., Galimberti M. Laser use for cutaneous vascular alterations of cosmetic interest. Dermatol Ther. 2012;25(4):340–351. doi: 10.1111/j.1529-8019.2012.01463.x.</mixed-citation><mixed-citation xml:lang="en">Benigni J.P., Bihari I., Rabe E., Uhl J.F., Partsch H., Cornu-Thenard A. et al. Venous symptoms in C0 and C1 patients: UIP consensus document. Int Angiol. 2013;32(3):261–265. Available at: https://pubmed.ncbi.nlm.nih.gov/23711678/.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Benigni J.P., Bihari I., Rabe E., Uhl J.F., Partsch H., Cornu-Thenard A. et al. Venous symptoms in C0 and C1 patients: UIP consensus document. Int Angiol. 2013;32(3):261–215. Available at: https://pubmed.ncbi.nlm.nih.gov/22990502/.</mixed-citation><mixed-citation xml:lang="en">Benigni J.P., Sadoun S., Thirion V., Sica M., Demagny A., Chahim M. Telangiectases and reticular veins treatment with a 0.25% aetoxisclerol foam. Presentation of a pilot study. Phlébologie. 1999;52(3):283–390.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Benigni J.P., Bihari I., Rabe E., Uhl J.F., Partsch H., Cornu-Thenard A. et al. Venous symptoms in C0 and C1 patients: UIP consensus document. Int Angiol. 2013;32(3):261–265. Available at: https://pubmed.ncbi.nlm.nih.gov/23711678/.</mixed-citation><mixed-citation xml:lang="en">Bernstein E.F., Lee J., Lowery J., Brown D.B., Geronemus R., Lask G. et al. Treatment of spider veins with the 595 nm pulsed-dye laser. J Am Acad Dermatol. 1998;39(5):746–750. doi: 10.1016/S0190-9622(98)70047-7.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Benigni J.P., Sadoun S., Thirion V., Sica M., Demagny A., Chahim M. Telangiectases and reticular veins treatment with a 0.25% aetoxisclerol foam. Presentation of a pilot study. Phlébologie. 1999;52(3):283–390.</mixed-citation><mixed-citation xml:lang="en">Bernstein E.F., Noyaner-Turley A., Renton B. Treatment of spider veins of the lower extremity with a novel 532 nm KTP laser. Lasers Surg Med. 2014;46(2):81–88. doi: 10.1002/lsm.22178.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein E.F., Lee J., Lowery J., Brown D.B., Geronemus R., Lask G. et al. Treatment of spider veins with the 595 nm pulsed-dye laser. J Am Acad Dermatol. 1998;39(5):746–750. doi: 10.1016/S0190-9622(98)70047-7.</mixed-citation><mixed-citation xml:lang="en">Bertanha M., Jaldin R.G., Moura R., Pimenta R.E.F., Mariúba J.V.O., Filho C.E.P.L. et al. Sclerotherapy for reticular veins in the lower limbs: a triple-dlind randomized clinical trial. JAMA Dermatol. 2017;153(12):1249–1255. doi: 10.1001/jamadermatol.2017.3426.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein E.F., Noyaner-Turley A., Renton B. Treatment of spider veins of the lower extremity with a novel 532 nm KTP laser. Lasers Surg Med. 2014;46(2):81–88. doi: 10.1002/lsm.22178.</mixed-citation><mixed-citation xml:lang="en">Bertanha M., Jaldin R.G., Moura R., Pimenta R.E.F., Mariúba J.V.O., Lucio Filho C.E.P. et al. Sclerotherapy for reticular veins in the lower limbs: a triple-dlind randomized clinical trial. JAMA Dermatol. 2017;153(12):1249–1255. doi: 10.1001/jamadermatol.2017.3426.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Bertanha M., Jaldin R.G., Moura R., Pimenta R.E.F., Mariúba J.V.O., Filho C.E.P.L. et al. Sclerotherapy for reticular veins in the lower limbs: a triple-dlind randomized clinical trial. JAMA Dermatol. 2017;153(12):1249–1255. doi: 10.1001/jamadermatol.2017.3426.</mixed-citation><mixed-citation xml:lang="en">Bevin A.A., Parlette E.C., Domankevitz Y., Ross E.V. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg. 2006;32(1):7–12. doi: 10.1111/1524-4725.2006.32001.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Bertanha M., Jaldin R.G., Moura R., Pimenta R.E.F., Mariúba J.V.O., Lucio Filho C.E.P. et al. Sclerotherapy for reticular veins in the lower limbs: a triple-dlind randomized clinical trial. JAMA Dermatol. 2017;153(12):1249–1255. doi: 10.1001/jamadermatol.2017.3426.</mixed-citation><mixed-citation xml:lang="en">Biegeleisen K. Primary lower extremity telangiectasias— relationship of size to color. Angiology. 1987;38(10):760–768. doi: 10.1177/000331978703801006.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bevin A.A., Parlette E.C., Domankevitz Y., Ross E.V. Variable-pulse Nd:YAG laser in the treatment of facial telangiectasias. Dermatol Surg. 2006;32(1):7–12. doi: 10.1111/1524-4725.2006.32001.</mixed-citation><mixed-citation xml:lang="en">Bihari I., Magyar E. Microshunt histology in telangiectasias. Int J Angiol. 1999;8(2):98–101. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1007/BF01616823.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Biegeleisen K. Primary lower extremity telangiectasias— relationship of size to color. Angiology. 1987;38(10):760–768. doi: 10.1177/000331978703801006.</mixed-citation><mixed-citation xml:lang="en">Bihari I., Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg. 2001;27(2):133–136. doi: 10.1046/j.1524-4725.2001.00298.x.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Bihari I., Magyar E. Microshunt histology in telangiectasias. Int J Angiol. 1999;8(2):98–101. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1007/BF01616823.</mixed-citation><mixed-citation xml:lang="en">Bihari I., Muranyi A., Bihari P. Laser-doppler examination shows high flow in some common telangiectasias of the lower limb. Dermatol Surg. 2005;31(4):388–390. doi: 10.1111/j.1524-4725.2005.31102.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Bihari I., Magyar E. Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg. 2001;27(2):133–136. doi: 10.1046/j.1524-4725.2001.00298.x.</mixed-citation><mixed-citation xml:lang="en">Bihari I., Tornoci L., Bihari P. Epidemiological study on varicose veins in Budapest. Phlebology. 2012;27(2):77–81. doi: 10.1258/phleb.2011.010063.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Bihari I., Muranyi A., Bihari P. Laser-doppler examination shows high flow in some common telangiectasias of the lower limb. Dermatol Surg. 2005;31(4):388–390. doi: 10.1111/j.1524-4725.2005.31102.</mixed-citation><mixed-citation xml:lang="en">Bjerring P., Christiansen K., Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet laser Ther. 2001;3(4):169–173. doi: 10.1080/14764170160260744.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Bihari I., Tornoci L., Bihari P. Epidemiological study on varicose veins in Budapest. Phlebology. 2012;27(2):77–81. doi: 10.1258/phleb.2011.010063.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Y. Benefits of MPFF in combination with sclerotherapy. Phlebolymphology. 2019;26(2):54–59. Available at: https://phlebolymphology.org/benefits-of-mpff-in-combination-withsclerotherapy/</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Bjerring P., Christiansen K., Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet laser Ther. 2001;3(4):169–173. doi: 10.1080/14764170160260744.</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Y., Boldin B.V., Lobanov V.N. Benefits of micronized purified flavonoid fraction as adjuvant therapy on inflammatory response after sclerotherapy. Int Angiol. 2018;37(1):71–78. doi: 10.23736/S0392-9590.17.03868-8.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev V.Y. Benefits of MPFF in combination with sclerotherapy. Phlebolymphology. 2019;26(2):54–59. Available at: https://phlebolymphology.org/benefits-of-mpff-in-combination-withsclerotherapy/</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Y., Boldin B.V., Turkin P.Y. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1. Adv Ther. 2018;35(7):1001–1008. doi: 10.1007/s12325-018-0731-z.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev V.Y., Boldin B.V., Lobanov V.N. Benefits of micronized purified flavonoid fraction as adjuvant therapy on inflammatory response after sclerotherapy. Int Angiol. 2018;37(1):71–78. doi: 10.23736/S0392-9590.17.03868-8.</mixed-citation><mixed-citation xml:lang="en">Böhler-Sommeregger K., Karnel F., Schuller-Petrovic S., Santler R. Do telangiectases communicate with the deep venous system? J Dermatol Surg Oncol. 1992;18(5):403–406. doi: 10.1111/j.1524-4725.1992.tb03693.x.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Bogachev V.Y., Boldin B.V., Turkin P.Y. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1. Adv Ther. 2018;35(7):1001–1008. doi: 10.1007/s12325-018-0731-z.</mixed-citation><mixed-citation xml:lang="en">Bowes L.E., Goldman M.P. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg. 2002;28(1):46–51. doi: 10.1046/j.1524-4725.2002.01154.x.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Böhler-Sommeregger K., Karnel F., Schuller-Petrovic S., Santler R. Do telangiectases communicate with the deep venous system? J Dermatol Surg Oncol. 1992;18(5):403–406. doi: 10.1111/j.1524-4725.1992.tb03693.x.</mixed-citation><mixed-citation xml:lang="en">Brandão M.L., Mustafá A.M.M., Costa J.L. Glucose as a cause of and treatment for cutaneous necrosis. J Vasc Bras. 2018;17(4):341–347. doi: 10.1590/1677-5449.004818.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Bowes L.E., Goldman M.P. Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest. Dermatol Surg. 2002;28(1):46–51. doi: 10.1046/j.1524-4725.2002.01154.x.</mixed-citation><mixed-citation xml:lang="en">Braverman I.M. The cutaneous microcirculation. J Investig Dermatol Symp Proc. 2000;5(1):3–9. doi: 10.1046/j.1087-0024.2000.00010.x.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Brandão M.L., Mustafá A.M.M., Costa J.L. Glucose as a cause of and treatment for cutaneous necrosis. J Vasc Bras. 2018;17(4):341–347. doi: 10.1590/1677-5449.004818.</mixed-citation><mixed-citation xml:lang="en">Braverman I.M., Keh-Yen A. Ultrastructure of the human dermal microcirculation. IV. Valve-containing collecting veins at the dermalsubcutaneous junction. J Invest Dermatol. 1983;81(5):438–442. doi: 10.1111/1523-1747.ep12522612.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Braverman I.M. The cutaneous microcirculation. J Investig Dermatol Symp Proc. 2000;5(1):3–9. doi: 10.1046/j.1087-0024.2000.00010.x.</mixed-citation><mixed-citation xml:lang="en">Breu F.X., Guggenbichler S., Wollmann J.C. 2nd European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(71 Suppl.):1–29. Available at: https://pubmed.ncbi.nlm.nih.gov/18426039/</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Braverman I.M., Keh-Yen A. Ultrastructure of the human dermal microcirculation. IV. Valve-containing collecting veins at the dermalsubcutaneous junction. J Invest Dermatol. 1983;81(5):438–442. doi: 10.1111/1523-1747.ep12522612.</mixed-citation><mixed-citation xml:lang="en">Brouwers M.C., Kho M.E., Browman G.P., Burgers J.S., Cluzeau F., Feder G. et al. AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010182(18):E839–E842. Available at: www.cmaj.ca/cgi/content/full/cmaj.090449/DC1.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Breu F.X., Guggenbichler S., Wollmann J.C. 2nd European consensus meeting on foam sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(71 Suppl.):1–29. Available at: https://pubmed.ncbi.nlm.nih.gov/18426039/</mixed-citation><mixed-citation xml:lang="en">Brunnberg S., Lorenz S., Landthaler M., Hohenleutner U. Evaluation of the long pulsed high fluence alexandrite laser therapy of leg telangiectasia. Lasers Surg Med. 2002;31(5):359–362. doi: 10.1002/lsm.10117.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Brouwers M.C., Kho M.E., Browman G.P., Burgers J.S., Cluzeau F., Feder G. et al. AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010182(18):E839–E842. Available at: www.cmaj.ca/cgi/content/full/cmaj.090449/DC1.</mixed-citation><mixed-citation xml:lang="en">Bugiantella W., Bovani B., Zini F. Endovenous and perivenous 808-nm laser treatment of lower limb collateral, reticular and telangiectasiac veins. J Cosmet laser Ther. 2017;19(1):30–35. doi: 10.1080/14764172.2016.1247967.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Brunnberg S., Lorenz S., Landthaler M., Hohenleutner U. Evaluation of the long pulsed high fluence alexandrite laser therapy of leg telangiectasia. Lasers Surg Med. 2002;31(5):359–362. doi: 10.1002/lsm.10117.</mixed-citation><mixed-citation xml:lang="en">Buscher B.A., McMeekin T.O., Goodwin D. Treatment of leg telangiectasia by using a long-pulse dye laser at 595 nm with and without dynamic cooling device. Lasers Surg Med. 2000;27(2):171–175. doi: 10.1002/1096-9101(2000)27:2&lt;171::AID-LSM9&gt;3.0.CO;2-V.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Bugiantella W., Bovani B., Zini F. Endovenous and perivenous 808-nm laser treatment of lower limb collateral, reticular and telangiectasiac veins. J Cosmet laser Ther. 2017;19(1):30–35. doi: 10.1080/14764172.2016.1247967.</mixed-citation><mixed-citation xml:lang="en">Bush R., Bush P. Histological findings correlated with clinical outcomes in telangiectasia treated with ohmic thermolysis and 940 nm laser. J Cosmet Dermatol. 2018;17(5):779–782. doi: 10.1111/jocd.12761.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Buscher B.A., McMeekin T.O., Goodwin D. Treatment of leg telangiectasia by using a long-pulse dye laser at 595 nm with and without dynamic cooling device. Lasers Surg Med. 2000;27(2):171–175. doi: 10.1002/1096-9101(2000)27:2&lt;171::AID-LSM9&gt;3.0.CO;2-V.</mixed-citation><mixed-citation xml:lang="en">Bustos L.L., Fronek A., Lopez-Kapke L., Henriquez J.A. Nonvisible insufficient subcutaneous reticular venous plexus can be observed through the skin using a new illumination method. Dermatol Surg. 2010;36(2 Suppl.):1046–1049. doi: 10.1111/j.1524-4725.2010.01471.x.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Bush R., Bush P. Histological findings correlated with clinical outcomes in telangiectasia treated with ohmic thermolysis and 940 nm laser. J Cosmet Dermatol. 2018;17(5):779–782. doi: 10.1111/jocd.12761.</mixed-citation><mixed-citation xml:lang="en">Butterwick K., Sadick N. Hand Rejuvenation Using a Combination Approach. Dermatol Surg. 2016;42(2):S108–S118. doi: 10.1097/DSS.0000000000000687.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Bustos L.L., Fronek A., Lopez-Kapke L., Henriquez J.A. Nonvisible insufficient subcutaneous reticular venous plexus can be observed through the skin using a new illumination method. Dermatol Surg. 2010;36(2 Suppl.):1046–1049. doi: 10.1111/j.1524-4725.2010.01471.x.</mixed-citation><mixed-citation xml:lang="en">Carniol P.J., Price J., Olive A. Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg. 2005;21(2):117–119. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-2005-872412.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Butterwick K., Sadick N. Hand Rejuvenation Using a Combination Approach. Dermatol Surg. 2016;42(2):S108–S118. doi: 10.1097/DSS.0000000000000687.</mixed-citation><mixed-citation xml:lang="en">Carpentier P.H., Cornu-Thénard A., Uhl J.F., Partsch H., Antignani P.L.; Société Française de Médecine Vasculaire; European Working Group on the Clinical Characterization of Venous Disorders. Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders: a multicenter evaluation of 872 patients. J Vasc Surg. 2003;37(4):827–833. doi: 10.1067/mva.2003.147.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Carniol P.J., Price J., Olive A. Treatment of telangiectasias with the 532-nm and the 532/940-nm diode laser. Facial Plast Surg. 2005;21(2):117–119. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-2005-872412.</mixed-citation><mixed-citation xml:lang="en">Cavezzi A., Labropoulos N., Partsch H., Ricci S., Caggiati A., Myers K. et al., UIP. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part II. Anatomy. Vasa. 2007;36(1):62–71. doi: 10.1024/0301-1526.36.1.62.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Carpentier P.H., Cornu-Thénard A., Uhl J.F., Partsch H., Antignani P.L.; Société Française de Médecine Vasculaire; European Working Group on the Clinical Characterization of Venous Disorders. Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders: a multicenter evaluation of 872 patients. J Vasc Surg. 2003;37(4):827–833. doi: 10.1067/mva.2003.147.</mixed-citation><mixed-citation xml:lang="en">Cavezzi A., Parsi K. Complications of foam sclerotherapy. Phlebology. 2012;27(1 Suppl.):46–51. doi: 10.1258/phleb.2012.012s09.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Cavezzi A., Labropoulos N., Partsch H., Ricci S., Caggiati A., Myers K. et al., UIP. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part II. Anatomy. Vasa. 2007;36(1):62–71. doi: 10.1024/0301-1526.36.1.62.</mixed-citation><mixed-citation xml:lang="en">Cavezzi A., Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology. 2009;24(6):247–251. doi: 10.1258/phleb.2009.009061.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Cavezzi A., Parsi K. Complications of foam sclerotherapy. Phlebology. 2012;27(1 Suppl.):46–51. doi: 10.1258/phleb.2012.012s09.</mixed-citation><mixed-citation xml:lang="en">Chen J., Liu Y.R., Sun Y.D., Liu C., Zhuo S.Y., Li K. et al. The risk of bacteria in foam sclerotherapy: does the condition of the air in outpatient vs. operating rooms make a difference? Br J Dermatol. 2014;171(6):138–1390. doi: 10.1111/bjd.13089.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Cavezzi A., Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology. 2009;24(6):247–251. doi: 10.1258/phleb.2009.009061.</mixed-citation><mixed-citation xml:lang="en">Cheng Y.J., Liu Z.H., Yao F.J., Zeng W.T., Zheng D.D., Dong Y.G. et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10(9):e1001515. doi: 1371/journal.pmed.1001515.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J., Liu Y.R., Sun Y.D., Liu C., Zhuo S.Y., Li K. et al. The risk of bacteria in foam sclerotherapy: does the condition of the air in outpatient vs. operating rooms make a difference? Br J Dermatol. 2014;171(6):138–1390. doi: 10.1111/bjd.13089.</mixed-citation><mixed-citation xml:lang="en">Chess C. Prospective study on combination diode laser and radiofrequency energies (ELOS) for the treatment of leg veins. J Cosmet laser Ther. 2004;6(2):86–90. doi: 10.1080/14764170410032569.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng Y.J., Liu Z.H., Yao F.J., Zeng W.T., Zheng D.D., Dong Y.G. et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10(9):e1001515. doi: 1371/journal.pmed.1001515.</mixed-citation><mixed-citation xml:lang="en">Christiansen K., Drosner M., Bjerring P. Optimized settings for Nd:YAG laser treatments of leg telangiectasias. J Cosmet laser Ther. 2015;17(2):69–76. doi: 10.3109/14764172.2014.988729.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Chess C. Prospective study on combination diode laser and radiofrequency energies (ELOS) for the treatment of leg veins. J Cosmet laser Ther. 2004;6(2):86–90. doi: 10.1080/14764170410032569.</mixed-citation><mixed-citation xml:lang="en">Cisneros J.L., Del Rio R., Palou J. Sclerosis and the Nd:YAG, Q-switched laser with multiple frequency for treatment of telangiectases, reticular veins, and residual pigmentation. Dermatol Surg. 1998;24(10):1119–1123. doi: 10.1111/j.1524-4725.1998.tb04084.x.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Christiansen K., Drosner M., Bjerring P. Optimized settings for Nd:YAG laser treatments of leg telangiectasias. J Cosmet laser Ther. 2015;17(2):69–76. doi: 10.3109/14764172.2014.988729.</mixed-citation><mixed-citation xml:lang="en">Clark C., Cameron H., Moseley H., Ferguson J., Ibbotson S.H. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1–5. doi: 10.1007/s10103-004-0294-x.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Cisneros J.L., Del Rio R., Palou J. Sclerosis and the Nd:YAG, Q-switched laser with multiple frequency for treatment of telangiectases, reticular veins, and residual pigmentation. Dermatol Surg. 1998;24(10):1119–1123. doi: 10.1111/j.1524-4725.1998.tb04084.x.</mixed-citation><mixed-citation xml:lang="en">Clementoni M.T., Gilardino P., Muti G.F., Signorini M., Pistorale A., Morselli P.G. et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37(1):9–13. doi: 10.1002/lsm.20187.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Clark C., Cameron H., Moseley H., Ferguson J., Ibbotson S.H. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1–5. doi: 10.1007/s10103-004-0294-x.</mixed-citation><mixed-citation xml:lang="en">Coleridge-Smith P., Labropoulos N., Partsch H., Myers K., Nicolaides A., Cavezzi A., UIP. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part I. Basic principles. Vasa. 2007;36(1):53–61. doi: 10.1024/0301-1526.36.1.53.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Clementoni M.T., Gilardino P., Muti G.F., Signorini M., Pistorale A., Morselli P.G. et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37(1):9–13. doi: 10.1002/lsm.20187.</mixed-citation><mixed-citation xml:lang="en">Coles C.M., Werner R.S., Zelickson B.D. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Lasers Surg Med. 2002;30(2):154–159. doi: 10.1002/lsm.10028.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Coleridge-Smith P., Labropoulos N., Partsch H., Myers K., Nicolaides A., Cavezzi A., UIP. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs – UIP consensus document. Part I. Basic principles. Vasa. 2007;36(1):53–61. doi: 10.1024/0301-1526.36.1.53.</mixed-citation><mixed-citation xml:lang="en">Conrad P., Malouf G.M., Stacey M.C. The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg. 1995;21(4):334–336. doi: 10.1111/j.1524-4725.1995.tb00184.x.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Coles C.M., Werner R.S., Zelickson B.D. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Lasers Surg Med. 2002;30(2):154–159. doi: 10.1002/lsm.10028.</mixed-citation><mixed-citation xml:lang="en">Crippa A., Menegatti E., Zini F., Tessari L., Taibi A., Maietti E. et al. Safety and short-term efficacy of telangiectasia treatment by means of an innovative combination of 532 and 808 nm transdermal diode laser. Phlebology. 2019;34(10):715–720. doi: 10.1177/0268355519841999.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Conrad P., Malouf G.M., Stacey M.C. The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg. 1995;21(4):334–336. doi: 10.1111/j.1524-4725.1995.tb00184.x.</mixed-citation><mixed-citation xml:lang="en">Davis L.T., Duffy D.M. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol. 1990;16(4):327–330. doi: 10.1111/j.1524-4725.1990.tb00043.x.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Crippa A., Menegatti E., Zini F., Tessari L., Taibi A., Maietti E. et al. Safety and short-term efficacy of telangiectasia treatment by means of an innovative combination of 532 and 808 nm transdermal diode laser. Phlebology. 2019;34(10):715–720. doi: 10.1177/0268355519841999.</mixed-citation><mixed-citation xml:lang="en">De Faria J.L., Moraes I.N. Histopathology of the telangiectasia associated with varicose veins. Dermatologica. 1963;127:321–319. doi: 10.1159/000254877.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Davis L.T., Duffy D.M. Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol. 1990;16(4):327–330. doi: 10.1111/j.1524-4725.1990.tb00043.x.</mixed-citation><mixed-citation xml:lang="en">De Roos K.-P., Groen L., Leenders A. Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg. 2011;37(8):1119–1124. doi: 10.1111/j.1524-4725.2011.02044.x.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">De Faria J.L., Moraes I.N. Histopathology of the telangiectasia associated with varicose veins. Dermatologica. 1963;127:321–319. doi: 10.1159/000254877.</mixed-citation><mixed-citation xml:lang="en">de Souza M.d., Cyrino F., Mayall M.R., Virgini-Magalhães C.E., Sicuro F.L., de Carvalho J.J. et al. Beneficial effects of the micronized purified flavonoid fraction (MPFF, Daflon® 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 2016;31(1):50–56. doi: 10.1177/0268355514564414.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">De Roos K.-P., Groen L., Leenders A. Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg. 2011;37(8):1119–1124. doi: 10.1111/j.1524-4725.2011.02044.x.</mixed-citation><mixed-citation xml:lang="en">Dover J.S., Sadick N.S., Goldman M.P. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg. 1999;25(4):328–336. doi: 10.1046/j.1524-4725.1999.08227.x.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">de Souza M.d., Cyrino F., Mayall M.R., Virgini-Magalhães C.E., Sicuro F.L., de Carvalho J.J. et al. Beneficial effects of the micronized purified flavonoid fraction (MPFF, Daflon® 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology. 2016;31(1):50–56. doi: 10.1177/0268355514564414.</mixed-citation><mixed-citation xml:lang="en">Dover J.S., Sadick N.S., Goldman M.P. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg. 1999;25(4):328–335. doi: 10.1046/j.1524-4725.1999.08227.x.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Dover J.S., Sadick N.S., Goldman M.P. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg. 1999;25(4):328–336. doi: 10.1046/j.1524-4725.1999.08227.x.</mixed-citation><mixed-citation xml:lang="en">Dragicevic N., Maibach H.I. (eds.). Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin – Heidelberg: Springer-Verlag; 2016, pp. 263–282. doi: 10.1007/978-3-662-47039-8.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Dover J.S., Sadick N.S., Goldman M.P. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg. 1999;25(4):328–335. doi: 10.1046/j.1524-4725.1999.08227.x.</mixed-citation><mixed-citation xml:lang="en">Dudelzak J., Hussain M., Goldberg D.J. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009;8(3):227–229. Available at: https://pubmed.ncbi.nlm.nih.gov/19271368/.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Dragicevic N., Maibach H.I. (eds.). Percutaneous penetration enhancers chemical methods in penetration enhancement. Berlin – Heidelberg: Springer-Verlag; 2016, pp. 263–282. doi: 10.1007/978-3-662-47039-8.</mixed-citation><mixed-citation xml:lang="en">Duffy D.M., Garcia C., Clark R.E. The role of sclerotherapy in abnormal varicose hand veins. Plast Reconstr Surg. 1999;104(5):1474–1481. Available at: https://pubmed.ncbi.nlm.nih.gov/10513934/.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Dudelzak J., Hussain M., Goldberg D.J. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009;8(3):227–229. Available at: https://pubmed.ncbi.nlm.nih.gov/19271368/.</mixed-citation><mixed-citation xml:lang="en">Engelhorn C.A., Engelhorn A.L., Cassou M.F., Salles-Cunha S. Patterns of saphenous venous reflux in women presenting with lower extremity telangiectasias. Dermatol Surg. 2007;33(3):282–288. doi: 10.1111/j.1524-4725.2007.33063.x.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Duffy D.M., Garcia C., Clark R.E. The role of sclerotherapy in abnormal varicose hand veins. Plast Reconstr Surg. 1999;104(5):1474–1481. Available at: https://pubmed.ncbi.nlm.nih.gov/10513934/.</mixed-citation><mixed-citation xml:lang="en">Engelhorn C.A., Engelhorn A.L., Salles-Cunha S.X., Terna P.R., Kovalski K.D., Parizotto T.V. Initial patterns of unilateral great saphenous vein reflux in women with telangiectasias and varicose veins. Veins and Lymphatics. 2017;6(2):56–60. doi: 10.4081/vl.2017.6757.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Engelhorn C.A., Engelhorn A.L., Cassou M.F., Salles-Cunha S. Patterns of saphenous venous reflux in women presenting with lower extremity telangiectasias. Dermatol Surg. 2007;33(3):282–288. doi: 10.1111/j.1524-4725.2007.33063.x.</mixed-citation><mixed-citation xml:lang="en">Eremia S., Li C., Umar S.H. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg. 2002;28(3):224–230. doi: 10.1046/j.1524-4725.2002.01162.x.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Engelhorn C.A., Engelhorn A.L., Salles-Cunha S.X., Terna P.R., Kovalski K.D., Parizotto T.V. Initial patterns of unilateral great saphenous vein reflux in women with telangiectasias and varicose veins. Veins and Lymphatics. 2017;6(2):56–60. doi: 10.4081/vl.2017.6757.</mixed-citation><mixed-citation xml:lang="en">Eremia S., Li C.Y. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244–247. doi: 10.1046/j.1524-4725.2002.01217.x.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Eremia S., Li C., Umar S.H. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg. 2002;28(3):224–230. doi: 10.1046/j.1524-4725.2002.01162.x.</mixed-citation><mixed-citation xml:lang="en">Eremia S., Li C.Y. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd:YAG laser – a prospective study of 47 patients. J Cosmet laser Ther. 2001;3(3):147–153. doi: 10.1080/147641701753414960.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Eremia S., Li C.Y. Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG Laser: a prospective study of 17 patients. Dermatol Surg. 2002;28(3):244–247. doi: 10.1046/j.1524-4725.2002.01217.x.</mixed-citation><mixed-citation xml:lang="en">Erkin A., Kosemehmetoglu K., Diler M.S., Koksal C. Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study. Eur J Vasc Endovasc Surg. 2012;44(6):593–597. doi: 10.1016/j.ejvs.2012.09.021.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Eremia S., Li C.Y. Treatment of leg and face veins with a cryogen spray variable pulse width 1064-nm Nd:YAG laser – a prospective study of 47 patients. J Cosmet laser Ther. 2001;3(3):147–153. doi: 10.1080/147641701753414960.</mixed-citation><mixed-citation xml:lang="en">Fabi S.G., Goldman M.P. Hand rejuvenation: a review and our experience. Dermatol Surg. 2012;38(7 Pt 2):1112–1127. doi: 10.1111/j.1524-4725.2011.02291.x.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Erkin A., Kosemehmetoglu K., Diler M.S., Koksal C. Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study. Eur J Vasc Endovasc Surg. 2012;44(6):593–597. doi: 10.1016/j.ejvs.2012.09.021.</mixed-citation><mixed-citation xml:lang="en">Fabi S.G., Peterson J.D., Goldman M.P., Guiha I. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins. Dermatol Surg. 2012;38(3):367–372. doi: 10.1111/j.1524-4725.2011.02184.x.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Fabi S.G., Goldman M.P. Hand rejuvenation: a review and our experience. Dermatol Surg. 2012;38(7 Pt 2):1112–1127. doi: 10.1111/j.1524-4725.2011.02291.x.</mixed-citation><mixed-citation xml:lang="en">Fante R.G., Goldman M.P. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433–434. doi: 10.1016/S0161-6420(00)00565-0.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Fabi S.G., Peterson J.D., Goldman M.P., Guiha I. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins. Dermatol Surg. 2012;38(3):367–372. doi: 10.1111/j.1524-4725.2011.02184.x.</mixed-citation><mixed-citation xml:lang="en">Farkas J.P., Hoopman J.E., Kenkel J.M. Five parameters you must understand to master control of your laser/light-based devices. Aesthet Surg J. 2013;33(7):1059–1064. doi: 10.1177/1090820X13501174.</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Fante R.G., Goldman M.P. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):433–434. doi: 10.1016/S0161-6420(00)00565-0.</mixed-citation><mixed-citation xml:lang="en">Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–871. doi: 10.1001/archderm.124.6.869.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Farkas J.P., Hoopman J.E., Kenkel J.M. Five parameters you must understand to master control of your laser/light-based devices. Aesthet Surg J. 2013;33(7):1059–1064. doi: 10.1177/1090820X13501174.</mixed-citation><mixed-citation xml:lang="en">Forrestal M., Neuhardt D. Fundamentals of Phlebology. 3rd ed. American College of Phlebology; 2014. 208 р.</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–871. doi: 10.1001/archderm.124.6.869.</mixed-citation><mixed-citation xml:lang="en">Fournier N., Brisot D., Mordon S. Treatment of leg telangiectases with a 532 nm KTP laser in multipulse mode. Dermatol Surg. 2002;28(7):564–571. doi: 10.1046/j.1524-4725.2002.01316.x.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Forrestal M., Neuhardt D. Fundamentals of Phlebology. 3rd ed. American College of Phlebology; 2014. 208 р.</mixed-citation><mixed-citation xml:lang="en">Fourtanier A., Moyal D., Seité S. Sunscreens containing the broadspectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results. Photodermatol Photoimmunol Photomed. 2008;24(4):164–174. doi: 10.1111/j.1600-0781.2008.00365.x.</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Fournier N., Brisot D., Mordon S. Treatment of leg telangiectases with a 532 nm KTP laser in multipulse mode. Dermatol Surg. 2002;28(7):564–571. doi: 10.1046/j.1524-4725.2002.01316.x.</mixed-citation><mixed-citation xml:lang="en">Fu J., Liu Z., Chen X. Acral necrosis induced by sodium morrhuate sclerotherapy in infantile haemangioma: a case report. J Hand Surg Eur Vol. 2017;42(2):206–206. doi: 10.1177/1753193415621244.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Fourtanier A., Moyal D., Seité S. Sunscreens containing the broadspectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results. Photodermatol Photoimmunol Photomed. 2008;24(4):164–174. doi: 10.1111/j.1600-0781.2008.00365.x.</mixed-citation><mixed-citation xml:lang="en">Garden J.M., Tan O.T., Kerschmann R., Boll J., Furumoto H., Anderson R.R. et al. Effect of dye laser pulse duration on selective cutaneous vascular injury. J Invest Dermatol. 1986;87(5):653–657. doi: 10.1111/1523-1747.ep12456368.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Fu J., Liu Z., Chen X. Acral necrosis induced by sodium morrhuate sclerotherapy in infantile haemangioma: a case report. J Hand Surg Eur Vol. 2017;42(2):206–206. doi: 10.1177/1753193415621244.</mixed-citation><mixed-citation xml:lang="en">Georgiev M. Postsclerotherapy hyperpigmentations: a one-year followup. J Dermatol Surg Oncol. 1990;16(7): 608–610. doi: 10.1111/j.1524-4725.1990.tb00088.x.</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Garden J.M., Tan O.T., Kerschmann R., Boll J., Furumoto H., Anderson R.R. et al. Effect of dye laser pulse duration on selective cutaneous vascular injury. J Invest Dermatol. 1986;87(5):653–657. doi: 10.1111/1523-1747.ep12456368.</mixed-citation><mixed-citation xml:lang="en">Gianesini S., Obi A., Onida S., Baccellieri D., Bissacco D., Borsuk D. et al. Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology &amp; Aesthetics, 23-25 January 2019. Phlebology. 2019;34(1):4–66. doi: 10.1177/0268355519870690.</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Georgiev M. Postsclerotherapy hyperpigmentations: a one-year followup. J Dermatol Surg Oncol. 1990;16(7): 608–610. doi: 10.1111/j.1524-4725.1990.tb00088.x.</mixed-citation><mixed-citation xml:lang="en">Gibson K., Gunderson K. Liquid and Foam Sclerotherapy for Spider and Varicose Veins. Surg Clin North Am. 2018;98(2):415–429. doi: 10.1016/j.suc.2017.11.010.</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Gianesini S., Obi A., Onida S., Baccellieri D., Bissacco D., Borsuk D. et al. Global guidelines trends and controversies in lower limb venous and lymphatic disease: Narrative literature revision and experts’ opinions following the vWINter international meeting in Phlebology, Lymphology &amp; Aesthetics, 23-25 January 2019. Phlebology. 2019;34(1):4–66. doi: 10.1177/0268355519870690.</mixed-citation><mixed-citation xml:lang="en">Gloviczki P., Dalsing M.C., Eklof B., Lurie F., Wakefield T.W. (eds.). Handbook of Venous and Lymphatic Disorders: Guidelines of the American Venous Forum. 4th ed. CRC Press; 2017. doi: 10.1201/9781315382449.</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Gibson K., Gunderson K. Liquid and Foam Sclerotherapy for Spider and Varicose Veins. Surg Clin North Am. 2018;98(2):415–429. doi: 10.1016/j.suc.2017.11.010.</mixed-citation><mixed-citation xml:lang="en">Goldman M., Weiss R., Guex J.-J., Partsch H., Perrin M., Ramelet A.-A. et al. Sclerotherapy. Treatment of varicose and telangiectatic leg veins. 6th ed. Elsevier; 2017. 464 p.</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Gloviczki P., Dalsing M.C., Eklof B., Lurie F., Wakefield T.W. (eds.). Handbook of Venous and Lymphatic Disorders: Guidelines of the American Venous Forum. 4th ed. CRC Press; 2017. doi: 10.1201/9781315382449.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P. My sclerotherapy technique for telangiectasia and reticular veins. Dermatol Surg. 2010;36(2):1040–1405. doi: 10.1111/j.1524-4725.2009.01408.x.</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M., Weiss R., Guex J.-J., Partsch H., Perrin M., Ramelet A.-A. et al. Sclerotherapy. Treatment of varicose and telangiectatic leg veins. 6th ed. Elsevier; 2017. 464 p.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P. Postsclerotherapy hyperpigmentation. Treatment with a flashlamp-excited pulsed dye laser. J Dermatol Surg Oncol. 1992;18(5):417–422. doi: 10.1111/j.1524-4725.1992.tb03695.x.</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P. My sclerotherapy technique for telangiectasia and reticular veins. Dermatol Surg. 2010;36(2):1040–1405. doi: 10.1111/j.1524-4725.2009.01408.x.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Eckhouse S. Photothermal sclerosis of leg veins. ESC Medical Systems, LTD Photoderm VL Cooperative Study Group. Dermatol Surg. 1996;22(4):323–330. doi: 10.1111/j.1524-4725.1996.tb00325.x.</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P. Postsclerotherapy hyperpigmentation. Treatment with a flashlamp-excited pulsed dye laser. J Dermatol Surg Oncol. 1992;18(5):417–422. doi: 10.1111/j.1524-4725.1992.tb03695.x.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Fitzpatrick R.E. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy. J Dermatol Surg Oncol. 1990;16(4):338–344. doi: 10.1111/j.1524-4725.1990.tb00045.x.</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Eckhouse S. Photothermal sclerosis of leg veins. ESC Medical Systems, LTD Photoderm VL Cooperative Study Group. Dermatol Surg. 1996;22(4):323–330. doi: 10.1111/j.1524-4725.1996.tb00325.x.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Georgiev M., Ricci S. (eds.). Ambulatory Phlebectomy. 2nd ed. CRC Press; 2015. 384 p.</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Fitzpatrick R.E. Pulsed-dye laser treatment of leg telangiectasia: with and without simultaneous sclerotherapy. J Dermatol Surg Oncol. 1990;16(4):338–344. doi: 10.1111/j.1524-4725.1990.tb00045.x.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Kaplan R.P., Duffy D.M. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol. 1987;13(5):547–550. doi: 10.1111/j.1524-4725.1987.tb00940.x.</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Georgiev M., Ricci S. (eds.). Ambulatory Phlebectomy. 2nd ed. CRC Press; 2015. 384 p.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Martin D.E., Fitzpatrick R.E., Ruiz-Esparza J. Pulsed dye laser treatment of telangiectases with and without subtherapeutic sclerotherapy. Clinical and histologic examination in the rabbit ear vein model. J Am Acad Dermatol. 1990;23(1):23–30. doi: 10.1016/0190-9622(90)70180-P.</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Kaplan R.P., Duffy D.M. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol. 1987;13(5):547–550. doi: 10.1111/j.1524-4725.1987.tb00940.x.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Sadick N.S., Weiss R.A. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg. 1995;21(1):19–32. doi: 10.1111/j.1524-4725.1995.tb00107.x.</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Martin D.E., Fitzpatrick R.E., Ruiz-Esparza J. Pulsed dye laser treatment of telangiectases with and without subtherapeutic sclerotherapy. Clinical and histologic examination in the rabbit ear vein model. J Am Acad Dermatol. 1990;23(1):23–30. doi: 10.1016/0190-9622(90)70180-P.</mixed-citation><mixed-citation xml:lang="en">Goldman M.P., Weiss R.A., Brody H.J., Coleman 3rd W.P., Fitzpatrick R.E. Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review. J Dermatol Surg Oncol. 1993;19(10):899–910. doi: 10.1111/j.1524-4725.1993.tb00976.x.</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Sadick N.S., Weiss R.A. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. Dermatol Surg. 1995;21(1):19–32. doi: 10.1111/j.1524-4725.1995.tb00107.x.</mixed-citation><mixed-citation xml:lang="en">Grad L., Sult T., Sult R. Scientific Evaluation of VSP Nd:YAG Lasers for Hair Removal. J laser Heal Acad. 2007;2/2:1–11. Available at: https://researchgate.net/publication/237302983_Scientific_evaluation_of_VSP_NdYAG_lasers_for_hair_removal.</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">Goldman M.P., Weiss R.A., Brody H.J., Coleman 3rd W.P., Fitzpatrick R.E. Treatment of facial telangiectasia with sclerotherapy, laser surgery, and/or electrodesiccation: a review. J Dermatol Surg Oncol. 1993;19(10):899–910. doi: 10.1111/j.1524-4725.1993.tb00976.x.</mixed-citation><mixed-citation xml:lang="en">Green D. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):442–448. doi: 10.1016/S0161-6420(00)00384-5.</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Grad L., Sult T., Sult R. Scientific Evaluation of VSP Nd:YAG Lasers for Hair Removal. J laser Heal Acad. 2007;2/2:1–11. Available at: https://researchgate.net/publication/237302983_Scientific_evaluation_of_VSP_NdYAG_lasers_for_hair_removal.</mixed-citation><mixed-citation xml:lang="en">Green D. Reticular veins, incompetent reticular veins, and their relationship to telangiectases. Dermatol Surg. 1998;24(10):1129–1141. doi: 10.1111/j.1524-4725.1998.tb04086.x.</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Green D. Removal of periocular veins by sclerotherapy. Ophthalmology. 2001;108(3):442–448. doi: 10.1016/S0161-6420(00)00384-5.</mixed-citation><mixed-citation xml:lang="en">Groot D., Rao J., Johnston P., Nakatsui T. Algorithm for using a longpulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg. 2003;29(1):35–42. doi: 10.1046/j.1524-4725.2003.29016.x.</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Green D. Reticular veins, incompetent reticular veins, and their relationship to telangiectases. Dermatol Surg. 1998;24(10):1129–1141. doi: 10.1111/j.1524-4725.1998.tb04086.x.</mixed-citation><mixed-citation xml:lang="en">Guevara C.J., Gonzalez-Araiza G., Kim S.K., Sheybani E., Darcy M.D. Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm. Cardiovasc Intervent Radiol. 2016;39(5):705–710. doi: 10.1007/s00270-015-1277-y.</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Groot D., Rao J., Johnston P., Nakatsui T. Algorithm for using a longpulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg. 2003;29(1):35–42. doi: 10.1046/j.1524-4725.2003.29016.x.</mixed-citation><mixed-citation xml:lang="en">Guex J.J., Allaert F.A., Gillet J.L., Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg. 2005;31(2):123–128. doi: 10.1111/j.1524-4725.2005.31030.</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Guevara C.J., Gonzalez-Araiza G., Kim S.K., Sheybani E., Darcy M.D. Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm. Cardiovasc Intervent Radiol. 2016;39(5):705–710. doi: 10.1007/s00270-015-1277-y.</mixed-citation><mixed-citation xml:lang="en">Haedersdal M. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura – use of pulsed dye laser, copper vapor laser, and argon laser. Acta Derm Venereol Suppl (Stockh). 1999;207:1–32. Available at: https://pubmed.ncbi.nlm.nih.gov/10605602/.</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Guex J.J., Allaert F.A., Gillet J.L., Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg. 2005;31(2):123–128. doi: 10.1111/j.1524-4725.2005.31030.</mixed-citation><mixed-citation xml:lang="en">Hamel-Desnos C., Allaert F.A. Liquid versus foam sclerotherapy. Phlebology. 2009;24(6):240–246. doi: 10.1258/phleb.2009.009047.</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Haedersdal M. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura – use of pulsed dye laser, copper vapor laser, and argon laser. Acta Derm Venereol Suppl (Stockh). 1999;207:1–32. Available at: https://pubmed.ncbi.nlm.nih.gov/10605602/.</mixed-citation><mixed-citation xml:lang="en">Hesse G., Breu F.X., Kuschmann A., Hartmann K., Salomon N. Sclerotherapy using air- or CO2-O2-foam. Phlebologie. 2012;41(2):77–88. Available at: https://researchgate.net/publication/236341845_</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru">Hamel-Desnos C., Allaert F.A. Liquid versus foam sclerotherapy. Phlebology. 2009;24(6):240–246. doi: 10.1258/phleb.2009.009047.</mixed-citation><mixed-citation xml:lang="en">Sclerotherapy_using_air-_or_CO2-O2-foam. Hirsch R. Iatrogenic laser complications. Clin Dermatol. 2011;29(6):691–695. doi: 10.1016/j.clindermatol.2011.08.010.</mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Hesse G., Breu F.X., Kuschmann A., Hartmann K., Salomon N. Sclerotherapy using air- or CO2-O2-foam. Phlebologie. 2012;41(2):77–88. Available at: https://researchgate.net/publication/236341845_</mixed-citation><mixed-citation xml:lang="en">Hohenleutner U., Wenig M., Walther T., Bäumler W., Landthaler M. Treatment of superficial varicosities with a flashlamp-pumped pulsed dye laser with 1.5 ms impulse time. Hautarzt. 1998;49(7):560–565. doi: 10.1007/s001050050789.</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru">Sclerotherapy_using_air-_or_CO2-O2-foam. Hirsch R. Iatrogenic laser complications. Clin Dermatol. 2011;29(6):691–695. doi: 10.1016/j.clindermatol.2011.08.010.</mixed-citation><mixed-citation xml:lang="en">Hsia J., Lowery J.A., Zelickson B. Treatment of leg telangiectasia using a long-pulse dye laser at 595 nm. Lasers Surg Med. 1997;20(1):1–5. doi: 10.1002/(SICI)1096-9101(1997)20:1&lt;1::AID-LSM1&gt;3.0.CO;2-U.</mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Hohenleutner U., Wenig M., Walther T., Bäumler W., Landthaler M. Treatment of superficial varicosities with a flashlamp-pumped pulsed dye laser with 1.5 ms impulse time. Hautarzt. 1998;49(7):560–565. doi: 10.1007/s001050050789.</mixed-citation><mixed-citation xml:lang="en">Ianosi G., Ianosi S., Calbureanu-Popescu M.X., Tutunaru C., Calina D., Neagoe D. Comparative study in leg telangiectasias treatment with Nd:YAG laser and sclerotherapy. Exp Ther Med. 2019;17(2):1106–1112. doi: 10.3892/etm.2018.6985.</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru">Hsia J., Lowery J.A., Zelickson B. Treatment of leg telangiectasia using a long-pulse dye laser at 595 nm. Lasers Surg Med. 1997;20(1):1–5. doi: 10.1002/(SICI)1096-9101(1997)20:1&lt;1::AID-LSM1&gt;3.0.CO;2-U.</mixed-citation><mixed-citation xml:lang="en">Ianosi N.G., Neagoe C.D., Tutunaru C.V., CĂlbureanu-Popescu M.X., DrĂguȘin L., GÎngeoveanu G. et al. Single Blind, Randomised Study Regarding the Treatment of the Telangiectasia of the Lower Limbs (C1EAP) Using Polidocanol 0,5%, 1%, and Nd:YAG Laser. Curr Health Sci J. 2020;46(2):141–149. doi: 10.12865/CHSJ.46.02.07.</mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Ianosi G., Ianosi S., Calbureanu-Popescu M.X., Tutunaru C., Calina D., Neagoe D. Comparative study in leg telangiectasias treatment with Nd:YAG laser and sclerotherapy. Exp Ther Med. 2019;17(2):1106–1112. doi: 10.3892/etm.2018.6985.</mixed-citation><mixed-citation xml:lang="en">Imanishi N., Kishi K., Chang H., Nakajima H., Aiso S. Three-dimensional venous anatomy of the dermis observed using stereography. J Anat. 2008;212(5):669–673. doi: 10.1111/j.1469-7580.2008.00890.x.</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru">Ianosi N.G., Neagoe C.D., Tutunaru C.V., CĂlbureanu-Popescu M.X., DrĂguȘin L., GÎngeoveanu G. et al. Single Blind, Randomised Study Regarding the Treatment of the Telangiectasia of the Lower Limbs (C1EAP) Using Polidocanol 0,5%, 1%, and Nd:YAG Laser. Curr Health Sci J. 2020;46(2):141–149. doi: 10.12865/CHSJ.46.02.07.</mixed-citation><mixed-citation xml:lang="en">Imhoff E., Stemmer R. Classification and mechanism of action of sclerosing agents. Phlebologie. 1969;22(2):145–148. (In French). Available at: https://pubmed.ncbi.nlm.nih.gov/5382245/.</mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Imanishi N., Kishi K., Chang H., Nakajima H., Aiso S. Three-dimensional venous anatomy of the dermis observed using stereography. J Anat. 2008;212(5):669–673. doi: 10.1111/j.1469-7580.2008.00890.x.</mixed-citation><mixed-citation xml:lang="en">Iyer S., Fitzpatrick R.E. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31(8):898–903. doi: 10.1097/00042728-200508000-00002.</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru">Imhoff E., Stemmer R. Classification and mechanism of action of sclerosing agents. Phlebologie. 1969;22(2):145–148. (In French). Available at: https://pubmed.ncbi.nlm.nih.gov/5382245/.</mixed-citation><mixed-citation xml:lang="en">Izzo M., Mariani F., Binaghi F., Amitrano M. Postsclerotherapy Hyperpigmentation: Incidence, Clinical Features and Therapy. In: Negus D., Jantet G., Coleridge-Smith P.D. (eds.). Phlebology ’95. London: Springe; 1995, pp. 550–551. doi: 10.1007/978-1-4471-3095-6_255.</mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">Iyer S., Fitzpatrick R.E. Long-pulsed dye laser treatment for facial telangiectasias and erythema: evaluation of a single purpuric pass versus multiple subpurpuric passes. Dermatol Surg. 2005;31(8):898–903. doi: 10.1097/00042728-200508000-00002.</mixed-citation><mixed-citation xml:lang="en">Jaquinandi V., Stivalet O., Grabas M. Cutaneous collagenous vasculopathy: Differential diagnosis of primary telangiectasia as generalized essential telangiectasia, hereditary hemorrhagic telangiectasia, and hereditary benign telangiectasia. Vasc Med. 2019;24(3):261–262. doi: 10.1177/1358863X18803162.</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru">Izzo M., Mariani F., Binaghi F., Amitrano M. Postsclerotherapy Hyperpigmentation: Incidence, Clinical Features and Therapy. In: Negus D., Jantet G., Coleridge-Smith P.D. (eds.). Phlebology ’95. London: Springe; 1995, pp. 550–551. doi: 10.1007/978-1-4471-3095-6_255.</mixed-citation><mixed-citation xml:lang="en">Jørgensen G.F., Hedelund L., Haedersdal M. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation. Lasers Surg Med. 2008;40(5):293–299. doi: 10.1002/lsm.20634.</mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">Jaquinandi V., Stivalet O., Grabas M. Cutaneous collagenous vasculopathy: Differential diagnosis of primary telangiectasia as generalized essential telangiectasia, hereditary hemorrhagic telangiectasia, and hereditary benign telangiectasia. Vasc Med. 2019;24(3):261–262. doi: 10.1177/1358863X18803162.</mixed-citation><mixed-citation xml:lang="en">Kamburoğlu H.O., Ozgür F. Postoperative satisfaction and the patient’s body image, life satisfaction, and self-esteem: a retrospective study comparing adolescent girls and boys after cosmetic surgery. Aesthetic Plast Surg. 2007;31(6):739–745. doi: 10.1007/s00266-006-0133-5.</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru">Jørgensen G.F., Hedelund L., Haedersdal M. Long-pulsed dye laser versus intense pulsed light for photodamaged skin: a randomized split-face trial with blinded response evaluation. Lasers Surg Med. 2008;40(5):293–299. doi: 10.1002/lsm.20634.</mixed-citation><mixed-citation xml:lang="en">Kamhawy A.H., Elbarbary A.H., Elhenidy M.A., Elwagih A.M.M. Periulcer Foam Sclerotherapy Injection in Chronic Venous Leg Ulcers Using Near-Infrared laser for Vein Visualization. Int J Low Extrem Wounds. 2020;19(1):63–69. doi: 10.1177/1534734619870680.</mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Kamburoğlu H.O., Ozgür F. Postoperative satisfaction and the patient’s body image, life satisfaction, and self-esteem: a retrospective study comparing adolescent girls and boys after cosmetic surgery. Aesthetic Plast Surg. 2007;31(6):739–745. doi: 10.1007/s00266-006-0133-5.</mixed-citation><mixed-citation xml:lang="en">Karsai S., Roos S., Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34(5):702–708. doi: 10.1111/j.1524-4725.2008.34131.x.</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru">Kamhawy A.H., Elbarbary A.H., Elhenidy M.A., Elwagih A.M.M. Periulcer Foam Sclerotherapy Injection in Chronic Venous Leg Ulcers Using Near-Infrared laser for Vein Visualization. Int J Low Extrem Wounds. 2020;19(1):63–69. doi: 10.1177/1534734619870680.</mixed-citation><mixed-citation xml:lang="en">Kaudewitz P., Klövekorn W., Rother W. Treatment of leg vein telangiectases: 1-year results with a new 940 nm diode laser. Dermatol Surg. 2002;28(11):1031–1034. doi: 10.1046/j.1524-4725.2002.02083.x.</mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Karsai S., Roos S., Raulin C. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation. Dermatol Surg. 2008;34(5):702–708. doi: 10.1111/j.1524-4725.2008.34131.x.</mixed-citation><mixed-citation xml:lang="en">Kauvar A.N., Lou W.W. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol. 2000;136(11):1371–1375. Available at: https://jamanetwork.com/journals/jamadermatology/fullarticle/190750.</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru">Kaudewitz P., Klövekorn W., Rother W. Treatment of leg vein telangiectases: 1-year results with a new 940 nm diode laser. Dermatol Surg. 2002;28(11):1031–1034. doi: 10.1046/j.1524-4725.2002.02083.x.</mixed-citation><mixed-citation xml:lang="en">Kauvar A.N.B., Khrom T. Laser treatment of leg veins. Semin Cutan Med Surg. 2005;24(4):184–192. doi: 10.1016/j.sder.2005.10.003.</mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Kauvar A.N., Lou W.W. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol. 2000;136(11):1371–1375. Available at: https://jamanetwork.com/journals/jamadermatology/fullarticle/190750.</mixed-citation><mixed-citation xml:lang="en">Kaygin M.A., Halici U. Evaluation of liquid or foam sclerotherapy in small varicose veins (ceap c1) with venous clinical severity score. Rev Assoc Med Bras. 2018;64(12):1117–1121. doi: 10.1590/1806-9282.64.12.1117.</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru">Kauvar A.N.B., Khrom T. Laser treatment of leg veins. Semin Cutan Med Surg. 2005;24(4):184–192. doi: 10.1016/j.sder.2005.10.003.</mixed-citation><mixed-citation xml:lang="en">Kern P. Pathophysiology of telangiectasias of the lower legs and its therapeutic implication: A systematic review. Phlebology. 2018;33(4):225–233. doi: 10.1177/0268355518756480.</mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Kaygin M.A., Halici U. Evaluation of liquid or foam sclerotherapy in small varicose veins (ceap c1) with venous clinical severity score. Rev Assoc Med Bras. 2018;64(12):1117–1121. doi: 10.1590/1806-9282.64.12.1117.</mixed-citation><mixed-citation xml:lang="en">Kern P., Ramelet A.A., Wutschert R., Mazzolai L. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Dermatol Surg. 2011;37(11):1590–1594. doi: 10.1111/j.1524-4725.2011.02130.x.</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru">Kern P. Pathophysiology of telangiectasias of the lower legs and its therapeutic implication: A systematic review. Phlebology. 2018;33(4):225–233. doi: 10.1177/0268355518756480.</mixed-citation><mixed-citation xml:lang="en">Kern P., Ramelet A.A., Wutschert R., Bounameaux H., Hayoz D. Singleblind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004;30(3):367–372. doi: 10.1111/j.1524-4725.2004.30102.x.</mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Kern P., Ramelet A.A., Wutschert R., Mazzolai L. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Dermatol Surg. 2011;37(11):1590–1594. doi: 10.1111/j.1524-4725.2011.02130.x.</mixed-citation><mixed-citation xml:lang="en">Kern P., Ramelet A.-A., Wütschert R., Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg. 2007;45(6):1212–1216. doi: 10.1016/j.jvs.2007.02.039.</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru">Kern P., Ramelet A.A., Wutschert R., Bounameaux H., Hayoz D. Singleblind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004;30(3):367–372. doi: 10.1111/j.1524-4725.2004.30102.x.</mixed-citation><mixed-citation xml:lang="en">Kersten R.C., Kulwin D.R. Management of cosmetically objectionable veins in the lower eyelids. Arch Ophthalmol. 1989;107(2):278–280. Available at: https://jamanetwork.com/journals/jamaophthalmology/article-abstract/637687.</mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">Kern P., Ramelet A.-A., Wütschert R., Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg. 2007;45(6):1212–1216. doi: 10.1016/j.jvs.2007.02.039.</mixed-citation><mixed-citation xml:lang="en">Khunger N., Sacchidanand S. Standard guidelines for care: sclerotherapy in dermatology. Indian J Dermatol Venereol Leprol. 2011;77(2):222–231. doi: 10.4103/0378-6323.77478.</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru">Kersten R.C., Kulwin D.R. Management of cosmetically objectionable veins in the lower eyelids. Arch Ophthalmol. 1989;107(2):278–280. Available at: https://jamanetwork.com/journals/jamaophthalmology/article-abstract/637687.</mixed-citation><mixed-citation xml:lang="en">Kikuchi M., Hosokawa K. Visualized sclerotherapy of varicose veins. Dermatol Surg. 2010;36(2 Suppl.):1050–1055. doi: 10.1111/j.1524-4725.2009.01410.x.</mixed-citation></citation-alternatives></ref><ref id="cit161"><label>161</label><citation-alternatives><mixed-citation xml:lang="ru">Khunger N., Sacchidanand S. Standard guidelines for care: sclerotherapy in dermatology. Indian J Dermatol Venereol Leprol. 2011;77(2):222–231. doi: 10.4103/0378-6323.77478.</mixed-citation><mixed-citation xml:lang="en">Klein A., Bäumler W., Koller M., Shafirstein G., Kohl E.A., Landthaler M. et al. Indocyanine green-augmented diode laser therapy of telangiectatic leg veins: a randomized controlled proof-of-concept trial. Lasers Surg Med. 2012;44(5):369–376. doi: 10.1002/lsm.22022.</mixed-citation></citation-alternatives></ref><ref id="cit162"><label>162</label><citation-alternatives><mixed-citation xml:lang="ru">Kikuchi M., Hosokawa K. Visualized sclerotherapy of varicose veins. Dermatol Surg. 2010;36(2 Suppl.):1050–1055. doi: 10.1111/j.1524-4725.2009.01410.x.</mixed-citation><mixed-citation xml:lang="en">Klein A., Buschmann M., Babilas P., Landthaler M., Bäumler W. Indocyanine green-augmented diode laser therapy vs. long-pulsed Nd:YAG (1064 nm) laser treatment of telangiectatic leg veins: a randomized controlled trial. Br J Dermatol. 2013;169(2):365–373. doi: 10.1111/bjd.12415.</mixed-citation></citation-alternatives></ref><ref id="cit163"><label>163</label><citation-alternatives><mixed-citation xml:lang="ru">Klein A., Bäumler W., Koller M., Shafirstein G., Kohl E.A., Landthaler M. et al. Indocyanine green-augmented diode laser therapy of telangiectatic leg veins: a randomized controlled proof-of-concept trial. Lasers Surg Med. 2012;44(5):369–376. doi: 10.1002/lsm.22022.</mixed-citation><mixed-citation xml:lang="en">Kono T., Yamaki T., Erçöçen A.R., Fujiwara O., Nozaki M. Treatment of leg veins with the long pulse dye laser using variable pulse durations and energy fluences. Lasers Surg Med. 2004;35(1):62–67. doi: 10.1002/lsm.20035.</mixed-citation></citation-alternatives></ref><ref id="cit164"><label>164</label><citation-alternatives><mixed-citation xml:lang="ru">Klein A., Buschmann M., Babilas P., Landthaler M., Bäumler W. Indocyanine green-augmented diode laser therapy vs. long-pulsed Nd:YAG (1064 nm) laser treatment of telangiectatic leg veins: a randomized controlled trial. Br J Dermatol. 2013;169(2):365–373. doi: 10.1111/bjd.12415.</mixed-citation><mixed-citation xml:lang="en">Kröger K., Ose C., Rudofsky G., Roesener J., Hirche H. Symptoms in individuals with small cutaneous veins. Vasc Med. 2002;7(1):13–17. doi: 10.1191/1358863x02vm416oa.</mixed-citation></citation-alternatives></ref><ref id="cit165"><label>165</label><citation-alternatives><mixed-citation xml:lang="ru">Kono T., Yamaki T., Erçöçen A.R., Fujiwara O., Nozaki M. Treatment of leg veins with the long pulse dye laser using variable pulse durations and energy fluences. Lasers Surg Med. 2004;35(1):62–67. doi: 10.1002/lsm.20035.</mixed-citation><mixed-citation xml:lang="en">Kunishige J.H., Goldberg L.H., Friedman P.M. Laser therapy for leg veins. Clin Dermatol. 2007;25(5):454–461. doi: 10.1016/j.clindermatol.2007.05.008.</mixed-citation></citation-alternatives></ref><ref id="cit166"><label>166</label><citation-alternatives><mixed-citation xml:lang="ru">Kröger K., Ose C., Rudofsky G., Roesener J., Hirche H. Symptoms in individuals with small cutaneous veins. Vasc Med. 2002;7(1):13–17. doi: 10.1191/1358863x02vm416oa.</mixed-citation><mixed-citation xml:lang="en">Lai S.W., Goldman M.P. Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser. J Cosmet Dermatol. 2007;6(1):6–8. doi: 10.1111/j.1473-2165.2007.00256.x.</mixed-citation></citation-alternatives></ref><ref id="cit167"><label>167</label><citation-alternatives><mixed-citation xml:lang="ru">Kunishige J.H., Goldberg L.H., Friedman P.M. Laser therapy for leg veins. Clin Dermatol. 2007;25(5):454–461. doi: 10.1016/j.clindermatol.2007.05.008.</mixed-citation><mixed-citation xml:lang="en">Langer R.D., Ho E., Denenberg J.O., Fronek A., Allison M., Criqui M.H. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med. 2005;165(12):1420–1424. Available at: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/486623.</mixed-citation></citation-alternatives></ref><ref id="cit168"><label>168</label><citation-alternatives><mixed-citation xml:lang="ru">Lai S.W., Goldman M.P. Treatment of facial reticular veins with dynamically cooled, variable spot-sized 1064 nm Nd:YAG laser. J Cosmet Dermatol. 2007;6(1):6–8. doi: 10.1111/j.1473-2165.2007.00256.x.</mixed-citation><mixed-citation xml:lang="en">Leach B.C., Goldman M.P. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg. 2003;29(6):612–614. doi: 10.1046/j.1524-4725.2003.29148.x.</mixed-citation></citation-alternatives></ref><ref id="cit169"><label>169</label><citation-alternatives><mixed-citation xml:lang="ru">Langer R.D., Ho E., Denenberg J.O., Fronek A., Allison M., Criqui M.H. Relationships between symptoms and venous disease: the San Diego population study. Arch Intern Med. 2005;165(12):1420–1424. Available at: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/486623.</mixed-citation><mixed-citation xml:lang="en">Lee B.B., Nicolaides A.N., Myers K., Meissner M., Kalodiki E., Allegra C. et al. Venous hemodynamic changes in lower limb venous disease: the UIP consensus according to scientific evidence. Int Angiol. 2016;35(3):236–352. Available at: https://pubmed.ncbi.nlm.nih.gov/27013029/.</mixed-citation></citation-alternatives></ref><ref id="cit170"><label>170</label><citation-alternatives><mixed-citation xml:lang="ru">Leach B.C., Goldman M.P. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg. 2003;29(6):612–614. doi: 10.1046/j.1524-4725.2003.29148.x.</mixed-citation><mixed-citation xml:lang="en">Lee B.J. The role of sclerotherapy in abnormal varicose hand veins. Plast Reconstr Surg. 2000;106(1):227–229. doi: 10.1097/00006534-200007000-00057.</mixed-citation></citation-alternatives></ref><ref id="cit171"><label>171</label><citation-alternatives><mixed-citation xml:lang="ru">Lee B.B., Nicolaides A.N., Myers K., Meissner M., Kalodiki E., Allegra C. et al. Venous hemodynamic changes in lower limb venous disease: the UIP consensus according to scientific evidence. Int Angiol. 2016;35(3):236–352. Available at: https://pubmed.ncbi.nlm.nih.gov/27013029/.</mixed-citation><mixed-citation xml:lang="en">Leslie-Mazwi T.M., Avery L.L., Sims J.R. Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care. 2009;11(1):97–100. doi: 10.1007/s12028-009-9202-3.</mixed-citation></citation-alternatives></ref><ref id="cit172"><label>172</label><citation-alternatives><mixed-citation xml:lang="ru">Lee B.J. The role of sclerotherapy in abnormal varicose hand veins. Plast Reconstr Surg. 2000;106(1):227–229. doi: 10.1097/00006534-200007000-00057.</mixed-citation><mixed-citation xml:lang="en">Levy J.L., Elbahr C., Jouve E., Mordon S. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med. 2004;34(3):273–276. doi: 10.1002/lsm.20010.</mixed-citation></citation-alternatives></ref><ref id="cit173"><label>173</label><citation-alternatives><mixed-citation xml:lang="ru">Leslie-Mazwi T.M., Avery L.L., Sims J.R. Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care. 2009;11(1):97–100. doi: 10.1007/s12028-009-9202-3.</mixed-citation><mixed-citation xml:lang="en">Lopez L., Dilley R.B., Henriquez J.A. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate. Dermatol Surg. 2001;27(9):795–798. doi: 10.1046/j.1524-4725.2001.01052.x.</mixed-citation></citation-alternatives></ref><ref id="cit174"><label>174</label><citation-alternatives><mixed-citation xml:lang="ru">Levy J.L., Elbahr C., Jouve E., Mordon S. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med. 2004;34(3):273–276. doi: 10.1002/lsm.20010.</mixed-citation><mixed-citation xml:lang="en">Lupton J.R., Alster T.S., Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg. 2002;28(8):694–697. doi: 10.1046/j.1524-4725.2002.02029.x.</mixed-citation></citation-alternatives></ref><ref id="cit175"><label>175</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez L., Dilley R.B., Henriquez J.A. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate. Dermatol Surg. 2001;27(9):795–798. doi: 10.1046/j.1524-4725.2001.01052.x.</mixed-citation><mixed-citation xml:lang="en">Lurie F., Passman M., Meisner M., Dalsing M., Masuda E., Welch H. et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342–352. doi: 10.1016/j.jvsv.2019.12.075.</mixed-citation></citation-alternatives></ref><ref id="cit176"><label>176</label><citation-alternatives><mixed-citation xml:lang="ru">Lupton J.R., Alster T.S., Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg. 2002;28(8):694–697. doi: 10.1046/j.1524-4725.2002.02029.x.</mixed-citation><mixed-citation xml:lang="en">Major A., Brazzini B., Campolmi P., Bonan P., Mavilia L., Ghersetich I. et al. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559–565. doi: 10.1046/j.1468-3083.2001.00354.x.</mixed-citation></citation-alternatives></ref><ref id="cit177"><label>177</label><citation-alternatives><mixed-citation xml:lang="ru">Lurie F., Passman M., Meisner M., Dalsing M., Masuda E., Welch H. et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342–352. doi: 10.1016/j.jvsv.2019.12.075.</mixed-citation><mixed-citation xml:lang="en">Mariani F., Bianchi V., Mancini S., Mancini S. Telangiectases in Venous Insufficiency: Point of Reflux and Treatment Strategy. Phlebology. 2000;15(1):38–42. doi: 10.1177/026835550001500107.</mixed-citation></citation-alternatives></ref><ref id="cit178"><label>178</label><citation-alternatives><mixed-citation xml:lang="ru">Major A., Brazzini B., Campolmi P., Bonan P., Mavilia L., Ghersetich I. et al. Nd:YAG 1064 nm laser in the treatment of facial and leg telangiectasias. J Eur Acad Dermatol Venereol. 2001;15(6):559–565. doi: 10.1046/j.1468-3083.2001.00354.x.</mixed-citation><mixed-citation xml:lang="en">McCoppin H.H., Hovenic W.W., Wheeland R.G. Laser treatment of superficial leg veins: a review. Dermatol Surg. 2011;37(6):729–741. doi: 10.1111/j.1524-4725.2011.01990..x.</mixed-citation></citation-alternatives></ref><ref id="cit179"><label>179</label><citation-alternatives><mixed-citation xml:lang="ru">Mariani F., Bianchi V., Mancini S., Mancini S. Telangiectases in Venous Insufficiency: Point of Reflux and Treatment Strategy. Phlebology. 2000;15(1):38–42. doi: 10.1177/026835550001500107.</mixed-citation><mixed-citation xml:lang="en">McCoy S., Evans A., Spurrier N. Sclerotherapy for leg telangiectasia – a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 1999;25(5):381–385. doi: 10.1046/j.1524-4725.1999.08263.x.</mixed-citation></citation-alternatives></ref><ref id="cit180"><label>180</label><citation-alternatives><mixed-citation xml:lang="ru">McCoppin H.H., Hovenic W.W., Wheeland R.G. Laser treatment of superficial leg veins: a review. Dermatol Surg. 2011;37(6):729–741. doi: 10.1111/j.1524-4725.2011.01990..x.</mixed-citation><mixed-citation xml:lang="en">McDaniel D.H., Ash K., Lord J., Newman J., Adrian R.M., Zukowski M. Laser therapy of spider leg veins: clinical evaluation of a new long pulsed alexandrite laser. Dermatol Surg. 1999;25(1):52–58. doi: 10.1046/j.1524-4725.1999.08117.x.</mixed-citation></citation-alternatives></ref><ref id="cit181"><label>181</label><citation-alternatives><mixed-citation xml:lang="ru">McCoy S., Evans A., Spurrier N. Sclerotherapy for leg telangiectasia – a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 1999;25(5):381–385. doi: 10.1046/j.1524-4725.1999.08263.x.</mixed-citation><mixed-citation xml:lang="en">Meesters A.A., Pitassi L.H.U., Campos V., Wolkerstorfer A., Dierickx C.C. Transcutaneous laser treatment of leg veins. Lasers Med Sci. 2014;29(2):481–492. doi: 10.1007/s10103-013-1483-2.</mixed-citation></citation-alternatives></ref><ref id="cit182"><label>182</label><citation-alternatives><mixed-citation xml:lang="ru">McDaniel D.H., Ash K., Lord J., Newman J., Adrian R.M., Zukowski M. Laser therapy of spider leg veins: clinical evaluation of a new long pulsed alexandrite laser. Dermatol Surg. 1999;25(1):52–58. doi: 10.1046/j.1524-4725.1999.08117.x.</mixed-citation><mixed-citation xml:lang="en">Miyake H., Langer B., Albers M.T., Bouabci A.S., Telles J.D. Tratamento cirúrgico das telangiectasias [Surgical treatment of telangiectasis]. Rev Hosp Clin Fac Med Sao Paulo. 1993;48(5):209–213. Available at: https://pubmed.ncbi.nlm.nih.gov/8165405/.</mixed-citation></citation-alternatives></ref><ref id="cit183"><label>183</label><citation-alternatives><mixed-citation xml:lang="ru">Meesters A.A., Pitassi L.H.U., Campos V., Wolkerstorfer A., Dierickx C.C. Transcutaneous laser treatment of leg veins. Lasers Med Sci. 2014;29(2):481–492. doi: 10.1007/s10103-013-1483-2.</mixed-citation><mixed-citation xml:lang="en">Miyake K., Pires-Davidson J.R. Augmented reality and duplex ultrasound in medical treatment decision: score 9–1. J Phlebol Lymphol. 2019;12(1):1–2. Available at: https://pulsus.com/scholarlyarticles/augmented-reality-and-duplex-ultrasound-in-medicaltreatment-decision-score-91.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit184"><label>184</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake H., Langer B., Albers M.T., Bouabci A.S., Telles J.D. Tratamento cirúrgico das telangiectasias [Surgical treatment of telangiectasis]. Rev Hosp Clin Fac Med Sao Paulo. 1993;48(5):209–213. Available at: https://pubmed.ncbi.nlm.nih.gov/8165405/.</mixed-citation><mixed-citation xml:lang="en">Miyake R., Duarte F., Fidelis R., Miyake H. New leg veins air cooled treatment using 1064 nm laser combined with sclerotherapy. Technique description and one year followup. Lasers Med Sci. 2003;18:S22.</mixed-citation></citation-alternatives></ref><ref id="cit185"><label>185</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake K., Pires-Davidson J.R. Augmented reality and duplex ultrasound in medical treatment decision: score 9–1. J Phlebol Lymphol. 2019;12(1):1–2. Available at: https://pulsus.com/scholarlyarticles/augmented-reality-and-duplex-ultrasound-in-medicaltreatment-decision-score-91.pdf.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K. Cryo-laser and cryo-sclerotherapy guided by Augmented Reality. Report of 140 Cases. Phlebologie. 2014;43:257–261. Available at: https://thieme-connect.com/products/ejournals/abstract/10.12687/phleb2218-5-2014.</mixed-citation></citation-alternatives></ref><ref id="cit186"><label>186</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R., Duarte F., Fidelis R., Miyake H. New leg veins air cooled treatment using 1064 nm laser combined with sclerotherapy. Technique description and one year followup. Lasers Med Sci. 2003;18:S22.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K. Cryo-laser and cryo-sclerotherapy guided by Augmented Reality Report of 140 Cases. Phlebologie-Stuttgart. 2014;43(5):257–261. doi: 10.12687/phleb2218-5-2014.</mixed-citation></citation-alternatives></ref><ref id="cit187"><label>187</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K. Cryo-laser and cryo-sclerotherapy guided by Augmented Reality. Report of 140 Cases. Phlebologie. 2014;43:257–261. Available at: https://thieme-connect.com/products/ejournals/abstract/10.12687/phleb2218-5-2014.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., Chi Y.W., Franklin I.J., Gianesini S. State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment. J Vasc Surg Venous Lymphat Disord. 2020;8(5):893–895. doi: 10.1016/j.jvsv.2020.01.003.</mixed-citation></citation-alternatives></ref><ref id="cit188"><label>188</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K. Cryo-laser and cryo-sclerotherapy guided by Augmented Reality Report of 140 Cases. Phlebologie-Stuttgart. 2014;43(5):257–261. doi: 10.12687/phleb2218-5-2014.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., Kikuchi R., Duarte F.H., Davidson J., Miyake H. Digital Vein Mapping Guiding laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Flebologia y Linfologia / Lecturas Vasculares. 2009;4:569–576. Available at: http://www.sflb.com.ar/revista/2009_04_10-03.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit189"><label>189</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., Chi Y.W., Franklin I.J., Gianesini S. State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment. J Vasc Surg Venous Lymphat Disord. 2020;8(5):893–895. doi: 10.1016/j.jvsv.2020.01.003.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., Kikuchi R., Duarte F.H., Davidson J., Miyake H. Digital Vein Mapping Guiding laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Flebologia y Linfologia / Lecturas Vasculares. 2009;4:569–576.</mixed-citation></citation-alternatives></ref><ref id="cit190"><label>190</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., Kikuchi R., Duarte F.H., Davidson J., Miyake H. Digital Vein Mapping Guiding laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Flebologia y Linfologia / Lecturas Vasculares. 2009;4:569–576. Available at: http://www.sflb.com.ar/revista/2009_04_10-03.pdf.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., King J.T., Kikuchi R., Duarte F.H., Davidson J.R.P., Oba C. Role of injection pressure, flow and sclerosant viscosity in causing cutaneous ulceration during sclerotherapy. Phlebology. 2012;27(8):383–389. doi: 10.1258/phleb.2011.011076.</mixed-citation></citation-alternatives></ref><ref id="cit191"><label>191</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., Kikuchi R., Duarte F.H., Davidson J., Miyake H. Digital Vein Mapping Guiding laser and Injection sclerotherapy to treat telangiectasias and Feeder Veins: Report of 140 Cases. Flebologia y Linfologia / Lecturas Vasculares. 2009;4:569–576.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., Ramacciotti E. Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment – The CLaCS technique white paper report. J Phlebol Lymphol. 2019;12(1):1–7. Available at: https://www.pulsus.com/scholarlyarticles/cryolaser-and-cryosclerotherapy-guided-by-augmented-realityfor-telangiectasias-feeder-and-small-varicose-vein-treatment.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit192"><label>192</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., King J.T., Kikuchi R., Duarte F.H., Davidson J.R.P., Oba C. Role of injection pressure, flow and sclerosant viscosity in causing cutaneous ulceration during sclerotherapy. Phlebology. 2012;27(8):383–389. doi: 10.1258/phleb.2011.011076.</mixed-citation><mixed-citation xml:lang="en">Miyake R.K., Zeman H.D., Duarte F.H., Kikuchi R., Ramacciotti E., Lovhoiden G. et al. Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment. Dermatol Surg. 2006;32(8):1031–1038. doi: 10.1111/j.1524-4725.2006.32226.x.</mixed-citation></citation-alternatives></ref><ref id="cit193"><label>193</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., Ramacciotti E. Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment – The CLaCS technique white paper report. J Phlebol Lymphol. 2019;12(1):1–7. Available at: https://www.pulsus.com/scholarlyarticles/cryolaser-and-cryosclerotherapy-guided-by-augmented-realityfor-telangiectasias-feeder-and-small-varicose-vein-treatment.pdf.</mixed-citation><mixed-citation xml:lang="en">Mlosek R.K., Woźniak W., Malinowska S., Migda B., Serafin-Król M., Miłek T. The removal of post-sclerotherapy pigmentation following sclerotherapy alone or in combination with crossectomy. Eur J Vasc Endovasc Surg. 2012;43(1):100–105. doi: 10.1016/j.ejvs.2011.10.005.</mixed-citation></citation-alternatives></ref><ref id="cit194"><label>194</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake R.K., Zeman H.D., Duarte F.H., Kikuchi R., Ramacciotti E., Lovhoiden G. et al. Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment. Dermatol Surg. 2006;32(8):1031–1038. doi: 10.1111/j.1524-4725.2006.32226.x.</mixed-citation><mixed-citation xml:lang="en">Moreno-Moraga J., Hernández E., Royo J., Alcolea J., Isarría M.J., Pascu M.L. et al. Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection. Lasers Med Sci. 2013;28(3):925–933. doi: 10.1007/s10103-012-1180-6.</mixed-citation></citation-alternatives></ref><ref id="cit195"><label>195</label><citation-alternatives><mixed-citation xml:lang="ru">Mlosek R.K., Woźniak W., Malinowska S., Migda B., Serafin-Król M., Miłek T. The removal of post-sclerotherapy pigmentation following sclerotherapy alone or in combination with crossectomy. Eur J Vasc Endovasc Surg. 2012;43(1):100–105. doi: 10.1016/j.ejvs.2011.10.005.</mixed-citation><mixed-citation xml:lang="en">Moreno-Moraga J., Pascu M.L., Alcolea J.M., Smarandache A., Royo J., David F. et al. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment. Lasers Med Sci. 2019;34(7):1325–1332. doi: 10.1007/s10103-019-02736-1.</mixed-citation></citation-alternatives></ref><ref id="cit196"><label>196</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Moraga J., Hernández E., Royo J., Alcolea J., Isarría M.J., Pascu M.L. et al. Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection. Lasers Med Sci. 2013;28(3):925–933. doi: 10.1007/s10103-012-1180-6.</mixed-citation><mixed-citation xml:lang="en">Moreno-Moraga J., Smarandache A., Pascu M.L., Royo J., Trelles M.A. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Phlebology. 2014;29(10):658–666. doi: 10.1177/0268355513502786.</mixed-citation></citation-alternatives></ref><ref id="cit197"><label>197</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Moraga J., Pascu M.L., Alcolea J.M., Smarandache A., Royo J., David F. et al. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment. Lasers Med Sci. 2019;34(7):1325–1332. doi: 10.1007/s10103-019-02736-1.</mixed-citation><mixed-citation xml:lang="en">Munavalli G.S., Weiss R.A. Complications of sclerotherapy. Semin Cutan Med Surg. 2007;26(1):22–28. doi: 10.1016/j.sder.2006.12.009.</mixed-citation></citation-alternatives></ref><ref id="cit198"><label>198</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Moraga J., Smarandache A., Pascu M.L., Royo J., Trelles M.A. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Phlebology. 2014;29(10):658–666. doi: 10.1177/0268355513502786.</mixed-citation><mixed-citation xml:lang="en">Munia M.A., Wolosker N., Munia C.G., Chao W.S., Puech-Leão P. Comparison of laser versus sclerotherapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg. 2012;38(4):635–639. doi: 10.1111/j.1524-4725.2011.02226.x.</mixed-citation></citation-alternatives></ref><ref id="cit199"><label>199</label><citation-alternatives><mixed-citation xml:lang="ru">Munavalli G.S., Weiss R.A. Complications of sclerotherapy. Semin Cutan Med Surg. 2007;26(1):22–28. doi: 10.1016/j.sder.2006.12.009.</mixed-citation><mixed-citation xml:lang="en">Munia M.A., Wolosker N., Munia C.G., Chao W.S., Puech-Leão P. Comparison of laser versus sclerotherapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg. 2012;38(4):635–639. doi: 10.1002/lsm.10028.</mixed-citation></citation-alternatives></ref><ref id="cit200"><label>200</label><citation-alternatives><mixed-citation xml:lang="ru">Munia M.A., Wolosker N., Munia C.G., Chao W.S., Puech-Leão P. Comparison of laser versus sclerotherapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg. 2012;38(4):635–639. doi: 10.1111/j.1524-4725.2011.02226.x.</mixed-citation><mixed-citation xml:lang="en">Nakano L.C.U., Cacione D.G., Baptista-Silva J.C.C., Flumignan R.L.G. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev. 2017;(7):CD012723. doi: 10.1002/14651858.CD012723.</mixed-citation></citation-alternatives></ref><ref id="cit201"><label>201</label><citation-alternatives><mixed-citation xml:lang="ru">Munia M.A., Wolosker N., Munia C.G., Chao W.S., Puech-Leão P. Comparison of laser versus sclerotherapy in the treatment of lower extremity telangiectases: a prospective study. Dermatol Surg. 2012;38(4):635–639. doi: 10.1002/lsm.10028.</mixed-citation><mixed-citation xml:lang="en">Nakano L.C.U., Cacione D.G., Baptista-Silva J.C.C., Flumignan R.L.G. Treatment for telangiectasias and reticular veins (protocol). Cochrane Database Syst Rev. 2017(7):CD012723. doi: 10.1002/14651858.CD012723.</mixed-citation></citation-alternatives></ref><ref id="cit202"><label>202</label><citation-alternatives><mixed-citation xml:lang="ru">Nakano L.C.U., Cacione D.G., Baptista-Silva J.C.C., Flumignan R.L.G. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev. 2017;(7):CD012723. doi: 10.1002/14651858.CD012723.</mixed-citation><mixed-citation xml:lang="en">Navratil L., Kymplova J. Contraindications in noninvasive laser therapy: truth and fiction. J Clin laser Med Surg. 2002;20(6):341–343. doi: 10.1089/104454702320901134.</mixed-citation></citation-alternatives></ref><ref id="cit203"><label>203</label><citation-alternatives><mixed-citation xml:lang="ru">Nakano L.C.U., Cacione D.G., Baptista-Silva J.C.C., Flumignan R.L.G. Treatment for telangiectasias and reticular veins (protocol). Cochrane Database Syst Rev. 2017(7):CD012723. doi: 10.1002/14651858.CD012723.</mixed-citation><mixed-citation xml:lang="en">Nicolaides A.N. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease. Adv Ther. 2020;37(1 Suppl.):1–5. doi: 10.1007/s12325-019-01218-8.</mixed-citation></citation-alternatives></ref><ref id="cit204"><label>204</label><citation-alternatives><mixed-citation xml:lang="ru">Navratil L., Kymplova J. Contraindications in noninvasive laser therapy: truth and fiction. J Clin laser Med Surg. 2002;20(6):341–343. doi: 10.1089/104454702320901134.</mixed-citation><mixed-citation xml:lang="en">Noël B. Polidocanol or chromated glycerin for sclerotherapy of telangiectatic leg veins? With reply from Dr Kern et al. Dermatol Surg. 2004;30(9):1272. doi: 10.1111/j.1524-4725.2004.30393.x.</mixed-citation></citation-alternatives></ref><ref id="cit205"><label>205</label><citation-alternatives><mixed-citation xml:lang="ru">Nicolaides A.N. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease. Adv Ther. 2020;37(1 Suppl.):1–5. doi: 10.1007/s12325-019-01218-8.</mixed-citation><mixed-citation xml:lang="en">Nootheti P.K., Cadag K.M., Magpantay A., Goldman M.P. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. Dermatol Surg. 2009;35(1):53–58. doi: 10.1111/j.1524-4725.2008.34382.x.</mixed-citation></citation-alternatives></ref><ref id="cit206"><label>206</label><citation-alternatives><mixed-citation xml:lang="ru">Noël B. Polidocanol or chromated glycerin for sclerotherapy of telangiectatic leg veins? With reply from Dr Kern et al. Dermatol Surg. 2004;30(9):1272. doi: 10.1111/j.1524-4725.2004.30393.x.</mixed-citation><mixed-citation xml:lang="en">Norris M.J., Carlin M.C., Ratz J.L. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad Dermatol. 1989;20(4):643–649. doi: 10.1016/s0190-9622(89)70077-3.</mixed-citation></citation-alternatives></ref><ref id="cit207"><label>207</label><citation-alternatives><mixed-citation xml:lang="ru">Nootheti P.K., Cadag K.M., Magpantay A., Goldman M.P. Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. Dermatol Surg. 2009;35(1):53–58. doi: 10.1111/j.1524-4725.2008.34382.x.</mixed-citation><mixed-citation xml:lang="en">Nymann P., Hedelund L., Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. doi: 10.1111/j.1468-3083.2009.03357.x.</mixed-citation></citation-alternatives></ref><ref id="cit208"><label>208</label><citation-alternatives><mixed-citation xml:lang="ru">Norris M.J., Carlin M.C., Ratz J.L. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol. J Am Acad Dermatol. 1989;20(4):643–649. doi: 10.1016/s0190-9622(89)70077-3.</mixed-citation><mixed-citation xml:lang="en">Ozyurt K., Colgecen E., Baykan H., Ozturk P., Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with the long-pulsed 1064 nm Nd:YAG laser. Scientific World Journal. 2012;2012:197139. doi: 10.1100/2012/197139.</mixed-citation></citation-alternatives></ref><ref id="cit209"><label>209</label><citation-alternatives><mixed-citation xml:lang="ru">Nymann P., Hedelund L., Haedersdal M. Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2010;24(2):143–146. doi: 10.1111/j.1468-3083.2009.03357.x.</mixed-citation><mixed-citation xml:lang="en">Palm M.D., Guiha I.C., Goldman M.P. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg. 2010;36(2 Suppl.):2:1026–1033. doi: 10.1111/j.1524-4725.2010.01496.x.</mixed-citation></citation-alternatives></ref><ref id="cit210"><label>210</label><citation-alternatives><mixed-citation xml:lang="ru">Ozyurt K., Colgecen E., Baykan H., Ozturk P., Ozkose M. Treatment of superficial cutaneous vascular lesions: experience with the long-pulsed 1064 nm Nd:YAG laser. Scientific World Journal. 2012;2012:197139. doi: 10.1100/2012/197139.</mixed-citation><mixed-citation xml:lang="en">Parlar B., Blazek C., Cazzaniga S., Naldi L., Kloetgen H.W., Borradori L. et al. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol. 2015;29(3):549–554. doi: 10.1111/jdv.12627.</mixed-citation></citation-alternatives></ref><ref id="cit211"><label>211</label><citation-alternatives><mixed-citation xml:lang="ru">Palm M.D., Guiha I.C., Goldman M.P. Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects. Dermatol Surg. 2010;36(2 Suppl.):2:1026–1033. doi: 10.1111/j.1524-4725.2010.01496.x.</mixed-citation><mixed-citation xml:lang="en">Parlette E.C., Groff W.F., Kinshella M.J., Domankevitz Y., O’Neill J., Ross E.V. Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser. Lasers Surg Med. 2006;38(2):98–105. doi: 10.1002/lsm.20245.</mixed-citation></citation-alternatives></ref><ref id="cit212"><label>212</label><citation-alternatives><mixed-citation xml:lang="ru">Parlar B., Blazek C., Cazzaniga S., Naldi L., Kloetgen H.W., Borradori L. et al. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol. 2015;29(3):549–554. doi: 10.1111/jdv.12627.</mixed-citation><mixed-citation xml:lang="en">Passeron T., Olivier V., Duteil L., Desruelles F., Fontas E., Ortonne J.-P. The new 940-nanometer diode laser: an effective treatment for leg venulectasia. J Am Acad Dermatol. 2003;48(5):768–774. doi. org/10.1067/mjd.2003.191.</mixed-citation></citation-alternatives></ref><ref id="cit213"><label>213</label><citation-alternatives><mixed-citation xml:lang="ru">Parlette E.C., Groff W.F., Kinshella M.J., Domankevitz Y., O’Neill J., Ross E.V. Optimal pulse durations for the treatment of leg telangiectasias with a neodymium YAG laser. Lasers Surg Med. 2006;38(2):98–105. doi: 10.1002/lsm.20245.</mixed-citation><mixed-citation xml:lang="en">Perrin M., Eklof B., VAN Rij A., Labropoulos N., Vasquez M., Nicolaides A. et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374–398. Available at: https://pubmed.ncbi.nlm.nih.gov/27081866/.</mixed-citation></citation-alternatives></ref><ref id="cit214"><label>214</label><citation-alternatives><mixed-citation xml:lang="ru">Passeron T., Olivier V., Duteil L., Desruelles F., Fontas E., Ortonne J.-P. The new 940-nanometer diode laser: an effective treatment for leg venulectasia. J Am Acad Dermatol. 2003;48(5):768–774. doi. org/10.1067/mjd.2003.191.</mixed-citation><mixed-citation xml:lang="en">Peterson J.D., Goldman M.P. Rejuvenation of the aging chest: a review and our experience. Dermatol Surg. 2011;37(5):555–571. doi: 10.1111/j.1524-4725.2011.01972.x.</mixed-citation></citation-alternatives></ref><ref id="cit215"><label>215</label><citation-alternatives><mixed-citation xml:lang="ru">Perrin M., Eklof B., VAN Rij A., Labropoulos N., Vasquez M., Nicolaides A. et al. Venous symptoms: the SYM Vein Consensus statement developed under the auspices of the European Venous Forum. Int Angiol. 2016;35(4):374–398. Available at: https://pubmed.ncbi.nlm.nih.gov/27081866/.</mixed-citation><mixed-citation xml:lang="en">Peterson J.D., Goldman M.P., Weiss R.A., Duffy D.M., Fabi S.G., Weiss M.A., Guiha I. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 2012;38(8):1322–1330. doi: 10.1111/j.1524-4725.2012.02422.x.</mixed-citation></citation-alternatives></ref><ref id="cit216"><label>216</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson J.D., Goldman M.P. Rejuvenation of the aging chest: a review and our experience. Dermatol Surg. 2011;37(5):555–571. doi: 10.1111/j.1524-4725.2011.01972.x.</mixed-citation><mixed-citation xml:lang="en">Prescott R.J. A comparative study of two sclerosing agents in the treatment of telangiectasias. Phlebology ‘92. Paris: John Libbey Eurotext; 1992. Vol. 2, pp. 803–804.</mixed-citation></citation-alternatives></ref><ref id="cit217"><label>217</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson J.D., Goldman M.P., Weiss R.A., Duffy D.M., Fabi S.G., Weiss M.A., Guiha I. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg. 2012;38(8):1322–1330. doi: 10.1111/j.1524-4725.2012.02422.x.</mixed-citation><mixed-citation xml:lang="en">Prieto V., Zhang P., Sadick N.S. Comparison of a combination diode laser and radiofrequency device (Polaris) and a long-pulsed 1064-nm Nd:YAG laser (Lyra) on leg telangiectases. Histologic and immunohistochemical analysis. J Cosmet laser Ther. 2006;8(4):191–195. doi: 10.1080/14764170600999302.</mixed-citation></citation-alternatives></ref><ref id="cit218"><label>218</label><citation-alternatives><mixed-citation xml:lang="ru">Prescott R.J. A comparative study of two sclerosing agents in the treatment of telangiectasias. Phlebology ‘92. Paris: John Libbey Eurotext; 1992. Vol. 2, pp. 803–804.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Berboth G., Pannier F. Epidemiology of chronic venous diseases. Wien Med Wochenschr. 2016;166(9–10):260–263. (In Germ.). doi: 10.1007/s10354-016-0465-y.</mixed-citation></citation-alternatives></ref><ref id="cit219"><label>219</label><citation-alternatives><mixed-citation xml:lang="ru">Prieto V., Zhang P., Sadick N.S. Comparison of a combination diode laser and radiofrequency device (Polaris) and a long-pulsed 1064-nm Nd:YAG laser (Lyra) on leg telangiectases. Histologic and immunohistochemical analysis. J Cosmet laser Ther. 2006;8(4):191–195. doi: 10.1080/14764170600999302.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Breu F.X., Cavezzi A., Coleridge Smith P., Frullini A., Gillet J.L. et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29(6):338–354. doi: 10.1177/0268355513483280.</mixed-citation></citation-alternatives></ref><ref id="cit220"><label>220</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Berboth G., Pannier F. Epidemiology of chronic venous diseases. Wien Med Wochenschr. 2016;166(9–10):260–263. (In Germ.). doi: 10.1007/s10354-016-0465-y.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Guex J.J., Puskas A., Scuderi A., Fernandez Quesada F., VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105–115. Available at: https://pubmed.ncbi.nlm.nih.gov/22466974/.</mixed-citation></citation-alternatives></ref><ref id="cit221"><label>221</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Breu F.X., Cavezzi A., Coleridge Smith P., Frullini A., Gillet J.L. et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29(6):338–354. doi: 10.1177/0268355513483280.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Pannier-Fischer F., Bromen K., Schuldt K., Stang A., Poncar Ch. et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Phlebologie. 2003;32:1–14. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0037-1617353.</mixed-citation></citation-alternatives></ref><ref id="cit222"><label>222</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Guex J.J., Puskas A., Scuderi A., Fernandez Quesada F., VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105–115. Available at: https://pubmed.ncbi.nlm.nih.gov/22466974/.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Partsch H., Hafner J., Lattimer C., Mosti G., Neumann M. et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement. Phlebology. 2018;33(3):163–184. doi: 10.1177/0268355516689631.</mixed-citation></citation-alternatives></ref><ref id="cit223"><label>223</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Pannier-Fischer F., Bromen K., Schuldt K., Stang A., Poncar Ch. et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie. Phlebologie. 2003;32:1–14. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0037-1617353.</mixed-citation><mixed-citation xml:lang="en">Rabe E., Schliephake D., Otto J., Breu F.X., Pannier F. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology. 2010;25(3):124–131. doi: 10.1258/phleb.2009.009043.</mixed-citation></citation-alternatives></ref><ref id="cit224"><label>224</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Partsch H., Hafner J., Lattimer C., Mosti G., Neumann M. et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement. Phlebology. 2018;33(3):163–184. doi: 10.1177/0268355516689631.</mixed-citation><mixed-citation xml:lang="en">Ramelet A.-A. Phlebectomy. Technique, indications and complications. Int Angiol. 2002;21(2 Suppl.):46–51. Available at: https://pubmed.ncbi.nlm.nih.gov/12515980/.</mixed-citation></citation-alternatives></ref><ref id="cit225"><label>225</label><citation-alternatives><mixed-citation xml:lang="ru">Rabe E., Schliephake D., Otto J., Breu F.X., Pannier F. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology. 2010;25(3):124–131. doi: 10.1258/phleb.2009.009043.</mixed-citation><mixed-citation xml:lang="en">Ramelet A.-A. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Dermatol Surg. 2012;38(5):748–751. doi: 10.1111/j.1524-4725.2011.02287.x.</mixed-citation></citation-alternatives></ref><ref id="cit226"><label>226</label><citation-alternatives><mixed-citation xml:lang="ru">Ramelet A.-A. Phlebectomy. Technique, indications and complications. Int Angiol. 2002;21(2 Suppl.):46–51. Available at: https://pubmed.ncbi.nlm.nih.gov/12515980/.</mixed-citation><mixed-citation xml:lang="en">Rao J., Wildemore J.K., Goldman M.P. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg. 2005;31(6):631–635. doi: 10.1111/j.1524-4725.2005.31602.</mixed-citation></citation-alternatives></ref><ref id="cit227"><label>227</label><citation-alternatives><mixed-citation xml:lang="ru">Ramelet A.-A. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Dermatol Surg. 2012;38(5):748–751. doi: 10.1111/j.1524-4725.2011.02287.x.</mixed-citation><mixed-citation xml:lang="en">Rautio T., Perälä J., Biancari F., Wiik H., Ohtonen P., Haukipuro K. et al. Accuracy of hand-held Doppler in planning the operation for primary varicose veins. Eur J Vasc Endovasc Surg. 2002;24(5):450–455. doi: 10.1053/ejvs.2002.1734.</mixed-citation></citation-alternatives></ref><ref id="cit228"><label>228</label><citation-alternatives><mixed-citation xml:lang="ru">Rao J., Wildemore J.K., Goldman M.P. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg. 2005;31(6):631–635. doi: 10.1111/j.1524-4725.2005.31602.</mixed-citation><mixed-citation xml:lang="en">Raymond-Martimbeau P., Dupuis J.L. Telangiectasias: Incidence, Classification, and Relationship with the Superficial and Deep Venous Systems: a Double-Blind Study. In: Negus D., Jantet G., Coleridge-</mixed-citation></citation-alternatives></ref><ref id="cit229"><label>229</label><citation-alternatives><mixed-citation xml:lang="ru">Rautio T., Perälä J., Biancari F., Wiik H., Ohtonen P., Haukipuro K. et al. Accuracy of hand-held Doppler in planning the operation for primary varicose veins. Eur J Vasc Endovasc Surg. 2002;24(5):450–455. doi: 10.1053/ejvs.2002.1734.</mixed-citation><mixed-citation xml:lang="en">Smith P.D. (eds.). Phlebology ’95. London: Springer; 1995, pp. 169–171. doi: 10.1007/978-1-4471-3095-6_76.</mixed-citation></citation-alternatives></ref><ref id="cit230"><label>230</label><citation-alternatives><mixed-citation xml:lang="ru">Raymond-Martimbeau P., Dupuis J.L. Telangiectasias: Incidence, Classification, and Relationship with the Superficial and Deep Venous Systems: a Double-Blind Study. In: Negus D., Jantet G., Coleridge-</mixed-citation><mixed-citation xml:lang="en">Redisch W., Pelzer R.H. Localized vascular dilatations of the human skin, capillary microscopy and related studies. Am Heart J. 1949;37(1):106–113. doi: 10.1016/0002-8703(49)91433-7.</mixed-citation></citation-alternatives></ref><ref id="cit231"><label>231</label><citation-alternatives><mixed-citation xml:lang="ru">Smith P.D. (eds.). Phlebology ’95. London: Springer; 1995, pp. 169–171. doi: 10.1007/978-1-4471-3095-6_76.</mixed-citation><mixed-citation xml:lang="en">Reichert D. Evaluation of the long-pulse dye laser for the treatment of leg telangiectasias. Dermatol Surg. 1998;24(7):737–740. doi: 10.1111/j.1524-4725.1998.tb04242.x.</mixed-citation></citation-alternatives></ref><ref id="cit232"><label>232</label><citation-alternatives><mixed-citation xml:lang="ru">Redisch W., Pelzer R.H. Localized vascular dilatations of the human skin, capillary microscopy and related studies. Am Heart J. 1949;37(1):106–113. doi: 10.1016/0002-8703(49)91433-7.</mixed-citation><mixed-citation xml:lang="en">Reina L. How to manage complications after sclerotherapy. Phlebolymphology. 2017;24(3):130–143. Available at: https://phlebolymphology.org/how-to-manage-complications-aftersclerotherapy/.</mixed-citation></citation-alternatives></ref><ref id="cit233"><label>233</label><citation-alternatives><mixed-citation xml:lang="ru">Reichert D. Evaluation of the long-pulse dye laser for the treatment of leg telangiectasias. Dermatol Surg. 1998;24(7):737–740. doi: 10.1111/j.1524-4725.1998.tb04242.x.</mixed-citation><mixed-citation xml:lang="en">Robertson L., Evans C., Fowkes F.G.R. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103-111. doi: 10.1258/phleb.2007.007061.</mixed-citation></citation-alternatives></ref><ref id="cit234"><label>234</label><citation-alternatives><mixed-citation xml:lang="ru">Reina L. How to manage complications after sclerotherapy. Phlebolymphology. 2017;24(3):130–143. Available at: https://phlebolymphology.org/how-to-manage-complications-aftersclerotherapy/.</mixed-citation><mixed-citation xml:lang="en">Robertson L., Lee A.J., Gallagher K., Carmichael S.J., Evans C.J., McKinstry B.H. et al. Risk factors for chronic ulceration in patients with varicose veins: a case control study. J Vasc Surg. 2009;49(6):1490–1498. doi: 10.1016/j.jvs.2009.02.237.</mixed-citation></citation-alternatives></ref><ref id="cit235"><label>235</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson L., Evans C., Fowkes F.G.R. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103-111. doi: 10.1258/phleb.2007.007061.</mixed-citation><mixed-citation xml:lang="en">Rochon P.J., Hill J.H., Smith M.T. Digital Ischemia during Sclerotherapy of an Arteriovenous Malformation. Semin Intervent Radiol. 2013;30(3):322–324. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1353486.</mixed-citation></citation-alternatives></ref><ref id="cit236"><label>236</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson L., Lee A.J., Gallagher K., Carmichael S.J., Evans C.J., McKinstry B.H. et al. Risk factors for chronic ulceration in patients with varicose veins: a case control study. J Vasc Surg. 2009;49(6):1490–1498. doi: 10.1016/j.jvs.2009.02.237.</mixed-citation><mixed-citation xml:lang="en">Rogachefsky A.S., Silapunt S., Goldberg D.J. Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg. 2002;28(3):220–223. doi: 10.1046/j.1524-4725.2002.01141.x.</mixed-citation></citation-alternatives></ref><ref id="cit237"><label>237</label><citation-alternatives><mixed-citation xml:lang="ru">Rochon P.J., Hill J.H., Smith M.T. Digital Ischemia during Sclerotherapy of an Arteriovenous Malformation. Semin Intervent Radiol. 2013;30(3):322–324. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1353486.</mixed-citation><mixed-citation xml:lang="en">Ross E.V., Domankevitz Y. Laser treatment of leg veins: Physical mechanisms and theoretical considerations. Lasers Surg Med. 2005;36(2):105–116. doi: 10.1002/lsm.20141.</mixed-citation></citation-alternatives></ref><ref id="cit238"><label>238</label><citation-alternatives><mixed-citation xml:lang="ru">Rogachefsky A.S., Silapunt S., Goldberg D.J. Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: efficacy as measured by vessel color and size. Dermatol Surg. 2002;28(3):220–223. doi: 10.1046/j.1524-4725.2002.01141.x.</mixed-citation><mixed-citation xml:lang="en">Ross E.V., Domankevitz Y. Laser leg vein treatment: a brief overview. J Cosmet laser Ther. 2003;5(3–4):192–197. doi: 10.1080/14764170310021878.</mixed-citation></citation-alternatives></ref><ref id="cit239"><label>239</label><citation-alternatives><mixed-citation xml:lang="ru">Ross E.V., Domankevitz Y. Laser treatment of leg veins: Physical mechanisms and theoretical considerations. Lasers Surg Med. 2005;36(2):105–116. doi: 10.1002/lsm.20141.</mixed-citation><mixed-citation xml:lang="en">Ross E.V., Meehan K.J., Gilbert S., Domankevitz Y. Optimal pulse durations for the treatment of leg telangiectasias with an alexandrite laser. Lasers Surg Med. 2009;41(2):104–109. doi: 10.1002/lsm.20737.</mixed-citation></citation-alternatives></ref><ref id="cit240"><label>240</label><citation-alternatives><mixed-citation xml:lang="ru">Ross E.V., Domankevitz Y. Laser leg vein treatment: a brief overview. J Cosmet laser Ther. 2003;5(3–4):192–197. doi: 10.1080/14764170310021878.</mixed-citation><mixed-citation xml:lang="en">Ross E.V., Uebelhoer N.S., Domankevitz Y. Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg. 2007;33(12):1466–1469. doi: 10.1111/j.1524-4725.2007.33317.x.</mixed-citation></citation-alternatives></ref><ref id="cit241"><label>241</label><citation-alternatives><mixed-citation xml:lang="ru">Ross E.V., Meehan K.J., Gilbert S., Domankevitz Y. Optimal pulse durations for the treatment of leg telangiectasias with an alexandrite laser. Lasers Surg Med. 2009;41(2):104–109. doi: 10.1002/lsm.20737.</mixed-citation><mixed-citation xml:lang="en">Ruckley C.V., Evans C.J., Allan P.L., Lee A.J., Fowkes F.G. Telangiectasia in the Edinburgh Vein Study: epidemiology and association with trunk varices and symptoms. Eur J Vasc Endovasc Surg. 2008;36(6):719–724. doi: 10.1016/j.ejvs.2008.08.012.</mixed-citation></citation-alternatives></ref><ref id="cit242"><label>242</label><citation-alternatives><mixed-citation xml:lang="ru">Ross E.V., Uebelhoer N.S., Domankevitz Y. Use of a novel pulse dye laser for rapid single-pass purpura-free treatment of telangiectases. Dermatol Surg. 2007;33(12):1466–1469. doi: 10.1111/j.1524-4725.2007.33317.x.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S. Choosing the appropriate sclerosing concentration for vessel diameter. Dermatol Surg. 2010;36(2 Suppl.):976–981. doi: 10.1111/j.1524-4725.2009.01405.x.</mixed-citation></citation-alternatives></ref><ref id="cit243"><label>243</label><citation-alternatives><mixed-citation xml:lang="ru">Ruckley C.V., Evans C.J., Allan P.L., Lee A.J., Fowkes F.G. Telangiectasia in the Edinburgh Vein Study: epidemiology and association with trunk varices and symptoms. Eur J Vasc Endovasc Surg. 2008;36(6):719–724. doi: 10.1016/j.ejvs.2008.08.012.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S. Laser and intense pulsed light therapy for the esthetic treatment of lower extremity veins. Am J Clin Dermatol. 2003;4(8):545–554. doi: 10.2165/00128071-200304080-00004.</mixed-citation></citation-alternatives></ref><ref id="cit244"><label>244</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S. Choosing the appropriate sclerosing concentration for vessel diameter. Dermatol Surg. 2010;36(2 Suppl.):976–981. doi: 10.1111/j.1524-4725.2009.01405.x.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S. Laser treatment with a 1064-nm laser for lower extremity class I-III veins employing variable spots and pulse width parameters. Dermatol Surg. 2003;29(9):916–919. doi: 10.1046/j.1524-4725.2003.29250.x.</mixed-citation></citation-alternatives></ref><ref id="cit245"><label>245</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S. Laser and intense pulsed light therapy for the esthetic treatment of lower extremity veins. Am J Clin Dermatol. 2003;4(8):545–554. doi: 10.2165/00128071-200304080-00004.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S. Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg. 2001;27(4):365–369. doi: 10.1046/j.1524-4725.2001.00295.x.</mixed-citation></citation-alternatives></ref><ref id="cit246"><label>246</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S. Laser treatment with a 1064-nm laser for lower extremity class I-III veins employing variable spots and pulse width parameters. Dermatol Surg. 2003;29(9):916–919. doi: 10.1046/j.1524-4725.2003.29250.x.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol. 1991;17(1):65–70. doi: 10.1111/j.1524-4725.1991.tb01595.x.</mixed-citation></citation-alternatives></ref><ref id="cit247"><label>247</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S. Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg. 2001;27(4):365–369. doi: 10.1046/j.1524-4725.2001.00295.x.</mixed-citation><mixed-citation xml:lang="en">Sadick N.S., Trelles M.A. A clinical, histological, and computer-based assessment of the Polaris LV, combination diode, and radiofrequency system, for leg vein treatment. Lasers Surg Med. 2005;36(2):98–104. doi: 10.1002/lsm.20127.</mixed-citation></citation-alternatives></ref><ref id="cit248"><label>248</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S. Sclerotherapy of varicose and telangiectatic leg veins. Minimal sclerosant concentration of hypertonic saline and its relationship to vessel diameter. J Dermatol Surg Oncol. 1991;17(1):65–70. doi: 10.1111/j.1524-4725.1991.tb01595.x.</mixed-citation><mixed-citation xml:lang="en">Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160(22):3415–3420. doi: 10.1001/archinte.160.22.3415.</mixed-citation></citation-alternatives></ref><ref id="cit249"><label>249</label><citation-alternatives><mixed-citation xml:lang="ru">Sadick N.S., Trelles M.A. A clinical, histological, and computer-based assessment of the Polaris LV, combination diode, and radiofrequency system, for leg vein treatment. Lasers Surg Med. 2005;36(2):98–104. doi: 10.1002/lsm.20127.</mixed-citation><mixed-citation xml:lang="en">Santana-Blank L. Contraindications in noninvasive laser therapy: truth and fiction. Photomed laser Surg. 2004;22(5):442. doi: 10.1089/pho.2004.22.442.</mixed-citation></citation-alternatives></ref><ref id="cit250"><label>250</label><citation-alternatives><mixed-citation xml:lang="ru">Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med. 2000;160(22):3415–3420. doi: 10.1001/archinte.160.22.3415.</mixed-citation><mixed-citation xml:lang="en">Santiago F.R., Piscoya M., Chi Y.W. A sonographic study of thigh telangiectasias. Phlebology. 2018;33(7):500–501. doi: 10.1177/0268355517717404.</mixed-citation></citation-alternatives></ref><ref id="cit251"><label>251</label><citation-alternatives><mixed-citation xml:lang="ru">Santana-Blank L. Contraindications in noninvasive laser therapy: truth and fiction. Photomed laser Surg. 2004;22(5):442. doi: 10.1089/pho.2004.22.442.</mixed-citation><mixed-citation xml:lang="en">Santiago F.R., Piscoya M., Chi Y.W. Change in perception of sclerotherapy results after exposure to pre-post intervention photographs. Phlebology. 2018;33(4):282–287. doi: 10.1177/0268355517736178.</mixed-citation></citation-alternatives></ref><ref id="cit252"><label>252</label><citation-alternatives><mixed-citation xml:lang="ru">Santiago F.R., Piscoya M., Chi Y.W. A sonographic study of thigh telangiectasias. Phlebology. 2018;33(7):500–501. doi: 10.1177/0268355517717404.</mixed-citation><mixed-citation xml:lang="en">Santiago F.R., Piscoya M., Chi Y.-W. A sonographic study of thigh telangiectasias. Phlebology. 2018;33(7):500–501. doi: 10.1177/0268355517717404.</mixed-citation></citation-alternatives></ref><ref id="cit253"><label>253</label><citation-alternatives><mixed-citation xml:lang="ru">Santiago F.R., Piscoya M., Chi Y.W. Change in perception of sclerotherapy results after exposure to pre-post intervention photographs. Phlebology. 2018;33(4):282–287. doi: 10.1177/0268355517736178.</mixed-citation><mixed-citation xml:lang="en">Sarradet D.M., Hussain M., Goldberg D.J. Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg. 2003;29(1):56–58. doi: 10.1046/j.1524-4725.2003.29008.x.</mixed-citation></citation-alternatives></ref><ref id="cit254"><label>254</label><citation-alternatives><mixed-citation xml:lang="ru">Santiago F.R., Piscoya M., Chi Y.-W. A sonographic study of thigh telangiectasias. Phlebology. 2018;33(7):500–501. doi: 10.1177/0268355517717404.</mixed-citation><mixed-citation xml:lang="en">Schul M.W., Eaton T., Erdman B. Compression versus sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes. Phlebology. 2011;26(4):148–156. doi: 10.1258/phleb.2010.009092.</mixed-citation></citation-alternatives></ref><ref id="cit255"><label>255</label><citation-alternatives><mixed-citation xml:lang="ru">Sarradet D.M., Hussain M., Goldberg D.J. Millisecond 1064-nm neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg. 2003;29(1):56–58. doi: 10.1046/j.1524-4725.2003.29008.x.</mixed-citation><mixed-citation xml:lang="en">Schuller-Petrović S., Pavlović M.D., Schuller S., Schuller-Lukic B., Adamic M. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Phlebology. 2013;28(6):320–323. doi: 10.1258/phleb.2012.012019.</mixed-citation></citation-alternatives></ref><ref id="cit256"><label>256</label><citation-alternatives><mixed-citation xml:lang="ru">Schul M.W., Eaton T., Erdman B. Compression versus sclerotherapy for patients with isolated refluxing reticular veins and telangiectasia: a randomized trial comparing quality-of-life outcomes. Phlebology. 2011;26(4):148–156. doi: 10.1258/phleb.2010.009092.</mixed-citation><mixed-citation xml:lang="en">Schuller-Petrović S., Pavlović M.D., Neuhold N., Brunner F., Wölkart G. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol. 2011;25(8):983–986. doi: 10.1111/j.1468-3083.2010.03873.x.</mixed-citation></citation-alternatives></ref><ref id="cit257"><label>257</label><citation-alternatives><mixed-citation xml:lang="ru">Schuller-Petrović S., Pavlović M.D., Schuller S., Schuller-Lukic B., Adamic M. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Phlebology. 2013;28(6):320–323. doi: 10.1258/phleb.2012.012019.</mixed-citation><mixed-citation xml:lang="en">Schwartz L., Maxwell H. Sclerotherapy for lower limb telangiectasias. Cochrane Database Syst Rev. 2011;(12):CD008826. doi: 10.1002/14651858.CD008826.pub2.</mixed-citation></citation-alternatives></ref><ref id="cit258"><label>258</label><citation-alternatives><mixed-citation xml:lang="ru">Schuller-Petrović S., Pavlović M.D., Neuhold N., Brunner F., Wölkart G. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol. 2011;25(8):983–986. doi: 10.1111/j.1468-3083.2010.03873.x.</mixed-citation><mixed-citation xml:lang="en">Scultetus A.H., Villavicencio J.L., Kao T.C., Gillespie D.L., Ketron G.D., Iafrati M.D. et al. Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg. 2003;38(5):896–903. doi: 10.1016/s0741-5214(03)00920-0.</mixed-citation></citation-alternatives></ref><ref id="cit259"><label>259</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz L., Maxwell H. Sclerotherapy for lower limb telangiectasias. Cochrane Database Syst Rev. 2011;(12):CD008826. doi: 10.1002/14651858.CD008826.pub2.</mixed-citation><mixed-citation xml:lang="en">Shafirstein G., Moreno M., Klein A., Siegel E., Babilas P., Landthaler M. et al. Treatment of leg veins with indocyanine green and lasers investigated with mathematical modelling. Int J Hyperthermia. 2011;27(8):771–781. doi: 10.3109/02656736.2011.602037.</mixed-citation></citation-alternatives></ref><ref id="cit260"><label>260</label><citation-alternatives><mixed-citation xml:lang="ru">Scultetus A.H., Villavicencio J.L., Kao T.C., Gillespie D.L., Ketron G.D., Iafrati M.D. et al. Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg. 2003;38(5):896–903. doi: 10.1016/s0741-5214(03)00920-0.</mixed-citation><mixed-citation xml:lang="en">Shah S., Alster T.S. Laser treatment of dark skin: an updated review. Am J Clin Dermatol. 2010;11(6):389–397. doi: 10.2165/11538940-000000000-00000.</mixed-citation></citation-alternatives></ref><ref id="cit261"><label>261</label><citation-alternatives><mixed-citation xml:lang="ru">Shafirstein G., Moreno M., Klein A., Siegel E., Babilas P., Landthaler M. et al. Treatment of leg veins with indocyanine green and lasers investigated with mathematical modelling. Int J Hyperthermia. 2011;27(8):771–781. doi: 10.3109/02656736.2011.602037.</mixed-citation><mixed-citation xml:lang="en">Shamma A.R., Guy R.J. Laser ablation of unwanted hand veins. Plast Reconstr Surg. 2007;120(7):2017–2024. doi: 10.1097/01.prs.0000287331.23007.01.</mixed-citation></citation-alternatives></ref><ref id="cit262"><label>262</label><citation-alternatives><mixed-citation xml:lang="ru">Shah S., Alster T.S. Laser treatment of dark skin: an updated review. Am J Clin Dermatol. 2010;11(6):389–397. doi: 10.2165/11538940-000000000-00000.</mixed-citation><mixed-citation xml:lang="en">Smarandache A. Laser beams interaction with polidocanol foam: molecular background. Photomed laser Surg. 2012;30(5):262–267. doi: 10.1089/pho.2011.3187.</mixed-citation></citation-alternatives></ref><ref id="cit263"><label>263</label><citation-alternatives><mixed-citation xml:lang="ru">Shamma A.R., Guy R.J. Laser ablation of unwanted hand veins. Plast Reconstr Surg. 2007;120(7):2017–2024. doi: 10.1097/01.prs.0000287331.23007.01.</mixed-citation><mixed-citation xml:lang="en">Smith P.C. Management of reticular veins and telangiectases. Phlebology. 2015;30(2):46–52. doi: 10.1177/0268355515592770.</mixed-citation></citation-alternatives></ref><ref id="cit264"><label>264</label><citation-alternatives><mixed-citation xml:lang="ru">Smarandache A. Laser beams interaction with polidocanol foam: molecular background. Photomed laser Surg. 2012;30(5):262–267. doi: 10.1089/pho.2011.3187.</mixed-citation><mixed-citation xml:lang="en">Somjen G.M. Anatomy of the superficial venous system. Dermatol Surg. 1995;21(1):35–45. doi: 10.1111/j.1524-4725.1995.tb00109.x.</mixed-citation></citation-alternatives></ref><ref id="cit265"><label>265</label><citation-alternatives><mixed-citation xml:lang="ru">Smith P.C. Management of reticular veins and telangiectases. Phlebology. 2015;30(2):46–52. doi: 10.1177/0268355515592770.</mixed-citation><mixed-citation xml:lang="en">Somjen G.M., Ziegenbein R., Johnston A.H., Royle J.P. Anatomical examination of leg telangiectases with duplex scanning. J Dermatol Surg Oncol. 1993;19(10):940–945. doi: 10.1111/j.1524-4725.1993.tb00982.x.</mixed-citation></citation-alternatives></ref><ref id="cit266"><label>266</label><citation-alternatives><mixed-citation xml:lang="ru">Somjen G.M. Anatomy of the superficial venous system. Dermatol Surg. 1995;21(1):35–45. doi: 10.1111/j.1524-4725.1995.tb00109.x.</mixed-citation><mixed-citation xml:lang="en">Sommer A., Van Mierlo P.L., Neumann H.A., Kessels A.G. Red and blue telangiectasias. Differences in oxygenation? Dermatol Surg. 1997;23(1):55–59. doi: 10.1111/j.1524-4725.1997.tb00009.x.</mixed-citation></citation-alternatives></ref><ref id="cit267"><label>267</label><citation-alternatives><mixed-citation xml:lang="ru">Somjen G.M., Ziegenbein R., Johnston A.H., Royle J.P. Anatomical examination of leg telangiectases with duplex scanning. J Dermatol Surg Oncol. 1993;19(10):940–945. doi: 10.1111/j.1524-4725.1993.tb00982.x.</mixed-citation><mixed-citation xml:lang="en">Srinivas C.R., Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77(3):349–368. doi: 10.4103/0378-6323.79728.</mixed-citation></citation-alternatives></ref><ref id="cit268"><label>268</label><citation-alternatives><mixed-citation xml:lang="ru">Sommer A., Van Mierlo P.L., Neumann H.A., Kessels A.G. Red and blue telangiectasias. Differences in oxygenation? Dermatol Surg. 1997;23(1):55–59. doi: 10.1111/j.1524-4725.1997.tb00009.x.</mixed-citation><mixed-citation xml:lang="en">Starr J.C. Integrating digital image management software for improved patient care and optimal practice management. Dermatol Surg. 2006;32(6):834–840. doi: 10.1111/j.1524-4725.2006.32169.x.</mixed-citation></citation-alternatives></ref><ref id="cit269"><label>269</label><citation-alternatives><mixed-citation xml:lang="ru">Srinivas C.R., Kumaresan M. Lasers for vascular lesions: standard guidelines of care. Indian J Dermatol Venereol Leprol. 2011;77(3):349–368. doi: 10.4103/0378-6323.79728.</mixed-citation><mixed-citation xml:lang="en">Stucker M., Reich S., Hermes N., Altmeyer P. Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon. J Dtsch Dermatol Ges. 2006;4(9):734–738. doi: 10.1111/j.1610-0387.2006.06085.x.</mixed-citation></citation-alternatives></ref><ref id="cit270"><label>270</label><citation-alternatives><mixed-citation xml:lang="ru">Starr J.C. Integrating digital image management software for improved patient care and optimal practice management. Dermatol Surg. 2006;32(6):834–840. doi: 10.1111/j.1524-4725.2006.32169.x.</mixed-citation><mixed-citation xml:lang="en">Stvrtinová V., Kolesár J., Wimmer G. Prevalence of varicose veins of the lower limbs in the women working at a department store. Int Angiol. 1991;10(1):2–5. Available at: https://pubmed.ncbi.nlm.nih.gov/2071970/.</mixed-citation></citation-alternatives></ref><ref id="cit271"><label>271</label><citation-alternatives><mixed-citation xml:lang="ru">Stucker M., Reich S., Hermes N., Altmeyer P. Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with Phenprocoumon. J Dtsch Dermatol Ges. 2006;4(9):734–738. doi: 10.1111/j.1610-0387.2006.06085.x.</mixed-citation><mixed-citation xml:lang="en">Tafazzoli A., Rostan E.F., Goldman M.P. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation. Dermatol Surg. 2000;26(7):653–656. doi: 10.1046/j.1524-4725.2000.99268.x.</mixed-citation></citation-alternatives></ref><ref id="cit272"><label>272</label><citation-alternatives><mixed-citation xml:lang="ru">Stvrtinová V., Kolesár J., Wimmer G. Prevalence of varicose veins of the lower limbs in the women working at a department store. Int Angiol. 1991;10(1):2–5. Available at: https://pubmed.ncbi.nlm.nih.gov/2071970/.</mixed-citation><mixed-citation xml:lang="en">Tanghetti E., Sherr E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star). J Cosmet laser Ther. 2003;5(2):71–75. Available at: https://pubmed.ncbi.nlm.nih.gov/12850799/.</mixed-citation></citation-alternatives></ref><ref id="cit273"><label>273</label><citation-alternatives><mixed-citation xml:lang="ru">Tafazzoli A., Rostan E.F., Goldman M.P. Q-switched ruby laser treatment for postsclerotherapy hyperpigmentation. Dermatol Surg. 2000;26(7):653–656. doi: 10.1046/j.1524-4725.2000.99268.x.</mixed-citation><mixed-citation xml:lang="en">Tanghetti E.A. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44(2):97–102. doi: 10.1002/lsm.21151.</mixed-citation></citation-alternatives></ref><ref id="cit274"><label>274</label><citation-alternatives><mixed-citation xml:lang="ru">Tanghetti E., Sherr E. Treatment of telangiectasia using the multi-pass technique with the extended pulse width, pulsed dye laser (Cynosure V-Star). J Cosmet laser Ther. 2003;5(2):71–75. Available at: https://pubmed.ncbi.nlm.nih.gov/12850799/.</mixed-citation><mixed-citation xml:lang="en">Tanzi E.L., Lupton J.R., Alster T.S. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49(1):1–34. doi: 10.1067/mjd.2003.582.</mixed-citation></citation-alternatives></ref><ref id="cit275"><label>275</label><citation-alternatives><mixed-citation xml:lang="ru">Tanghetti E.A. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44(2):97–102. doi: 10.1002/lsm.21151.</mixed-citation><mixed-citation xml:lang="en">Tepavcevic B., Matic P., Radak D. Comparison of sclerotherapy, laser, and radiowave coagulation in treatment of lower extremity telangiectasias. J Cosmet laser Ther. 2012;14(5):239–242. doi: 10.3109/14764172.2012.723806.</mixed-citation></citation-alternatives></ref><ref id="cit276"><label>276</label><citation-alternatives><mixed-citation xml:lang="ru">Tanzi E.L., Lupton J.R., Alster T.S. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49(1):1–34. doi: 10.1067/mjd.2003.582.</mixed-citation><mixed-citation xml:lang="en">Tessari L., Cavezzi A., Rosso M., Cabrera Garrido A. Variables in foam sclerotherapy: literature and experimental data. ANZJ Phleb. 2008;11:83–84.</mixed-citation></citation-alternatives></ref><ref id="cit277"><label>277</label><citation-alternatives><mixed-citation xml:lang="ru">Tepavcevic B., Matic P., Radak D. Comparison of sclerotherapy, laser, and radiowave coagulation in treatment of lower extremity telangiectasias. J Cosmet laser Ther. 2012;14(5):239–242. doi: 10.3109/14764172.2012.723806.</mixed-citation><mixed-citation xml:lang="en">Thibault P., Bray A., Wlodarczyk J., Lewis W. Cosmetic leg veins: evaluation using duplex venous imaging. J Dermatol Surg Oncol. 199016(7):612–618. doi: 10.1111/j.1524-4725.1990.tb00089.x.</mixed-citation></citation-alternatives></ref><ref id="cit278"><label>278</label><citation-alternatives><mixed-citation xml:lang="ru">Tessari L., Cavezzi A., Rosso M., Cabrera Garrido A. Variables in foam sclerotherapy: literature and experimental data. ANZJ Phleb. 2008;11:83–84.</mixed-citation><mixed-citation xml:lang="en">Thibault P., Wlodarczyk J. Postsclerotherapy hyperpigmentation. The role of serum ferritin levels and the effectiveness of treatment with the copper vapor laser. J Dermatol Surg Oncol. 1992;18(1):47–52. doi: 10.1111/j.1524-4725.1992.tb03300.x.</mixed-citation></citation-alternatives></ref><ref id="cit279"><label>279</label><citation-alternatives><mixed-citation xml:lang="ru">Thibault P., Bray A., Wlodarczyk J., Lewis W. Cosmetic leg veins: evaluation using duplex venous imaging. J Dermatol Surg Oncol. 199016(7):612–618. doi: 10.1111/j.1524-4725.1990.tb00089.x.</mixed-citation><mixed-citation xml:lang="en">Tierney E., Hanke C.W. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diodelaser. Lasers Surg Med. 2009;41(8):555–562. doi: 10.1002/lsm.20811.</mixed-citation></citation-alternatives></ref><ref id="cit280"><label>280</label><citation-alternatives><mixed-citation xml:lang="ru">Thibault P., Wlodarczyk J. Postsclerotherapy hyperpigmentation. The role of serum ferritin levels and the effectiveness of treatment with the copper vapor laser. J Dermatol Surg Oncol. 1992;18(1):47–52. doi: 10.1111/j.1524-4725.1992.tb03300.x.</mixed-citation><mixed-citation xml:lang="en">Trelles M.A., Allones I., Martín-Vázquez M.J., Trelles O., Vélez M., Mordon S. Long pulse Nd:YAG laser for treatment of leg veins in 40 patients with assessments at 6 and 12 months. Lasers Surg Med. 2004;35(1):68–76. doi: 10.1002/lsm.20038.</mixed-citation></citation-alternatives></ref><ref id="cit281"><label>281</label><citation-alternatives><mixed-citation xml:lang="ru">Tierney E., Hanke C.W. Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diodelaser. Lasers Surg Med. 2009;41(8):555–562. doi: 10.1002/lsm.20811.</mixed-citation><mixed-citation xml:lang="en">Trelles M.A., Allones I., Trelles O. An 810 nm diode laser in the treatment of small (&lt; or = 1.0 mm) leg veins: a preliminary assessment. Lasers Med Sci. 2004;19(1):21–26. doi: 10.1007/s10103-004-0295-9.</mixed-citation></citation-alternatives></ref><ref id="cit282"><label>282</label><citation-alternatives><mixed-citation xml:lang="ru">Trelles M.A., Allones I., Martín-Vázquez M.J., Trelles O., Vélez M., Mordon S. Long pulse Nd:YAG laser for treatment of leg veins in 40 patients with assessments at 6 and 12 months. Lasers Surg Med. 2004;35(1):68–76. doi: 10.1002/lsm.20038.</mixed-citation><mixed-citation xml:lang="en">Trelles M.A., Martín-Vázquez M., Trelles O.R., Mordon S.R. Treatment effects of combined radio-frequency current and a 900 nm diode laser on leg blood vessels. Lasers Surg Med. 2006;38(3):185–195. doi: 10.1002/lsm.20280.</mixed-citation></citation-alternatives></ref><ref id="cit283"><label>283</label><citation-alternatives><mixed-citation xml:lang="ru">Trelles M.A., Allones I., Trelles O. An 810 nm diode laser in the treatment of small (&lt; or = 1.0 mm) leg veins: a preliminary assessment. Lasers Med Sci. 2004;19(1):21–26. doi: 10.1007/s10103-004-0295-9.</mixed-citation><mixed-citation xml:lang="en">Tremaine A.M., Friedmann D.P., Goldman M.P. Foam sclerotherapy for reticular veins of the dorsal hands: a retrospective review. Dermatol Surg. 2014;40(8):892–898. doi: 10.1097/DSS.0000000000000076.</mixed-citation></citation-alternatives></ref><ref id="cit284"><label>284</label><citation-alternatives><mixed-citation xml:lang="ru">Trelles M.A., Martín-Vázquez M., Trelles O.R., Mordon S.R. Treatment effects of combined radio-frequency current and a 900 nm diode laser on leg blood vessels. Lasers Surg Med. 2006;38(3):185–195. doi: 10.1002/lsm.20280.</mixed-citation><mixed-citation xml:lang="en">Tretbar L.L. Injection sclerotherapy for spider telangiectasias: a 20-year experience with sodium tetradecyl sulfate. J Dermatol Surg Oncol. 1989;15(2):223–225. doi: 10.1111/j.1524-4725.1989.tb03029.x.</mixed-citation></citation-alternatives></ref><ref id="cit285"><label>285</label><citation-alternatives><mixed-citation xml:lang="ru">Tremaine A.M., Friedmann D.P., Goldman M.P. Foam sclerotherapy for reticular veins of the dorsal hands: a retrospective review. Dermatol Surg. 2014;40(8):892–898. doi: 10.1097/DSS.0000000000000076.</mixed-citation><mixed-citation xml:lang="en">Uebelhoer N.S., Bogle M.A., Stewart B., Arndt K.A., Dover J.S. A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol Surg. 2007;33(4):441–448. doi: 10.1111/j.1524-4725.2007.33091.x.</mixed-citation></citation-alternatives></ref><ref id="cit286"><label>286</label><citation-alternatives><mixed-citation xml:lang="ru">Tretbar L.L. Injection sclerotherapy for spider telangiectasias: a 20-year experience with sodium tetradecyl sulfate. J Dermatol Surg Oncol. 1989;15(2):223–225. doi: 10.1111/j.1524-4725.1989.tb03029.x.</mixed-citation><mixed-citation xml:lang="en">Uhl J.F., Cornu-The´nard A., Carpentier P.H., Schadeck M., Parpex P., Chleir F. Reproducibility of the “C” classes of the CEAP classification. J Phlebology. 2001;1:39–48. Available at: https://researchgate.net/publication/285777952_The_C_of_CEAP_Suggested_definitions_and_refinements_an_International_Union_of_Phlebology_conference_of_experts.</mixed-citation></citation-alternatives></ref><ref id="cit287"><label>287</label><citation-alternatives><mixed-citation xml:lang="ru">Uebelhoer N.S., Bogle M.A., Stewart B., Arndt K.A., Dover J.S. A split-face comparison study of pulsed 532-nm KTP laser and 595-nm pulsed dye laser in the treatment of facial telangiectasias and diffuse telangiectatic facial erythema. Dermatol Surg. 2007;33(4):441–448. doi: 10.1111/j.1524-4725.2007.33091.x.</mixed-citation><mixed-citation xml:lang="en">Uhl J.F., Cornu-Thénard A., Carpentier P.H., Widmer M.T., Partsch H., Antignani P.L. Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders. J Vasc Surg. 2005;42(6):1163–1168. doi: 10.1016/j.jvs.2005.08.031.</mixed-citation></citation-alternatives></ref><ref id="cit288"><label>288</label><citation-alternatives><mixed-citation xml:lang="ru">Uhl J.F., Cornu-The´nard A., Carpentier P.H., Schadeck M., Parpex P., Chleir F. Reproducibility of the “C” classes of the CEAP classification. J Phlebology. 2001;1:39–48. Available at: https://researchgate.net/publication/285777952_The_C_of_CEAP_Suggested_definitions_and_refinements_an_International_Union_of_Phlebology_conference_of_experts.</mixed-citation><mixed-citation xml:lang="en">Uhl J.F., Cornu-Thenard A., Satger B., Carpentier P.H. Clinical analysis of the corona phlebectatica. J Vasc Surg. 2012;55(1):150–153. doi: 10.1016/j.jvs.2011.04.070.</mixed-citation></citation-alternatives></ref><ref id="cit289"><label>289</label><citation-alternatives><mixed-citation xml:lang="ru">Uhl J.F., Cornu-Thénard A., Carpentier P.H., Widmer M.T., Partsch H., Antignani P.L. Clinical and hemodynamic significance of corona phlebectatica in chronic venous disorders. J Vasc Surg. 2005;42(6):1163–1168. doi: 10.1016/j.jvs.2005.08.031.</mixed-citation><mixed-citation xml:lang="en">Uncu H. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Phlebology. 2010;25(1):44–49. doi: 10.1258/phleb.2009.008064.</mixed-citation></citation-alternatives></ref><ref id="cit290"><label>290</label><citation-alternatives><mixed-citation xml:lang="ru">Uhl J.F., Cornu-Thenard A., Satger B., Carpentier P.H. Clinical analysis of the corona phlebectatica. J Vasc Surg. 2012;55(1):150–153. doi: 10.1016/j.jvs.2011.04.070.</mixed-citation><mixed-citation xml:lang="en">Van der Molen H.R., Kuiper J.P., Lukkes J. Stasis spots, corona phlebectatica and other signs of venous stasis. Folia Angiologica. 1961;VIII:28–52.</mixed-citation></citation-alternatives></ref><ref id="cit291"><label>291</label><citation-alternatives><mixed-citation xml:lang="ru">Uncu H. Sclerotherapy: a study comparing polidocanol in foam and liquid form. Phlebology. 2010;25(1):44–49. doi: 10.1258/phleb.2009.008064.</mixed-citation><mixed-citation xml:lang="en">Van Gemert M.C., Welch A.J. Clinical use of laser-tissue interactions. IEEE Eng Med Biol Mag. 1989;8(4):10–13. doi: 10.1109/51.45950.</mixed-citation></citation-alternatives></ref><ref id="cit292"><label>292</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Molen H.R., Kuiper J.P., Lukkes J. Stasis spots, corona phlebectatica and other signs of venous stasis. Folia Angiologica. 1961;VIII:28–52.</mixed-citation><mixed-citation xml:lang="en">Vigo R.L., Premoli J. Removal of periocular eyelid veins by ambulatory phlebectomy with a regular crochet hook. Ophthalmic Plast Reconstr Surg. 2012;28(3):219–220. doi: 10.1097/IOP.0b013e318249d420.</mixed-citation></citation-alternatives></ref><ref id="cit293"><label>293</label><citation-alternatives><mixed-citation xml:lang="ru">Van Gemert M.C., Welch A.J. Clinical use of laser-tissue interactions. IEEE Eng Med Biol Mag. 1989;8(4):10–13. doi: 10.1109/51.45950.</mixed-citation><mixed-citation xml:lang="en">Vin F. Esthetic treatment of varicosities. Rev Prat. 2000;50(11):1204–1207. Available at: https://pubmed.ncbi.nlm.nih.gov/11008501/</mixed-citation></citation-alternatives></ref><ref id="cit294"><label>294</label><citation-alternatives><mixed-citation xml:lang="ru">Vigo R.L., Premoli J. Removal of periocular eyelid veins by ambulatory phlebectomy with a regular crochet hook. Ophthalmic Plast Reconstr Surg. 2012;28(3):219–220. doi: 10.1097/IOP.0b013e318249d420.</mixed-citation><mixed-citation xml:lang="en">Vitale-Lewis V.A. Aesthetic treatment of leg veins. Aesthet Surg J. 2008;28(5):573–583. doi: 10.1016/j.asj.2008.06.006.</mixed-citation></citation-alternatives></ref><ref id="cit295"><label>295</label><citation-alternatives><mixed-citation xml:lang="ru">Vin F. Esthetic treatment of varicosities. Rev Prat. 2000;50(11):1204–1207. Available at: https://pubmed.ncbi.nlm.nih.gov/11008501/</mixed-citation><mixed-citation xml:lang="en">von Soest T., Kvalem I.L., Roald H.E., Skolleborg K.C. The effects of cosmetic surgery on body image, self-esteem, and psychological problems. J Plast Reconstr Aesthet Surg. 2009;62(10):1238–1244. doi: 10.1016/j.bjps.2007.12.093.</mixed-citation></citation-alternatives></ref><ref id="cit296"><label>296</label><citation-alternatives><mixed-citation xml:lang="ru">Vitale-Lewis V.A. Aesthetic treatment of leg veins. Aesthet Surg J. 2008;28(5):573–583. doi: 10.1016/j.asj.2008.06.006.</mixed-citation><mixed-citation xml:lang="en">Weiss M.A., Hsu J.T.S., Neuhaus I., Sadick N.S., Duffy D.M. Consensus for sclerotherapy. Dermatol Surg. 2014;40(12):1309–1318. doi: 10.1097/DSS.0000000000000225.</mixed-citation></citation-alternatives></ref><ref id="cit297"><label>297</label><citation-alternatives><mixed-citation xml:lang="ru">von Soest T., Kvalem I.L., Roald H.E., Skolleborg K.C. The effects of cosmetic surgery on body image, self-esteem, and psychological problems. J Plast Reconstr Aesthet Surg. 2009;62(10):1238–1244. doi: 10.1016/j.bjps.2007.12.093.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Ramelet A.-A. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg. 2002;28(1):43–45. doi: 10.1046/j.1524-4725.2002.01189.x.</mixed-citation></citation-alternatives></ref><ref id="cit298"><label>298</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss M.A., Hsu J.T.S., Neuhaus I., Sadick N.S., Duffy D.M. Consensus for sclerotherapy. Dermatol Surg. 2014;40(12):1309–1318. doi: 10.1097/DSS.0000000000000225.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Sadick N.S. Epidermal cooling crystal collar device for improved results and reduced side effects on leg telangiectasias using intense pulsed light. Dermatol Surg. 2000;26(11):1015–1018. doi: 10.1046/j.1524-4725.2000.0260111015.x.</mixed-citation></citation-alternatives></ref><ref id="cit299"><label>299</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Ramelet A.-A. Removal of blue periocular lower eyelid veins by ambulatory phlebectomy. Dermatol Surg. 2002;28(1):43–45. doi: 10.1046/j.1524-4725.2002.01189.x.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Sadick N.S., Goldman M.P., Weiss M.A. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg. 1999;25(2):105–108. doi: 10.1046/j.1524-4725.1999.08180.x.</mixed-citation></citation-alternatives></ref><ref id="cit300"><label>300</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Sadick N.S. Epidermal cooling crystal collar device for improved results and reduced side effects on leg telangiectasias using intense pulsed light. Dermatol Surg. 2000;26(11):1015–1018. doi: 10.1046/j.1524-4725.2000.0260111015.x.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol. 1993;19(10):947–951. doi: 10.1111/j.1524-4725.1993.tb00983.x.</mixed-citation></citation-alternatives></ref><ref id="cit301"><label>301</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Sadick N.S., Goldman M.P., Weiss M.A. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg. 1999;25(2):105–108. doi: 10.1046/j.1524-4725.1999.08180.x.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Early clinical results with a multiple synchronized pulse 1064 NM laser for leg telangiectasias and reticular veins. Dermatol Surg. 1999;25(5):399–402. Available at: https://journals.lww.com/dermatologicsurgery/Abstract/1999/05000/Early_Clinical_Results_with_a_Multiple.12.aspx.</mixed-citation></citation-alternatives></ref><ref id="cit302"><label>302</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol. 1993;19(10):947–951. doi: 10.1111/j.1524-4725.1993.tb00983.x.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Long pulsed dye laser (LPDL) treatment of resistant telangiectatic matting of the legs. Lasers Surg Med 2002;(14 Suppl.):86.</mixed-citation></citation-alternatives></ref><ref id="cit303"><label>303</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Early clinical results with a multiple synchronized pulse 1064 NM laser for leg telangiectasias and reticular veins. Dermatol Surg. 1999;25(5):399–402. Available at: https://journals.lww.com/dermatologicsurgery/Abstract/1999/05000/Early_Clinical_Results_with_a_Multiple.12.aspx.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol. 1990;16(4):333–336. doi: 10.1111/j.1524-4725.1990.tb00044.x.</mixed-citation></citation-alternatives></ref><ref id="cit304"><label>304</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Long pulsed dye laser (LPDL) treatment of resistant telangiectatic matting of the legs. Lasers Surg Med 2002;(14 Suppl.):86.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Treatment of severe post-sclerotherapy hyperpigmentation with Q-switched ruby laser. Lasers Med Surg. 2004;34(16 Suppl.):55.</mixed-citation></citation-alternatives></ref><ref id="cit305"><label>305</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol. 1990;16(4):333–336. doi: 10.1111/j.1524-4725.1990.tb00044.x.</mixed-citation><mixed-citation xml:lang="en">Weiss R.A., Weiss M.A. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol. 1990;16(9):800–804. doi: 10.1111/j.1524-4725.1990.tb01563.x.</mixed-citation></citation-alternatives></ref><ref id="cit306"><label>306</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Treatment of severe post-sclerotherapy hyperpigmentation with Q-switched ruby laser. Lasers Med Surg. 2004;34(16 Suppl.):55.</mixed-citation><mixed-citation xml:lang="en">West T.B., Alster T.S. Comparison of the long-pulse dye (590-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24(2):221-226. doi: 10.1111/j.1524-4725.1998.tb04140.x.</mixed-citation></citation-alternatives></ref><ref id="cit307"><label>307</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss R.A., Weiss M.A. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol. J Dermatol Surg Oncol. 1990;16(9):800–804. doi: 10.1111/j.1524-4725.1990.tb01563.x.</mixed-citation><mixed-citation xml:lang="en">Whiteley M.S., Dos Santos S.J., Fernandez-Hart T.J., Lee C.T.D., Li J.M. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations. Eur J Vasc Endovasc Surg. 2016;51(3):421–428. doi: 10.1016/j.ejvs.2015.11.011.</mixed-citation></citation-alternatives></ref><ref id="cit308"><label>308</label><citation-alternatives><mixed-citation xml:lang="ru">West T.B., Alster T.S. Comparison of the long-pulse dye (590-595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24(2):221-226. doi: 10.1111/j.1524-4725.1998.tb04140.x.</mixed-citation><mixed-citation xml:lang="en">Wiek K., Vanscheidt W., Ishkhanian S., Weyl A., Schöpf E. Selective photothermolysis of superficial varicose veins telangiectasias of the lower extremity. Hautarzt. 1996;47(4):258–263. doi: 10.1007/s001050050411.</mixed-citation></citation-alternatives></ref><ref id="cit309"><label>309</label><citation-alternatives><mixed-citation xml:lang="ru">Whiteley M.S., Dos Santos S.J., Fernandez-Hart T.J., Lee C.T.D., Li J.M. Media Damage Following Detergent Sclerotherapy Appears to be Secondary to the Induction of Inflammation and Apoptosis: An Immunohistochemical Study Elucidating Previous Histological Observations. Eur J Vasc Endovasc Surg. 2016;51(3):421–428. doi: 10.1016/j.ejvs.2015.11.011.</mixed-citation><mixed-citation xml:lang="en">Wienert V., Simon H.P., Böhler U. Angioarchitecture of spider veins: Scanning electron microscope study of corrosion specimens. Phlebologie. 2006;35:24–29. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0037-1622127.</mixed-citation></citation-alternatives></ref><ref id="cit310"><label>310</label><citation-alternatives><mixed-citation xml:lang="ru">Wiek K., Vanscheidt W., Ishkhanian S., Weyl A., Schöpf E. Selective photothermolysis of superficial varicose veins telangiectasias of the lower extremity. Hautarzt. 1996;47(4):258–263. doi: 10.1007/s001050050411.</mixed-citation><mixed-citation xml:lang="en">Willenberg T., Smith P.C., Shepherd A., Davies A.H. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology. 2013;28(3):123–131. doi: 10.1258/phleb.2012.012051.</mixed-citation></citation-alternatives></ref><ref id="cit311"><label>311</label><citation-alternatives><mixed-citation xml:lang="ru">Wienert V., Simon H.P., Böhler U. Angioarchitecture of spider veins: Scanning electron microscope study of corrosion specimens. Phlebologie. 2006;35:24–29. Available at: https://thieme-connect.com/products/ejournals/abstract/10.1055/s-0037-1622127.</mixed-citation><mixed-citation xml:lang="en">Willey A., Anderson R.R., Azpiazu J.L., Bakus A.D., Barlow R.J., Dover J.S. et al. Complications of laser dermatologic surgery. Lasers Surg Med. 2006;38(1):1–15. doi: 10.1002/lsm.20286.</mixed-citation></citation-alternatives></ref><ref id="cit312"><label>312</label><citation-alternatives><mixed-citation xml:lang="ru">Willenberg T., Smith P.C., Shepherd A., Davies A.H. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology. 2013;28(3):123–131. doi: 10.1258/phleb.2012.012051.</mixed-citation><mixed-citation xml:lang="en">Wittens C., Davies A.H., Bækgaard N., Broholm R., Cavezzi A., Chastanet S. et al. Editor’s Choice – Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678–737. doi: 10.1016/j.ejvs.2015.02.007.</mixed-citation></citation-alternatives></ref><ref id="cit313"><label>313</label><citation-alternatives><mixed-citation xml:lang="ru">Willey A., Anderson R.R., Azpiazu J.L., Bakus A.D., Barlow R.J., Dover J.S. et al. Complications of laser dermatologic surgery. Lasers Surg Med. 2006;38(1):1–15. doi: 10.1002/lsm.20286.</mixed-citation><mixed-citation xml:lang="en">Wollina U., Konrad H., Schmidt W-D., Haroske G., Astafeva L.G., Fassler D. Response of spider leg veins to pulsed diode laser (810 nm): a clinical, histological and remission spectroscopy study. J Cosmet laser Ther. 2003;5(3-4):154–162. doi: 10.1080/14764170310017071.</mixed-citation></citation-alternatives></ref><ref id="cit314"><label>314</label><citation-alternatives><mixed-citation xml:lang="ru">Wittens C., Davies A.H., Bækgaard N., Broholm R., Cavezzi A., Chastanet S. et al. Editor’s Choice – Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678–737. doi: 10.1016/j.ejvs.2015.02.007.</mixed-citation><mixed-citation xml:lang="en">Woo W.K., Jasim Z.F., Handley J.M. 532-nm Nd:YAG and 595-nm pulsed dye laser treatment of leg telangiectasia using ultralong pulse duration. Dermatol Surg. 2003;29(12):1176–1180. doi: 10.1111/j.1524-4725.2003.29383.x.</mixed-citation></citation-alternatives></ref><ref id="cit315"><label>315</label><citation-alternatives><mixed-citation xml:lang="ru">Wollina U., Konrad H., Schmidt W-D., Haroske G., Astafeva L.G., Fassler D. Response of spider leg veins to pulsed diode laser (810 nm): a clinical, histological and remission spectroscopy study. J Cosmet laser Ther. 2003;5(3-4):154–162. doi: 10.1080/14764170310017071.</mixed-citation><mixed-citation xml:lang="en">Worthington-Kirsch R.L. Injection sclerotherapy. Semin Intervent Radiol. 2005;22(3):209–217. doi: 10.1055/s-2005-921954. Yiannakopoulou E. Safety Concerns for Sclerotherapy of Telangiectases, Reticular and Varicose Veins. Pharmacology. 2016;98(1–2):62–69. doi: 10.1159/000445436.</mixed-citation></citation-alternatives></ref><ref id="cit316"><label>316</label><citation-alternatives><mixed-citation xml:lang="ru">Woo W.K., Jasim Z.F., Handley J.M. 532-nm Nd:YAG and 595-nm pulsed dye laser treatment of leg telangiectasia using ultralong pulse duration. Dermatol Surg. 2003;29(12):1176–1180. doi: 10.1111/j.1524-4725.2003.29383.x.</mixed-citation><mixed-citation xml:lang="en">Zhang J., Jing Z., Schliephake D.E., Otto J., Malouf G.M., Gu Y.Q. Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study). Phlebology. 2012;27(4):184–190. doi: 10.1258/phleb.2011.010094.</mixed-citation></citation-alternatives></ref><ref id="cit317"><label>317</label><citation-alternatives><mixed-citation xml:lang="ru">Worthington-Kirsch R.L. Injection sclerotherapy. Semin Intervent Radiol. 2005;22(3):209–217. doi: 10.1055/s-2005-921954. Yiannakopoulou E. Safety Concerns for Sclerotherapy of Telangiectases, Reticular and Varicose Veins. Pharmacology. 2016;98(1–2):62–69. doi: 10.1159/000445436.</mixed-citation><mixed-citation xml:lang="en">Zolotukhin I.A., Seliverstov E.I., Shevtsov Y.N., Avakiants I.P., Nikishkov A.S., Tatarintsev A.M. et al. Prevalence and Risk Factors for Chronic Venous Disease in the General Russian Population. Eur J Vasc Endovasc Surg. 2017;54(6):752–758. doi: 10.1016/j.ejvs.2017.08.033.</mixed-citation></citation-alternatives></ref><ref id="cit318"><label>318</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J., Jing Z., Schliephake D.E., Otto J., Malouf G.M., Gu Y.Q. Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study). Phlebology. 2012;27(4):184–190. doi: 10.1258/phleb.2011.010094.</mixed-citation><mixed-citation xml:lang="en">Zuccarelli F. Combination of Aetoxisclerol with Glucose for the Treatment of Varicose Veins and Telangiectasias. In: Negus D., Jantet G., Coleridge-Smith P.D. (eds.). Phlebology ’95. London: Springer; 1995. doi: 10.1007/978-1-4471-3095-6_265.</mixed-citation></citation-alternatives></ref><ref id="cit319"><label>319</label><citation-alternatives><mixed-citation xml:lang="ru">Zolotukhin I.A., Seliverstov E.I., Shevtsov Y.N., Avakiants I.P., Nikishkov A.S., Tatarintsev A.M. et al. Prevalence and Risk Factors for Chronic Venous Disease in the General Russian Population. Eur J Vasc Endovasc Surg. 2017;54(6):752–758. doi: 10.1016/j.ejvs.2017.08.033.</mixed-citation><mixed-citation xml:lang="en">Zolotukhin I.A., Seliverstov E.I., Shevtsov Y.N., Avakiants I.P., Nikishkov A.S., Tatarintsev A.M. et al. Prevalence and Risk Factors for Chronic Venous Disease in the General Russian Population. Eur J Vasc Endovasc Surg. 2017;54(6):752–758. doi: 10.1016/j.ejvs.2017.08.033.</mixed-citation></citation-alternatives></ref><ref id="cit320"><label>320</label><citation-alternatives><mixed-citation xml:lang="ru">Zuccarelli F. Combination of Aetoxisclerol with Glucose for the Treatment of Varicose Veins and Telangiectasias. In: Negus D., Jantet G., Coleridge-Smith P.D. (eds.). Phlebology ’95. London: Springer; 1995. doi: 10.1007/978-1-4471-3095-6_265.</mixed-citation><mixed-citation xml:lang="en">Zuccarelli F. Combination of Aetoxisclerol with Glucose for the Treatment of Varicose Veins and Telangiectasias. In: Negus D., Jantet G., Coleridge-Smith P.D. (eds.). Phlebology ’95. London: Springer; 1995. doi: 10.1007/978-1-4471-3095-6_265.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
